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CHAPTER 1 
INTRODUCTION 
Chapter 1.1 
GENERAL INTRODUCTION 
The increasing costs of public health care urge questions concer-
ning cost-benefit in the medical discipline. Tests performed in 
clinical laboratories are among the main diagnostic aids availa-
ble to physicians. The diversity of these tests and the number of 
patient samples analysed daily have increased enormeously the 
last twenty years as have the costs attendant upon it. In addition 
ever higher levels of reliability of the clinical chemistry inves-
tigations are required. The still growing demand for the assays 
increase the public and governmental interests in the manner in 
which they are carried out [1]. 
In many countries basic standards of operation are set for accep-
table laboratories through legislation. In general these acts re-
quire participation in an 'approved' proficiency testing program 
[2]. As yet no legislation for quality assurance of clinical la-
boratories exists in the Netherlands, and laboratories assess 
their performance on a voluntary base. 
Quality assessment and control have become an integral part of, 
and main topic in clinical chemistry. Quality control is defined 
as "the study of those sources of variation which are the respon-
sibility of the laboratory, and of the procedures used to recog-
nize and minimize them, including all sources which arise within 
the laboratory between the receipt of the specimen and the dis-
patch of the report" [3]. Control of the analytic process is a 
major component of total laboratory quality assurance [4,5]. Pro-
cess control usually is divided into internal and external quali-
ty control. 
Internal qualtty control 
In the internal process control laboratories use most frequently 
control samples with analytes at known target values. Statistics 
concerning this control component yield information about the ac-
ceptability or lack of acceptability of a given analytic run. 
This is a real-time decision process that has a direct impact on 
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patient testing. Subsequent statistical analysis of the control 
results gives information on analytic precision at the concentra-
tion levels of the control materials. 
One of the specific aims of internal quality control stated by 
the IFCC expert panel on nomenclature and principles of quality 
control [6] is to detect undue variation and identify its sources. 
Many error detection procedures have been described most of which 
are based on concepts of Shewhart [7], Levey and Jennings [8] and 
modifications [9,10], the cumulative sum technique [11,12] or ana-
lysis of variance schemes [13,14]. These procedures intend to de-
tect process fluctuations running out of control, thus indicating 
the unacceptability of an analytic run. This information can lead 
to improvement of performance through modifications in equipment, 
method, organization or training. Little attention has been paid 
in literature to the future need of feed-back control to adjust 
for detected deviations [15]. 
A technique for dynamic deviation control of analytic processes 
in the clinical laboratory has been described. It is based on the 
assumption that these systems can be considered as stationary 
first order stochastic processes characterized by time constants 
equal to the length of time of several runs [16]. Sufficient ex-
perimental evidence for this assumption or a practical applica-
tion of the technique has not yet been published. Adjustment of 
results by feed-back control -if such a system can be realized-
may lead to improved within-laboratory variability. The neces-
sity of such improvement and ths issue of allowable analytic va-
riation has been discussed by many autors [1,17,18,19,20,21,22]. 
Three types of laboratory testing situations are of concern in 
considering this variation [22,23]: group screening, individual 
single point· testing, and multiple serial testing of the same 
individual. The total variance is a function of the biological 
and the analytical variance. The biological variance consists of 
a frequently large inter-individual and a usually much smaller 
mtra-mdividual component. The inter-individual biological vari-
ation component is involved only in the first type mentioned 
whereas the intra-individual variation holds for all three types. 
State of the art investigations [20,24,25] indicate that current 
analytic variation does not need to be reduced for most serum 
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constituents if testing concerns group screening. However, reduc-
tion of analytic variance, no matter how slight, will be valuable 
in the other two types of testing. 
A fundamental premise in the use of control sera for quality con-
trol is the assumption of commutability of these sera and patient 
sera. 
This assumption may not be met [6,26]. Differences in behaviour 
between control and patient sera have been demonstrated [27,28,29] 
as well as compatibilities [30,31]. Intervial differences may oc-
cur for lyophilized materials due to lack of homogeneity [32]. 
Yet the use of lyophilized control sera is widespread because of 
the commercial availability, the generally long term stability of 
the specimens, and the practicability in the daily routine of the 
laboratory. Methods to test their suitability have been proposed 
[33]. If used judiciously, lyophilized control sera are believed 
to offer a sound indication of routine performance, particularly 
if concentration levels are at medical decision levels. Material 
of human origin should be prefered to animal sera. However the 
latter is of course more widely available. A particular problem 
in this context are the serum enzymes. Even human control sera 
are mostly spiked with enzyme preuarations of animal origin. 
External quality control 
Lyophilized control sera are also frequently used in interlabora-
tory proficiency testing. Most laboratories have adopted the con-
cept of continuous comparison of results between laboratories in 
one or more external quality control programs. A more exact term 
for such type of testing is 'quality assessment program' since no 
real-time control actions can be incorporated in it. In fact the 
purpose of these surveys is to assess the internal quality con-
trol programs of the participating laboratories and to compare 
results amoung them. The participation to external quality assess-
ment programs is stressed by professional as well as governmental 
authorities, to further the interchangeability of patient data 
from one hospital to another. To achieve this purpose laborato-
ries should adjust or modify their analytic procedures in such a 
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manner that the interlaboratory variance, observed in the exter-
nal programs, is minimized. Two types of interlaboratory compari-
son are presently widely used. In the first type samples from se-
rum pools are provided to laboratories a few or several times each 
year [2,34,35,36], and each laboratory analyzes only one sample 
from each pool. In the second type laboratories are provided with 
a number of samples from one or two pools and analyze these over 
a prolonged period of time [37,2], which may extend to one or two 
years. In these quality assessment programs results of individual 
laboratories are compared to target values. To establish these 
target values three aooroaches can be used. The first approach is 
to establish the concentration of analytes by the method of manu-
facture [38]. An accurately weighted amount of pure analyte is 
added to a matrix material. The strategy has not been widely used 
because of practical difficulties: many analytes are already pre-
sent in the serum matrix, and attempts to remove them may change 
the matrix for the analyte of concern or have secondary effects 
on other analytes. Other analytes cannot be removed at all. 
The second approach is to establish values before distributing the 
samples. In this strategy the validity of the concentration values 
will depend on the choice of analytical methods and the protocols 
used for measurement. So called definitive methods have been de-
veloped [39,40] providing the closest estimate to the true value 
independent of the matrix. The technology is expensive and has 
been applied only to inorganic and a few organic analytes. Refe-
rence methods have been proposed for many analytes [41,42,43]. 
In an interlaboratory trial of the reference method for calcium 
in serum, problems associated with such methods were investigated 
[44]. It was concluded that it was not possible to guarantee the 
accuracy of the reference method on the base of a strictly defined 
protocol alone. The incorporation of reference control materials 
appeared to be essential. Moreover, to obtain an acceptably accu-
rate and precise value computation of a consensus value from the 
results of a substantial group of laboratories appeared necessary. 
Neither definitive nor reference methods are used commonly for pro-
viding target values. 
The third approach is the use of participant results. This stra-
tegy has been the most widely used. Consensus target values have 
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been demonstrated to be closely repeatable when they are based on 
the work of hundreds of laboratories [45]. In addition to this, 
comparison with definitive values showed that consensus values can 
be accurate and the accuracy can be maintained over a period of 
years [31]. The accuracy depends on the employment of accurate me-
thods by the participants or at least absence of methods showing 
comparable bias by many laboratories [46]. The distribution of in-
dividual results around the consensus value may be non-normal. For 
instance two peakes can be expected in the analysis of choleste-
rol when enzymatic and non-enzymatic methods are included. In this 
case computation of two consensus values can be more practical 
than calculation of one such value. Laboratories should minimize 
their bias from the consensus value, even so when the true value, 
or the relation between it and the consensus value, is not known. 
Only then will patient results be interchangeable between labora-
tories. The fact that the consensus value for many analytes tends 
to be very accurate is an additional chance. The problem is much 
more complicated for serum enzymes. The interlaboratory variance 
for these analytes is enormous [47,48,49,50,51], and the consen-
sus mean seems to be of no value unless rigorous standardisation 
of methodology is introduced [52,53,54,55,56,57]. 
The two types of interlaboratory quality assessment programs in 
which laboratories are provided with one samóle of a pool, respec-
tively with serverai samples of a pool both provide information 
concerning accuracy. In addition the second type can provide in-
formation on precision. Scoring systems have been proposed for 
both performance characteristics to facilitate the interpretation 
of survey results for the individual participants [34,35,58]. 
Systems providing a single index combining inaccuracy and impre-
cision should be rejected [58,59], since no differentiation is 
made between measuring precisely but systematically different from 
the target value, and measuring imprecisely but on the average not 
different from the target value. The quality assessment programs 
in which participants analyse a control serum over a prolonged 
period of time yield more information about laboratory performance 
than the other type of external proficiency testing. However the 
additional workload in the former programs is substantially lar-
ger than in the latter. For this reason laboratories often use 
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these programs as (an integral part of) their internal quality 
control programs. This may flatter the laboratory performance in 
the periodical reports. As stated, the sera in these programs are 
often used for more than one year. After possible adjustments of 
equipment the laboratory performance may seem satisfactory from 
the results of the program. However the use of the same serum for 
both internal and external control may obscure matrix susceptibi-
lity of the applied methods. Moreover the technicians become fa-
miliar with the results, which influences the precision. Use of 
different sera for internal control and external assessment of it 
is necessary therefore. An additional advantage is the quality 
assessment of control sera themselves. From the data bases of sur-
veys the quality of control sera can be compared [32,60,61]. Sera 
that have been proven to be stable and homogeneous can be used 
for internal control. Moreover the consensus values established 
in the surveys can be adopted as reference points. 
Goals of external quality assessment and internal quality control 
programs are the improvement of between-laboratory and withm-
laboratory analytical variability. To offer laboratories the pos-
sibility of selecting the best current methods, attempts have 
been made to evaluate analytical methods m clinical laboratories 
under conditions identical to those for testing patient specimens, 
analysing data bases of interlaboratory survey's [62,63,64,65,66, 
67]. The information given in these investigations usually is 
difficult to interpret. Comparisons of the performance characte-
ristics of the various methods are often hard to make. In general 
the relevance of the various performance characteristics cannot 
be determined. Therefore objective techniques to distinguish rou-
tine analytical methods and to obtain information about their 
reliability are needed [68,69,15]. 
In this thesis an investigation to the solution of some of the 
problems mentioned is described. In the next section objectives 
and strategy of investigation are given. 
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Chapter 1.2 
OBJECTIVES AND STRATEGY OF THE INVESTIGATION 
Professional external quality assessment surveys for clinical 
chemistry laboratories in the Netherlands are organized by the 
Foundation for Quality Control in Clinical Chemical Hospital La-
boratories (Stichting Kwaliteitsbewaking Klinisch Chemische Zie-
kenhuislaboratona-SKZL) . About 90% of all clinical chemistry la-
boratories m the Netherlands participate at present in the exter-
nal chemistry program of the SKZL [1]. This is a proficiency tes-
ting program in which participants analyse two lyophilized sera 
on 24 analytes six times a year. From the results of this program 
indications are obtained on laboratory performances. However the 
need of a more sophisticated and comprehensive program was felt. 
The present investigation was started therefore. 
The objectives of this investigation are the following: 
- introduction of an external program designed to assess both in-
terlaboratory and mtralaboratory performance. 
- development of a technique to assess objectively routine analy-
tical methods. 
- indication of ways to reduce interlaboratory analytical varia-
bility 
- development of procedures to reduce mtralaboratory analytical 
variability. 
To assess interlaboratory and mtralaboratory performance a cou-
pled external/internal quality control program was designed and 
introduced in the Netherlands. The program yields detailed infor-
mation about the efficiency of the internal quality control pro-
grams of the participants. To prevent habituation of technicians 
to values, and to be able to detect matrix [2] susceptibilities, 
sera of different origin and/or manufacturer are used in each 
survey period. The program is based on proposals of Limonard [3]. 
The statistical methods used in the program, the computation of 
target values and target standarddeviations, the scoring systems 
for participant means and standarddeviations, and results of the 
first trials are presented in Chapter 2. A special application of 
the program in a trial for the determination of serum enzymes is 
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also described in Chapter 2. The extreme interlaboratory varia-
tions in determinations of serum enzymes are a well known problem. 
As stated, attempts to reduce this variance mainly concentrate on 
standardization of methodology. A trial was organized to investi-
gate application of enzyme standard preparations to reduce the 
interlaboratory variability in comparison with standardization of 
methodology. 
Reduction of the variability between laboratories for other ana-
lytes may be achieved by the detection of those routine analyti-
cal methods showing a significant bias and subsequent dissuading 
the use of these methods. Intralaboratory performance may be im-
proved when methods having high imprecision or other bad perfor-
mance characteristics are recognized and their use disapproved. 
In contrast analytical methods, satisfying the conditions set, 
should be recommended. A technique for the objective assessment 
of routine analytical methods is presented in Chapter 3. The 
technique utilizes results from the coupled external/internal 
quality assessment program, and is based on pattern recognition 
procedures. In Chapters 3.1 and 3.2 the statistical methods used 
are described as well as examples to illustrate the possibilities 
of the technique. In Chapter 3.3 results are given applying va-
lues obtained for seven analytes in twelve trials of the exter-
nal/internal program. 
A second way to improve intralaboratory performance is presented 
in Chapter 4. In this chapter the problem of reducing the analy-
tical imprecision of the methods in use in a laboratory is dealt 
with. Installing of even the best current analytical method is 
no absolute guarantee for a satisfying laboratory performance. 
Besides, installation of a new method may be too expensive, not-
withstanding an insufficient precision of the method in use. Di-
gital filtering techniques are presented to reduce the within la-
boratory variance. 
The basic premise for the filtering procedures is the postulation 
of a model describing the analytical processes. In this model the 
processes are assumed to be non-stationary stochastic, characte-
rized by a between-run variance component which is significantly 
greater than the within-run variance component. In Chapter 4.1 a 
simple exponential low-pass filter is described and results apply-
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ing i t in t h e d e t e r m i n a t i o n of s i x serum a n a l y t e s in four funda­
m e n t a l l y d i f f e r e n t a n a l y t i c a l sys tems a r e g i v e n . In C h a p t e r s 4.2 
and 4.3 t h e o r y and r e s u l t s a r e p r e s e n t e d of a more s o p h i s t i c a t e d 
Kalman-l ike f i l t e r . The main advantage of t h i s f i l t e r i s t h e p o s ­
s i b i l i t y t o extend i t t o more c o m p l i c a t e d models i n c l u d i n g for 
i n s t a n c e a d d i t i o n a l w i t h m - r u n d r i f t p a r a m e t e r s . 
The g e n e r a l c o n c l u s i o n s , drawn from t h i s i n v e s t i g a t i o n , he ld un­
der t h e a u s p i c e s of t h e S t i c h t i n g K w a l i t e i t s b e w a k i n g K l i n i s c h 
Chemische Z i e k e n h u i s l a b o r a t o r i a , a r e g iven in Chapter 5. 
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CHAPTER 2 
INTERLABORATORY QUALITY ASSESSMENT 
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Chaoter 2.1 
A COUPLED EXTERNAL/INTERNAL QUALITY CONTROL PROGRAM FOR CLINICAL 
LABORATORIES IN THE NETHERLANDS 
Rob T.P. Jansen and Ad P. Jansen 
Clinica Chimica Acta, 107 (1980) 185-201 
Summary 
A coupled external/internal quality control program in the Nether-
lands is discussed. The statistics used in the program are consi-
dered. These are based on an analysis of variance scheme with re-
plicates. The "reference" values, that are computed, are very 
similar to the values obtained with the best analytical methods. 
Tntroduatbon 
The investigations of Limonard [1,2] suggest that clinical chemi-
cal analyses can be considered as time variant processes to which 
a dynamic deviation control can be applied. A first step to such 
a control system is a coupled external/internal quality control 
program, based upon an analysis of variance scheme. 
The participants of the national external quality control program 
[3] wanted a more extensive program than the present one, and a 
combination of external and internal quality control was asked for. 
For these reasons and to test the theoretical considerations of 
Limonard in practice it was decided to set up a quality control 
program based upon his results. 
For this purpose a computer program was written to allow statisti-
cal analysis of data submitted by laboratories, based on analysis 
of a provisional maximum of 11 components in a lyophilized commer-
cial control serum five times per week for eight weeks. After each 
period of eight weeks the results were processed by a computer and 
printed out. The most important features of this program are the 
detection of: (a) systematic differences between the participating 
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laboratories; (b) time effects that hold for a large group of par-
ticipants; (c) time effects in the results of individual labora-
tories; (d) residual effects. 
All of these effects contribute to the total variance of the sub-
mitted data. To establish a "reference" value for a given compo-
nent and its standard deviation, influenced only by residual fac-
tors, results from laboratories causing a significant contribution 
to the total variance due to one of the other effects are removed 
in a second and third computer run. All laboratories receive 
scores for the mean value as well as for the standard deviation 
of each serum component, after conroanson with the "reference" 
values and standard deviations. If their laboratories are opera-
ting satisfactorily the oarticipants should meet three criteria: 
(1) no removal of results; (2) a bias score of 9 or 10; (3) a 
standard deviation score of 9 or 10. 
Apart from these features the program also offers the possibility 
of judging the merits of the various analytical methods. 
This paper discusses the statistics used in this program and is 
illustrated by examples of computer printouts for chloride. In 
addition the results from four trials are presented. 
Computational considerations ; statistics and examples of printout 
After an analysis period of eight weeks the participating labor-
atories submit the results from a provisional maximum of 11 serum 
components: sodium, potassium, calcium, chloride inorganic, 
phosphate, urea, creatinine, urate, cholesterol, glucose 
and total protein; the results from the determination of choles-
terol are subdivided into chemical analytical methods and enzym-
atic analytical methods. 
Analysis of variance table 
The program is based upon a two-way analysis of variance with 
replicates. The two variables are time and laboratories. This an-
alysis of variance allows detection of sources of error that might 
contribute to the total variance of all results obtained for a 
given serum component. These possible sources of error are 
(Table 1): (a) between laboratory or systematic interlaboratory 
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TABLE 1 
EXAMPLE OF THE UNCORRECTED PRINTOUT; ANALYSIS OF VARIANCE TABLE (Variables: 
laboratories and time. MSX, mean square of source of variation X; MSRES, mean 
square of residual; SG, significant.) 
CHLCmiDE (MMOL/L) 
ANALYSIS Ol· VARIANCE ΓΑΒΓE 
KURT05ISTEST В2- 1 2^ 
SOlIRCl· OF SUM OF DEGREtS OF MEAN FCOMPVTED 
VARIATION (X) SQUARES FREEDOM SQUARE M^X/MSRES 
BETWEEN 4Û23 9a 
LABORATORIES 
BETWEEN 37.11 
WEEKS 
INTERACTION 1135 44 275 
RESIDUAL 1808 66 12Θ4 
m is 
s 30 
4 . 1 3 
1 41 
61 6П 
JÍSGM 
J 76 
use* 
2 91 
»SGx 
VARIANCE OF BETWFEN LABORATORIES IS 55.П OF TOTAL VARIANCE 
VARIANCE OF BFTWEEN WEEKS IS 0 4* OF TOTAL VARIANCE 
VARIANCE OF INTERACTION IS 12 4% OF TOTAL VARIANCE 
VARIANCE OF RESIDUAL IS 32 U OF TOTAL VARIANCE 
effects; (b) between week or time effects which hold for a large 
group of laboratoies (caused by e.g. instability of a control 
serum); (c) interactions caused by for example a laboratory whose 
measured values increase or decrease with time; (d) residual 
effects such as inter-vial variability of the lyophilized serum, 
the performance of the technician, temperature fluctuations in 
the analytical process, etc. 
In order to test the significance of the effects, the mean square 
are each compared with the mean square of the residual effects in 
a Fisher test at the 95% confidence level! The variances of the 
various effects are conrouted from the mean squares, e.g?: 
BL (MS BL σ )/n.k re s 
where 4SBL is the mean square of the inter-laboratory effects, 
aBL i s t h e v a r i a n c e of the inter- laboratory ef fects , σ2 i s the 
notes added after publication 
1. At present mean squares of between laboratories and between weeks are 
tested versus the interaction meansquare 
2. At present: σ. = 'мо _ ~^ _2 
BL 
(MS - σ . 
BL interaction 
σ~ ì/n.k 
res 
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variance of the residual effects, η is the number of replicates, 
and к is the number of weeks. 
Requirements for application of this analysis of variance are: 
(a) homogeneity of the withm-week variances. A within-week vari­
ance is determined by the variations of the five values of a cer­
tain week of a laboratory with respect to the week-mean for that 
week of that laboratory. These withm-week variances should not 
differ significantly; (b) a kurtosis value of 3.0 + 0.5. 
Homogeneity of variances 
The homogeneity of variances is tested by Cochran's test [4,5] at 
the 99% confidence level. If the ratio of the largest withm-week 
variance to the sum of all variances of all laboratories exceeds 
Cochran's corresponding limit value at the 99% confidence level, 
it is concluded that this variance differs significantly from the 
other variances. The five values pertaining to this particular 
week should not be used in the analysis of variance. Simply re­
moving these values would lead to a nonorthogonal scheme to which 
application of analysis of variance is very complicated. For this 
reason the values are substituted by estimates. For the first 
estimate the overall mean of the laboratory concerned is used. 
Fig. 1. Every cell represents a week with five results from a laboratory. 
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Then the week with the next largest variance is selected and tes­
ted. When this variance differs significantly from the other va­
riances the results for that week of the laboratory concerned are 
temporarily replaced by the overall mean of this laboratory and 
so on, until the largest variance does not differ significantly 
from the other variances. 
To create a working set of results to which analysis of variance 
can be applied the provisional values are replaced by better es­
timates in an iterative procedure (Fig. 1): suppose the five chlo­
ride measurements for two weeks (cells) L.W and L W differed as 
far as their variances were concerned from all other cells. Both 
cells are then temporarily filled with the overall means of the 
respective laboratories. Now seven differences D (j ψ 1) are 
computed from the means of the five values in each cell L.W 
(] φ 1) with respect to the mean of all other cells of the corres­
ponding column ]. 
Next a mean difference D is computed from the seven differences 
D . 
1 
Subsequently the five values in cell L.W are equalized to D plus 
the mean of all other cells of column one. Afterwards an analogous 
procedure is applied to cell L.W . Now that both cells contain 
better estimates, the whole procedure is repeated again for both 
cells to obtain even better ones. 
To take into account the less reliable results in the replaced 
cells in the analysis of variance, the number of degrees of free­
dom of "interaction" (Table 1) is diminished by one per replaced 
cell and the number of degrees of freedom of "residual" by five. 
Kurtosis test 
Kurtosis is a parameter which describes the peaked nature of the 
distribution curve. A study of Snvastava [6] reveals that devi­
ations of kurtosis of a distribution indicate that less reliable 
results are to be expected from the analysis of variance test, 
and this is more important than, for instance, skewness. The 
effect diminishes with increasing sample size. Departures in kur­
tosis of say 3.0 + 0.5 do not diminish the power of the analysis 
of variance test [6]. At kurtosis values outside these limits,the 
interpretation of significant contributing effects m the analysis 
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of variance should be made with reservation especially when rela­
tively small sample size (e.g. less than 200) are considered. 
In the program kurtosis is computed after the test on the homoge-
1 
neity of variances . 
Possible causes of significant effects 
The "reference" value that sets the standard should be governed 
exclusively by the variance of the residual factors. If the con­
tributions of all other sources of variance, which contribute 
significantly to the total variance, are to be diminished it is 
necessary to examine their nature. The causes of significant con­
tributing sources of variance (Table 1) can be demonstrated by 
graphs showing the week-means of the various laboratories (Fig.2). 
Each laboratory is indicated by a code number between 1 and 200. 
A time effect, which holds for a large group of participants (e.g. 
instability of a control serum), will cause a significant between-
weeks effect (Table 1). If between-weeks variance contributes 
noticeably to the total variance (e.g. 5% of more) this effect is 
shown by a slope of the graph of the week-means of the various 
laboratories plotted as a function of time (Fig. 2A, Graph 1). 
When the overall mean values of the laboratories per week are 
plotted versus time, that graph also will be sloping (Fig. 3). 
Removal of the time-dependent (week) component [X = X 
(X - X), where X is the mean value of lab ι in week j , X is 
overall mean of all laboratories in week j, X is the total mean] 
will show a non-sloning picture. In the four trials held up to now 
such an effect was not seen: the proportional contribution of the 
between-weeks variance to the total variance has been less than 
1%. Therefore Graphs 1 and 2 of Fig. 2A are very similar. 
A ^ significant inter-laboratory effect (Table 1) finds expression 
as a broad band of labcodes (Fig. 2, Graph 1). Laboratories at the 
edges of this band are the main causes of the significant mter-
laboratory effect. To select the laboratories which are the main 
causes, scores are given to the mean values of the laboratories 
note added after publication 
1. At present kurtosis is not computed anymore .If testing of kurtosis is 
necessary at all, it should be done for the within laboratory distributions 
and not for the overall distribution. 
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GE 10Θ.00 
107.00 
106.00 
105.00 
104.00 
103.00 
102.00 
101.00 
100.00 
99.00 
9Θ.00 
97.00 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
49 
XXX 49 
XXX XXX 
XXX XXX 
XXX XXX 
XXX XXX 
XXX XXX 
XXX XXX 
XXX 
30 
15Θ 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
1Θ9 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
Θ5 
49 
49 
XXX 
XXX XXX 
XXX XXX 
XXX XXX 
XXX XXX 
XXX XXX 
1B4 XXX 
GE 10Θ.00 
107.00 
106.00 
105.00 
104.00 
103.00 
102.00 
101.00 
100.00 
99.00 
98.00 
LE 97.00 
1 
159 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
45 
4Θ 
2 
49 
XXX 
33 
XXX 
XXX 
XXX 
XXX 
XXX 
199 
3 
158 
49 
1S9 
XXX 
XXX 
XXX 
XXX 
XXX 
85 
30 
4 
15Θ 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
199 
5 
158 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
6 
109 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
85 
144 
7 
49 
XXX 
XXX 
XXX 
XXX 
XXX 
XXX 
154 
8 WEEK j 
4 9 
19Э 
XXX 
XXX 
XXX 
XXX 
XXX 
10Θ 
θ WEEK j 
GRAPH D GE 0Θ 00 
07 00 
06 00 
OS 00 
04 00 
03 00 
02 00 
01 00 
00 00 
99 00 
96 00 
97 00 
KXX XXH 
XXX XKX XXX XXX XXX 
HHH XXX XXX XXX XXX KXX XXX 
M-HEEX VAR: 
N-WBEK VAR: 
N-NEEK VAR: 
N-WEEK VAR: 
N-WEEK VAR] 
N-WEEK VAR] 
N-WEEK VAR] 
: N-WEEK VAR] 
WEEK VAR] 
N-WEEK VAR] 
WEEK VAR] 
WEEK VAR] 
OF LABORATORY 
OF LABORATORY 
OP LABORATORY 
OF LABORATORY 
OF LABORATORY 
OF LABORATORY 
OF LABORATORY 
OF LABORATORY 
OF LABORATORY 
OP LABORATORY 
OF LABORATORY 
OF LABORATORY 
1 WAS s : 
49 WAS s : 
5Θ WAS s : 
72 WAS s : 
72 WAS S 
100 WAS S] 
100 WAS S 
100 WAS S 
100 WAS S 
1 3 S WAS S 
ICANTLy 
:CANTLY 
ICANTLV 
:CANTLY 
CANTLY 
:CANTLY 
CANTLY 
:CANTLY 
:CANTLY 
TOO H 
TOO H 
TOO H 
TOO H. 
TOO HI 
TOO H 
TOO HI 
TOO H; 
TOO H: 
TOO H 
TOO H: 
TOO H: 
ICH 
IGH 
IGH 
JGH 
ICH 
ICH 
I C I 
IGH 
IGH 
IGH 
IGH 
ICH 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
N 
WEEK Ì 
WEEK Ì 
HEEK Î 
WEEX ] 
WEfcK 4 
WEEK 2 
WEEK 5 
WEEK 4 
WEEK 6 
WEEK θ 
WEEK 4 
WEEK 5 
al 
a) 
л і 
a) 
ЛІ 
a) 
Λ) 
a) 
Λ) 
a) 
a) 
LAB 25 CORRECTED WEEK-НЕЛЫ OF WEEK Ь IS SIGN 
LAB 4Θ CORRECTED WEEK-HEAN OF WEEK 1 IS SIGN 
LAB 1 0 0 CORRECTED WEEК-MEAN OP WEEK I IS SIGN 
LAB 100 CORHECTm HEEK-HEAN OF WEEK θ IS SIGN 
LAB 15Θ CORRECTO) WEEK-HEAN OF WEEK 3 IS SIGN 
LAB Ι ϊ θ CORRECTED ИЕЕК-МЕЛИ OF WEEK 7 IS SIGN 
LAB 15θ CORRECTFD WEEK-HEAN OP WEEK В I S SIGN 
LAB 162 CORRECTED WEEK-HEAN OP WEEK β I S SIGN. 
LAB 4 S 
TOO UM WITH RESPECT TO THE TOTAL MEAN 
TOO UM WITH RESPECT TO THE TOTAL MEAN 
TOO HIGH WITH RESPECT TO THE TOTAL MEAN 
TOO LOW WITH RESPECT TO THE TOTAL MEAN 
TOO HIGH WITH RESPECT TO THE TOTAL MEAN 
TOO LOW WITH RESPECT TO THE TOTAL MEAN 
TOO LOW WITH RESPECT TO THE TOTAL MEAN 
TOO LOW WITH RESPECT TO THE TOTAL HEAN 
Fig. 2 (A and B). Example of the uncorrected printout. Ciphers are labcodes. 
XXX indicates three or more superposed labcodes. (A) Graph 1: week meens X.. 
of the laboratories; Graph 2: week-means X!. of the laboratories after re-1'' 
moval of the general time component. (B) Graph 3: week-means XV. of the labo­
ratories after removal of the general time and the systematic lib. component. 
(a) Laboratories with too high within-week variances (Cochran's test at the 
99% confidence level). The results of these weeks have been replaced as des­
cribed in "Homogeneity of variances", (b) Week-means of laboratories (correc­
ted for general time and systematic lab. component), that deviate significant­
ly from the total mean (significance level is 99%). (c) Laboratories with 
increasing or decreasing values. RC, regression coefficient; CC, correla­
tion coefficient. Significance level of the linear regression is 99%. 
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GRAPH -1 í.t 108 00 
107 00 
106 00 
105 00 
104 00 
103 00 
102 00 
101 no 
100 00 
У9 00 
98 00 
LE 97 00 
Fig. 3. Example of the uncorrected printout. Graph 4: overall week-means X . 
after comparison with an optimal total mean, computed from the 
week-means of the laboratories after removal of the time-depen­
dent component and the systematic inter-laboratory component 
[X" = X' - (X - X), X. is the mean value of lab i]. The scoring 
ID 13 ι ι 
system is based upon the deviation of the mean value of a labor-
atroy from this optimal total mean and expressed in multiples of 
an optimal standard deviation. This optimal standard deviation 
is defined as the square root of the residual variance. Details 
of the scoring system are given in Table 2. 
The causes of a significant interaction effect follow from Fig.2B, 
Graph 3, where the corrected week-means (X" ) of the laboratories 
are plotted as a function of time. This type of effect can occur 
for instance if a laboratory measured systematically significant­
ly higher or lower in one week than in the other weeks (e.g. Fig. 
2, Graph 3: lab 158, weeks 3,7 and 8). 
In order to detect these occurrences, the week-means of each la­
boratory, corrected for the general time component and the sys­
tematic component (X" ), are compared with the total mean in an 
excentricity test (u-test): 
u = (X" - X)/SDI 
i] 
where SDI is the square root of the interaction mean square; u is 
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tested at the 99% confidence level. 
A laboratory, which measured increasing or decreasing values in 
time, also may cause a significant interaction effect. Such a 
trend is described by the regression coefficient. The tangent 
(regression coefficient) of the line through the eight corrected 
week-means of each laboratory is computed by the method of the 
least squares and the accompanying coefficients of correlation 
are determined (Fig. 2B, Graph 3). Also the error of the regres­
sion coefficient is computed. In a t-test at the 99% confidence 
level, the regression coefficient and its error are compared [7]. 
Only the tangents of the lines, which have significant linear re­
gression, are printed. 
TABLE 2 
SCORING SYSTEM FOR THE MEAN VALUES OF THE LABORATORIES AND THE ANALYTICAL 
METHODS 
X is within X + 0.5 S.D. score. 10 
ι — 
X is within X + 1 S.D. score: 9 
ι — 
X is within X + 1.5 S.D. score. 7 
ι — 
X is within X + 2 S.D. score. 5 
ι — 
X is within X + 2.5 S.D. score· 3 
ι — 
X is outside X + 2.5 S.D. score. 0 
X , the mean value of the laboratory or the analytical method. 
, the optimal tota l mean ("uncorrected printout") or the "reference" value 
("corrected" pr intout) . 
S.D., the optimal standard deviation ("uncorrected printout") or the "refe­
rence" standard deviation ("corrected" pr intout) . 
Procedure of removal 
To e s t a b l i s h a " r e f e r e n c e " v a l u e , which i s f r e e of s y s t e m a t i c , 
t ime and i n t e r a c t i o n e f f e c t s , i t i s n e c e s s a r y t o e x c l u d e t h e con­
t r i b u t i o n of t h e s e s o u r c e s of v a r i a n c e d e t e c t e d in t h e f i r s t com­
p u t e r r u n . To a c h i e v e t h i s , t h e r e s u l t s of l a b o r a t o r i e s c a u s i n g 
s i g n i f i c a n t e f f e c t s a r e removed i n a second and sometimes a t h i r d 
computer run. 
Al l r e s u l t s of l a b o r a t o r i e s wi th b i a s - s c o r e s 0 (see Table 2) a r e 
removed. In t h e example (Fig .2) t h e r e s u l t s of l a b o r a t o r i e s 49, 
85 and 144 w i l l be removed for t h i s r e a s o n . As only t h e r e s u l t s 
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of laboratories with extreme scores are removed, a considerably 
significant inter-laboratory effect is noticed m the second com-
puter run as well as a substantial contribution of the inter-la-
boratory variance to the total variance (Table 3). However, as 
the "reference" value is computed from the corrected week-means 
of the laboratories, this contribution does not influence the re-
sult. To exclude a significant interaction effect, the results of 
individual weeks of laboratories with systematical significantly 
too high or too low corrected values are removed in the second 
computer run. Results of weeks with too high withm-week variance 
are automatically replaced in the program (see "homogeneity of 
variances"). All results of a laboratory are removed if the total 
of weeks with erroneous measurements (too high or too low correc-
ted week-mean or too high within-week variance) of that labora-
tory is more than three. 
Only the results of the weeks with too high or too low corrected 
week-means are removed if the total of weeks with erroneous mea-
surements is less than four. On the basis of Fig. 2B (Graph 3) 
the following results are removed in the second computer run: 
(a) all results of lab 100 (more than three, in fact six weeks, 
with erroneous results); (b) results of weeks 3, 7 and 8 of lab 
158; (c) results of week 5 of lab 25; (d) results of week 8 of 
lab 162. 
Also all results of laboratories with significant linear regres-
sion in their corrected week-means (Fig. 2B, Graph 3: labs 48 and 
103) are removed. In most instances three computer runs are need-
ed to remove results, which turn out to cause a significant inter-
action effect. Even after the corrections in this third or final 
computer run, a significant interaction effect remains. However, 
the cause of this obscure. Table 3 and Fig. 4 show the results 
after the procedure of removal. 
"Reference" value and "reference" standard deviation 
After the procedure of removal, a "reference value is computed in 
the final computer run from the week-means of the laboratories 
after correction for general time-effects and systematic effects. 
As long as the true value is not known, this "reference" value 
is used to attribute scores to the mean values of the laborato-
28 
TABLE 3 
EXAMPLE OF THE CORRECTED PRINTOUT (PRINTOUT AFTER REMOVAL OF THE MAIN CAUSES 
OF SIGNIFICANT CONTRIBUTING EFFECTS): ANALYSIS OF VARIANCE TABLE (Variables: 
laboratories and time. MSX, mean square of source of variation X; MSRES, mean 
square of residual; SG, significant; NS, non significant). 
CHLÜHIDf (MM0L/L1 KURTOSISTEST S.'- 3.C5 
ANALYSIS OF VARIANCE TABLE 
SOURCE OF SUM OF DEGREES OF MEAN FCOMPUTED 
VARIATION (X) SQUARES FREEDOM SQUARE MSX/MSRFS 
BETWEEN 
LABORATORI E- S 
BETWEEN 
WEEKS 
INTERACTION 
RESIDUAL 
2J0S. 
15. 
5П6. 
1403. 
.Bt 
.00 
,93 
.89 
52 66 
KSGH 
1.96 
»SG» 
VARIANCE OF BETWEEN LABORATORIES IS 51 94 OF TOTAL VARIANCE 
VARIANCE OF BETWEEN WEEKS IS 0 24 OF TOTAL VARIANCE 
VARIANCE OF INTERACTION IS 7 7% OF TOTAL VARIANCF 
VARIANCI OF RESIDUAL 1^ 40.2* OF TOTAL VARIANCF 
Note: The F-computed values for a l l t h r e e sources of variance have become 
smaller and the r e l a t i v e percentage c o n t r i b u t i o n to the t o t a l var iance of the 
r e s i d u a l variance i s l a r g e r compared t o t h a t in Table 1. This i n d i c a t e s t h a t 
the e l iminat ion procedure has been appl ied in a c o r r e c t way. 
r i e s . Now, f i n a l s c o r e s a r e g iven based on t h e number of " r e f e ­
r e n c e " s t a n d a r d d e v i a t i o n s d e v e r g i n g from t h e " r e f e r e n c e " v a l u e 
(Table 2 ) . The " r e f e r e n c e " s t a n d a r d d e v i a t i o n e q u a l s t h e s q u a r e 
r o o t of t h e r e s i d u a l v a r i a n c e , which i s de termined merely by r e ­
s i d u a l f a c t o r s . Scores a r e a l s o g iven t o t h e s t a n d a r d d e v i a t i o n s 
of t h e l a b o r a t o r i e s . The s c o r i n g system i s d e f i n e d in a way t h a t 
re sembles a c o n t r o l l a b i l i t y f a c t o r [ 1 , 2 ] : 
2 2 ? 
l a b r e f l a b 
2 
where ^1аЪ is the squared standard deviation of the laboratory 
concerned; tf
ref is the squared "reference" standard deviation. 
The scoring system is described in Table 4. 
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WITH1N-WEEK VARIANCE OF [.ABORATORY Ì WAS Ы С М І П С А Г Л Ъ TOO HIGH IN HVEX > '¿ 
WITH1N-WEEK VARIANCE OF LABORATORY 5S WAS SIGNIFICANTLY TOO HIGH IN WEEK I (¿ 
WITHIN-WIEK VARIANCE OF LABORATORY 72 WAS S I G N I U C A m X Y ΓΟΟ HIGH IN WEEK 1 !г 
WITHIN-WEEK VARIANCE OF LABORATORY 72 WAS S I G N I U C A N T L Y ПХ> HIGH IN WEEK 4 (i 
WITHIN-WEEK VARIANCE OF LABORATORY 125 WAS SIGNIFICANTLY TOO HIGH IN WEEK 2 >. 
WITHIN-WEEK VARIANCE OF LABORATORY 125 WAS SIGNIFICANTLY TOO HIGH IN WEEK β (¿ 
Fig. 4 Example of the corrected printout. Ciphers are labcodes. XXX indicates 
three or more superposed labcodes. Graph 1: week-means X. of the laboratories; 
(Graph 2 is omitted because of the similarity with Graph 1). Note: labcodes 
49, 85 and 144 have disappeared (compare Fig. 2); Graph 3: week-means X'.'. of 
the laboratories after removal of the general time and the systematic lab. 
component, (a) Weeks of laboratories with too high within-week variance. The 
results of these weeks have been replaced as described in Homogeneity of va-
riances. Note: labcodes 48, 100, 158, 25 and 162 have disappeared (compare 
Fig. 2). 
A n a l y t i c a l methods 
To demons t ra t e whether e r roneous r e s u l t s of l a b o r a t o r i e s could be 
caused by t h e a n a l y t i c a l method used , an a n a l y s i s of v a r i a n c e i s 
performed wi th t he v a r i a b l e s t ime and a n a l y t i c a l methods. Here an 
a n a l y t i c a l method i s de f ined as t he method as i t i s r eco rded in 
t h e method c o d e s . This method code i s de te rmined by the p r i n c i p l e 
of t h e chemical r e a c t i o n and by t h e i n s t r u m e n t a l methodology (ma-
n u a l , con t inuous f low, d i s c r e t e , c e n t r i f u g a l a n a l y s e r e t c . ) [ 3 ] . 
The t echn ique of t he "unweighted means" [8] i s a p p l i e d t o t h i s 
a n a l y s i s of v a r i a n c e s i n c e some a n a l y t i c a l methods a r e used by 
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TABLE 4 
SCORING SYSTEM FOR THE STANDARD DEVIATIONS OF THE LABORATORIES AND THE ANALY­
TICAL METHODS 
У = 
0 
0.1 
0.2 
0 .3 
0.4 
0 .5 
0.6 
0.7 
0 .8 
0 .9 
( α 2 
1 
< 
< 
< 
< 
< 
< 
< 
< 
< 
< 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
У 
-
< 
< 
< 
< 
< 
< 
< 
< 
< 
< 
< 
Ί^Ι 
0 
0 . 1 
0.2 
0 . 3 
0 .4 
0 .5 
0.6 
0.7 
о. 
0.9 
1.0 
score : 
score 
score : 
score : 
score· 
score: 
score : 
score : 
score : 
score: 
score : 
10 
9 
8 
7 
6 
5 
4 
3 
2 
1 
0 
σ . the squared standard deviation of the laboratory or analytical method. 
1
σ ,_, the squared optimal standard deviation ("uncorrected" printout) or f ' 
the squared 
' re ference" standard dev ia t ion ("corrected" p r i n t o u t ) 
TABLE 5 
EXAMPLE OF THE UNCORRECTED PRINTOUT; ANALYSIS OF VARIANCE TABLE (Variables: 
analytical methods and time. MSX, mean square of source of variation X; MSRES, 
mean square of residual; SG, significant, NS, non significant). 
CHLORIDE (MHOL/L) 
ANALYSIS OF VARIANCE TABLE 
SOURCE OF SUM OF DEGREES OF MEAN FCOMPUTED 
VARIATION (X) SQUARES FREEDOM S5UARE MSX/MSRES 
BETWEEN 
METHODS 
BETWEEN 
WEEKS 
INTERACTION 
RESIDUAL 
1132 
14 
125 
o j i a 
13 
64 
30 
37 
2Θ3 03 70 78 
xSCli 
VARIANCE OF BETWEEN METHODS IS 44 3% OF TOTAL VARIANCE 
VARIANCE OF BETWEEN WEEKS IS 0 0* OF TOTAL VARIANCE 
VARIANCE OF INTERACTION IS 2 0» OF TOTAL VARIANCE 
VARIANCE OF RESIDUAL IS 53 7» OF TOTAL VARIANCE 
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16 
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Fig. 5 (A and B). Example of the uncorrected printout. Ciphers are method co­
des. (A) Graph 5: week-means X . of the analytical methods. Graph 6: week-
means X' of the analytical methods after removal of the general time compo­
nent. ПО (B) Graph 7: week-means X of the analytical methods after remo­
val of the general time and the systematic method component. 
more participants than others, and this causes the cell frequen­
cies (number of observations per week per method) not to be equal 
for all cells. 
The homogeneity of variances does not need to be tested again: 
e.g. if laboratories using the same analytical method show a sys­
tematical bias, the residual mean square could be significantly 
larger than for example the mean square of "interaction" (Table 5) 
This indicates non-homogeneity of variances and no conclusions 
may be drawn from the analysis of variance other than that labor­
atories using a certain analytical method showed a significant 
32 
bias. 
The computations and interpretations are analogous to the analysis 
of variance with the variables time and laboratories (see Table 5 
and Fig. 5). 
Table 6 and Fig. 6 show the results for the analytical methods 
after the removal of results of laboratories causing significant 
effects. Scores are also given to the mean values of the various 
analytical methods. These mean values are computed from the mean 
values of all laboratories using the same analytical method (see 
Table 7). 
TABLE 6 
EXAMPLE OF THE CORRECTED PRINTOUT; ANALYSIS OF VARIANCE TABLE (Variables: ana­
lytical methods and time; MSX, mean square of source of variation X; MSRES, 
mean square of residual; SG, significant; ΝΞ, non significant). 
CHLORIDE (MMOL/L) 
ANALYSIS OF VARIANCE TABLE 
SOURCE OF SUM OF DEGREES OF MEAN FCOMPUTED 
VARIATION (X) SQUARES FREEDOM SQUARE MSX/MSRES 
BETWEEN 
METHODS 
BETWEEN 
WEEKS 
INTERACTION 
RESIDUAL 
371 
19 
68 
4036 
97 
54 
76 
96 
41 10 
HSGH 
1 23 
NS 
VARIANCE OF BETWEEN METHODS IS 29 1% OF TOTAL VARIANCE 
VARIANCE OF BETWEEN WEEKS IS 0 0% OF TOTAL VARIANCE 
VARIANCE OF INTERACTION IS 1 3% OF TOTAL VARIANCE 
VARIANCE OF RESIDUAL IS 69 6% OF TOTAL VARIANCE 
Note: The relative percentage contribution to the total variance of the vari­
ance between methods has become less. That of the interaction effects has be­
come less. That of the residual effects has become larger (compare Table 5). 
The scoring system i s the same as t h a t described in Table 2. The 
standard deviat ions of the various a n a l y t i c a l methods are compu­
ted from the equation: 
, 2 2 2 
2 φ 1 Ξ 1 + * 2 S 2 + ·•· * i S i 
s = 
1 + φ 2 + • · · *
 1 
33 
where ψ., φ 2 — are the numbers of accepted results minus 1 for 
each laboratory 1,2, ... that applies the analytical method under 
2 2 
consideration, s , s , ... are the variances of these laboratories. 
Thus the standard deviation of an analytical method is not influ­
enced by systematic differences between the laboratories. Scores 
also are given to the standard deviations of the various analyti­
cal methods (see Table 7). The scoring system is the same as the 
system described in Table 4. 
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Fig. 6 (A and В). Example of the corrected printout. Ciphers are method codes. 
(A) Graph 5: week-means X . of the analytical methods. Graph 6: week-means X'. 
of the analytical methods after removal of the general time component. Note: 
method code 35 has disappeared (compare Fig.5). This method was used by only 
one participant of which all results had been removed. In such a case no con­
clusions can be drawn of course with respect to the analytical method. (B) 
Graph 7: week-means X". of the analytical methods after removal of the gene­
ral time and the systematic method component. 
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TABLE 7 
EXAMPLE OF PRINTOUT OF INDIVIDUAL RESULTS 
Chloride (mmol/l) 
Your Mean Value: 102.90 Your Standard deviation. 0.96 Your Method. 32 
Number of Participants for this determination: 35 
"Reference" Value: 102.80 "Reference" Standard deviation: 1.14 
All your results for this serum component have been removed from the computa­
tions (see "uncorrected" printout for the reason of the removal) (a) 
Your within-week variance was significantly too high in week... . Your 
values of this week have been replaced in the analysis of variance. (a) 
Your results of week... for this determination have been removed from 
all computations (see "uncorrected" printout for the reason of the 
removal) (a) 
In t h i s d e t e r m i n a t i o n none of your r e s u l t s h a s been r e p l a c e d o r removed (a) 
S c o r e f o r Your Mean V a l u e : 10 Mean B i a s s c o r e f o r a l l p a r t i c i p a n t s : 7 . θ 
S c o r e f o r Your S t a n d a r d d e v i a t i o n : 10 Mean S t a n d a r d d e v i a t i o n s c o r e 7 . 7 
Method: 31 N 
Method. 32 N 
Method 33 N 
Method: 36 N 
2. Mean V a l u e : 
24 . Mean Value 
8. Mean V a l u e : 
1. Mean Value : 
101.74 B i a s s c o r e · 9 S.D. 
102.85 B i a s s c o r e 10 S.D. 
102.73 B i a s s c o r e : 10 S.D. 
104.45 B i a s s c o r e : 7 S .D. 
1.22 S .D. s c o r e : 8 
1.38 S.D. s c o r e : б 
1.10 S.D. s c o r e : 10 
1.43 S .D. s c o r e 6 
N, number of p a r t i c i p a n t s 
( a ) : Any one o r more of t h e s e s e n t e n c e s can a p p e a r i n t h e c a s e of a r e p l a c e ­
ment or r e m o v a l . 
Results and discussion 
About 45 l a b o r a t o r i e s p a r t i c i p a t e d i n t h e f o u r s u r v e y s u s e d i n 
t h i s i n v e s t i g a t i o n . I n e v e r y t r i a l a d i f f e r e n t l y o p h i l l z e d c o n ­
t r o l s e r u m of c o m m e r c i a l o r i g i n was u s e d . A d v a n t a g e s of t h i s p r o ­
c e d u r e a r e t h e p o s s i b i l i t y of t e s t i n g s e r a f o r t h e i r q u a l i t y ( h o ­
m o g e n e i t y , s t a b i l i t y ) and t h e f a c t t h a t i t i s i m p o s s i b l e f o r t h e 
t e c h n i c i a n s t o become f a m i l i a r w i t h t h e r e s u l t s of t h e a n a l y s i s . 
Once t e s t e d , t h e s e r a c a n b e u s e d by t h e l a b o r a t o r i e s f o r i n t e r ­
n a l c o n t r o l . 
One of t h e r e q u i r e m e n t s f o r a p p l i c a t i o n of t h e a n a l y s i s of v a r i ­
a n c e , upon w h i c h t h e p r o g r a m i s b a s e d , i s h o m o g e n e i t y of w i t h i n -
week v a r i a n c e s . On t h e a v e r a g e 3% of t h e c e l l s (week of a l a b o r ­
a t o r y w i t h f i v e r e s u l t s ) a r e r e p l a c e d i n t h e f i n a l c o m p u t e r r u n . 
I n t h e p r i n t o u t i t i s i n d i c a t e d w h i c h w e e k s and w h i c h l a b o r a t o r i e s 
had t o o l a r g e w i t h m - w e e k v a r i a n c e s ( F i g . 2 a n d 4 and T a b l e 7 ) . 
35 
The other requirement, a kurtosis value between 2.5 and 3.5, is 
not met for potassium because of "rounding-up" effects. In order 
to reveal abnormalities in the distribution, the printout contains 
a histogram of all results (Fig. 7). 
In the analysis of variance in the final run (Table 3) the compu­
ted F-values are smaller than the computed F-values in Table 1 
(analysis of variance before any removal of results). This indi­
cated that the elimination procedure was applied m the correct 
way. 
CHLORIDE (MMOL/L) KURTOSISTEST B2= 3 27 
GE 111 Э 
110 91 
109 7Θ X 
106 76 X 
107 73 XX 
106 70 XXXXXX 
105 6Θ XXXXXXXXXXXXX 
104 65 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 
103 63 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 
102 60 XXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXXX 
101 57 xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 
100 55 xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 
99 52 xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 
9Θ 50 xxxxxxxxxxxxxxxxxx 
97 47 XX 
96 44 X 
95 42 X 
94 39 
93 37 
LE 92 34 
Fig. 7. Histogram of the distribution of all values of all laboratories after 
testing the homogeneity of withm-week variances. One X depicts five results. 
GE 109 00 
108 00 
107 00 
106 00 
105 00 D 
104 00 CDCCCCGCCC 
103 00 HCDCCDDCC 
102 00 DCCCCDCB 
101 00 DCBCC 
100 00 cc 
99 00 
9Θ 00 
97 00 
96 00 
95 00 
94 00 
93 00 
92 00 
91 00 
LE 90 00 
Fig. Θ. Histogram of the mean values of the participants. The astenx indica­
tes "Your mean value". The letters denote the analytical method used by other 
participants: method 31 = B, 32 = C, 3 3 = D , etc. 
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Laboratory performances should be such that the only contributing 
factors to the total variance are the residual factors (Table 3). 
At present, after the procedure of removal, the mter-laboratory 
variance contributes on the average about 50% to the total vari-
ance and the residual variance about 40%. For potassium, the sys-
tematic differences between the laboratories are smaller. Here 
inter-laboratory variance contributes about 40% and residual va-
riance about 50%. The systematic differences between the analy-
tical methods are smaller: in the analysis of variance with va-
riables time and analytical methods (Table 6) it appears that the 
residual factors contribute on the average 70% of the total va-
riance. 
To reveal systematic differences between the laboratories and be-
tween the analytical methods, the printout contains a histogram 
of the mean values of all laboratories. "Your mean value" is in-
dicated by an astenx. The mean values of the other participants 
are given by a letter indicating the analytical method used (Fig. 
8). 
If any values of a laboratory have been removed, this in indica-
ted on its individual printout (Table 7). This laboratory also 
receives an "uncorrected" printout from which the values have not 
been removed. From the analysis of variance with variables time 
and laboratories m combination with the analysis of variance 
with variables time and analytical methods, it can be determined 
whether erroneous results could be caused by the analytical me-
thod itself or by the way the particular laboratory uses it. Of 
course it is necessary that the analytical method is used by many 
participants to be able to draw this conclusion. The computed 
"reference" value seems to be a good approximation to the true 
value. In one of the surveys, a serum was used which was analysed 
partially by (semi) definitive methods (Seronorm batch 136). The 
"reference" values for calcium and glucose were within 2% of the 
definitive values and the "reference" values for sodium, potas-
sium and chloride were within 1% of the definitive values. 
(Table 8). For the other constituents only "recommended values" 
were available. The "reference" values for urea, urate, creati-
nine and cholesterol (enzymatic methods) were within 3% and the 
"reference" values for phosphate and total protein were within 
37 
1% of the recommended values. As could be expected the "reference" 
value for cholesterol analysed by non-enzymatic methods was about 
7% above the recommended value for cholesterol, since no extrac­
tion step was involved in these methods. The definitive or recom­
mended values for all the constituents were within the "reference" 
values + 1 "reference" standard deviation except for the choles­
terol non-enzymatic methods (Table 8). 
TABLE 8 
C O M P A R I Ξ I O N O F T H E " R E F E R E N C E " V A L U E S W I T H T H E D E F I N I T I V E R E C O M M E N D E D V A L U E S 
O F S E R O N O R M B A T C H 1 3 6 
Component Defenitive Recommended "Reference" Percentage "Reference" 
value value value dev ia t ion stand.dev. 
Sodium (mmol/l) 
Potassium (mmol/l) 
Calcium (mmol/l) 
Chloride (mmol/l) 
Phosphate (mmol/l) 
Urea (mmol/l) 
Creatinine (ymol/l) 
Urate (mmol/l) 
Cholesterol (mmol/l) 
non-enzym. meth. 
Glucose (mmol/l) 
Total protein (g/1) 
Cholesterol (mmol/l) 
enzym. meth. 
136. 
4. 
2. 
103 
6. 
.0 
.53 
.20 
.12 
1. 
10. 
115 
0. 
5. 
72 
5. 
,6 
,2 
.440 
.15 
,15 
136.62 
4.51 
2.17 
102.80 
1.59 
9.98 
112.65 
0.430 
5.50 
6.23 
71.54 
5.04 
0.4% 
0.5% 
1.4% 
0.2% 
0.6% 
2.2% 
2.0% 
2.3% 
6.7% 
1.8% 
0.6% 
2.1% 
1.08 
0.06 
0.03 
1.14 
0.04 
0.22 
3.81 
0.015 
0.13 
0.16 
1.15 
0.12 
Table 9 g i v e s an i m p r e s s i o n of t h e o r d e r of magnitude of t h e " r e ­
f e r e n c e " s t a n d a r d d e v i a t i o n . 
For s a t i s f a c t o r y performance each l a b o r a t o r y should meet t h r e e 
c r i t e r i a : (1) no removal o r r e p l a c e m e n t of v a l u e s , (2) s c o r e for 
i t s mean v a l u e 9 or 10, (3) s c o r e for i t s s t a n d a r d d e v i a t i o n 9 or 
10. 
I n t h e four t r i a l s in t h i s i n v e s t i g a t i o n 20-40% of t h e p a r t i c i ­
p a n t s met t h e s e c r e t e r i a (Table 1 0 ) . 
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TABLE 9 
"REFERENCE" VALUES, "REFERENCE" 
TION OF THREE TRIALS 
STANDARD DEVIATIONS AND COEFFICIENTS OF VARIA-
Component Trial 1 
"réf." 
value 
136.35 
4.30 
2.23 
104.30 
1.69 
12.08 
171.69 
0.45 
3.84 
6.36 
71.87 
"réf." 
S.D. 
1.13 
0.06 
0.04 
1.34 
0.04 
0.30 
5.35 
0.01 
0.14 
0.17 
1.25 
С. 
0. 
1, 
1. 
1. 
2. 
2. 
3. 
2, 
3. 
2. 
1. 
.V. 
.83° 
.40% 
.79% 
.28% 
.37% 
.48% 
.12% 
.22% 
.65% 
.67% 
.74% 
Trial 2 
"réf." 
value 
143.62 
6.00 
2.31 
113.08 
1.13 
7.17 
147.10 
0.38 
3.79 
5.35 
70.05 
"réf." 
S.D. 
1.11 
0.07 
0.04 
1.39 
0.03 
0.19 
4.68 
0.01 
0.12 
0.18 
1.22 
С 
0 
1. 
1. 
1. 
2. 
2. 
3. 
2. 
3. 
3. 
1. 
.V. 
.77% 
.17% 
.73% 
.23% 
.65% 
.65% 
.18% 
.63% 
.17% 
.36% 
.74% 
Trial : 
"réf." 
value 
136.62 
4.51 
2.17 
102.80 
1.59 
9.98 
112.65 
0.43 
5.50 
6.23 
71.54 
3 
"ref 
S.D. 
1.08 
0.06 
0.03 
1.14 
0.04 
0.22 
3.81 
0.01 
0.13 
0.16 
1.15 
' C.V. 
0.79% 
1. 33% 
1.38% 
1.1П 
2.51% 
2.20% 
3.38% 
2.32% 
2.35% 
2.57% 
1.61% 
Sodium(mmol/1) 
Potassium(mmol/1) 
Calcium(mmol/l) 
Chloride(mmol/1) 
Phosphate (mmol/1) 
Urea(mmol/1) 
Creatinine 
(Umol/l) 
Urate(mmol/1) 
Cholesterol non-
enzym. meth. 
(mmol/l) 
Glucose(mmol/l) 
Total protein(g/1) 
Cholesterol enzym. 
meth. (mmol/1) 3.34 0.13 3.89% 3.26 0.10 3.07% 5.04 0.12 2.38% 
TABLE 10 
PERCENTAGE OF THE TOTAL NUMBER OF PARTICIPANTS MEETING THE CRITERIA: NO RE­
MOVAL OR REPLACEMENT OF RESULTS г BIAS SCORE OF 9 or 10; STANDARD DEVIATION 
SCORE OF 9 OR 10 
Component 
Sodium(mmol/1) 
Potassium(mmol/1) 
Calcium(mmol/1) 
Chloride(mmol/l) 
Phosphate(mmol/l) 
Urea(mmol/1) 
Creatinine(pmol/l) 
Urate(mmol/1) 
Trial 1(N) 
44.7%(47) 
46.8%(47) 
31.9%(47) 
37.8%(45) 
32.6%(46) 
29.8%(47) 
29.2%(48) 
26.7%(45) 
Cholesterol(mmol/l) 
non-enzym. meth. 
Glucose(mmol/1) 
Total protein(g/1) 
Cholesterol(mmol/1] 
enzym. meth. 
23.8%(21) 
21.7%(46) 
38.3%(47) 
) 
23.1%(26) 
Trial 2(N) 
28, 
41, 
44. 
34, 
35. 
30, 
20, 
25, 
26. 
21. 
38. 
31. 
.3%(46) 
.3%(46) 
.2%(44) 
.9%(43) 
.6%(45) 
.4%(46) 
.0%(45) 
.0%(44) 
.3%(19) 
.7%(47) 
.3%(47) 
.0%(29) 
Trial 3(N) 
40.9%(44) 
38.6%(44) 
26.2%(42) 
38.1%(42) 
39.5%(43) 
18.6%(43) 
22.2%(45) 
20.9%(43) 
23.5%(17) 
17.8%(45) 
42.2%(45) 
24.1%(29) 
Trial 4(N) 
38.3%(47) 
42.6%(47) 
28.9%(45) 
32.6%(46) 
32.6%(46) 
20.0%(45) 
22.9%(48) 
13.0%(46) 
18.8%(16) 
31.3%(48) 
45.7%(46) 
24.2%(33) 
total number of participants. 
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Conclusbons 
The first results of this coupled external/internal quality con-
trol program indicate that the program offers the possibility of 
really testing the internal quality control systems of the parti-
cipating laboratories. The "reference" value given by this pro-
gram appears to agree well with values found with the best analy-
tical methods available at the moment. 
The "reference" standard deviation is a hard criterion for the 
participants to meet. If the "reference" value is considered to 
be a good approximation to the true value, four different kinds 
of errors in the results of a laboratory can be detected: (1) an 
overall systematic error; (2) significantly too high within-week 
variances in individual weeks; (3) systematic deviations of va-
lues in individual weeks; and (4) systematic increasing or de-
creasing measurements during the trial period. 
On the average about 30% of the laboratories meet the criteria: 
(a) no removal or replacement of results; (b) bias score of 9 or 
10; and (c) standard deviation score 9 or 10. 
This indicates that a large percentage of the laboratories has to 
improve its performance for most of the serum components. This 
investigation is continuing to determine whether it is possible 
to improve the performance of a laboratory, which, according to 
the controllability factor, is regarded as poor. The program also 
offers the possibility of judging the merits of various analyti-
cal methods for the same serum component. In a current investiga-
tion pattern recognition techniques are being used to assess whe-
ther the performance of a particular analytical method differs 
from those of other methods. 
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Chapter 2.2 
STANDARDS VERSUS STANDARDIZED METHODS IN ENZYME ASSAY 
Rob T.P. Jansen and Ad P. Jansen 
Annals of Clinical Biochemistry, 1982, accepted for publication 
Summary 
In a trial of the Netherlands coupled external/internal quality 
control program a control serum and an enzyme standard were ana­
lysed during eight weeks, five times a week on five enzymes: alka­
line phosphatase, creatine kinase, lactate dehydrogenase, alanine 
aminotransferase and γ-glutamyltransferase. The measured values 
in the serum were converted to the standards. Those laboratories 
using the recommended methods submitted also their non-transform­
ed serum values. 
The following standardization techniques have been compared: 
a) no standardization of methodology but use of enzyme standards 
b) standardization of methodology 
c) standardization of methodology combined with use of an enzyme 
standard. 
Results were submitted to analysis of variance. Standardization 
of methodology did not yield smaller interlaboratory variation 
than the standardization with enzyme standards. 
In this trial combination of both standardization techniques yiel­
ded generally the better results. Results for y-glutamyltransfe-
rase indicate that standardization of substrate may be necessary 
apart from the use of an enzyme standard. 
The preparation of stable enzyme standards is urged. 
Introduction 
The efforts to reduce interlaboratory variance of serum enzyme 
measurements mainly concentrate on standardization of analytic 
methodology [1-8]. In 1979 the enzyme commission of the Nether-
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lands Society for Clinical Chemistry recommended analytical me­
thods for the determination of six enzymes [1]. These methods are 
basically the Scandinavian [2-6]. The effect of the introduction 
of recommended methods in laboratories appeared from trials of 
the Netherlands National External Quality Control Program [9]. 
Between laboratory coefficients of variation for the determination 
of aspartate aminotransferase (ASAT) and alanine aminotransferase 
(ALAT) for a group of 40 laboratories, decreased from about 50% 
before the introduction to about 15% afterwards. Similar results 
were obtained by Grannis e.a. [8] for their reference laboratories. 
Apparently standardization of methodology effectuates a substan­
tial reduction of between laboratory variability. 
Little attention has been paid in literature to the use of enzyme 
standards to achieve such a reduction. At the Atlanta conference 
late 1977, on "a national understanding for the development of 
reference materials and methods for clinical chemistry", it was 
stated by Lott that 'enzyme standard may be utODian, but some 
start must be made towards enzyme preparation for all clinically 
important enzymes' [10]. 
In 1978, unaware of the Atlanta conference, albumine solutions of 
ASAT and ALAT preparations were used as standards in three trials 
of the external quality control program in the Netherlands (fig 1 
JS SO TS 100 125 ISO ITS ZOO 
COT Β υ 
ASAT 
Fig. 1 A. Typical Youden-plot for ASAT in a trial of the external program. In 
this program laboratories assay two sera and suomit their results. Note: al­
though laboratories measure precisely (values are positioned close to a 
straight line) large systematical differences are observed. 
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0
 • 20 40 60 Θ0 100 120 140 160 В U/l 
Fig. 1 B. Typical Youden-plot for ASAT in a trial in which a 2% albumine so­
lution of ASAT was used as a standard. Note: the large systematical differen­
ces have disappeared. At the time of this trial none of the laboratories ap­
plied pyridoxal phosphate (PDP) in its assay. Adding PDP may worsen results 
since standard and control serum may be activated differently. 
П 50 75 100 126 ISO ITS 200 
OPI-B U/L 
ALAT 
Fig. 2 A. Typical Youden-plot for ALAT in a trial of the external program. 
Note: values are positioned close to a line indicating precise but systema­
tically different measuring. 
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Fig. 2 Β. Typical Youden-plot for ALAT in a trial in which a 2% albumine so­
lution was used as a standard. Note: the systematical differences have dis­
appeared . 
Between laboratory coefficients of variation decreased from 50% 
without use of the standards to about 10% with it. At that time 
such standards were not produced on a large scale commercially, 
therefore prohibiting further investigation. 
Then a lyophilized enzyme standard preparation was made available 
by Nyegaard, Oslo, Norway. It was used in a trial of the Nether­
lands coupled external/internal quality control program [11]. In 
this trial participants analysed both a control serum and the en­
zyme standard during eight consecutive weeks, five times a week. 
In this paper results are presented for five enzymes: alkaline 
phosphatase (AP), creatine kinase (CK), lactate dehydrogenase (LD), 
alanine aminotransferase (ALAT) and γ-glutamyltransferase (γ-GT). 
Results for aspartate aminotransferase (ASAT) were not taken into 
consideration because of the unacceptably high enzyme content. 
This was caused by the extra addition of ASAT as a contaminant of 
the added leucine amino peptidase preparation of the enzyme stan­
dard. 
Materials and Methods 
Participants to the trial were supplied with sufficient amounts 
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of a lyophilized control serum and 1 ml ampoules containing the 
lyophilized enzyme standard. The sources of the enzymes in con­
trol serum and standard have been listed in Table 1. Reference 
values were assigned to the enzyme standard after assay in our la­
boratory applying recommended methods [1]. Laboratories analysed 
control serum and enzyme standard for five enzymes: AP, CK, LD, 
ALAT, γ-GT. Both specimens were analysed during eight weeks five 
times a week. A variety of analytical methods was used by the la­
boratories. Reaction temperatures ranged from 25 С to 37 С. Ma­
nual , centrifugal fast analyser, continuous flow, reaction rate 
analyser and automatic discrete systems were employed. Also the 
chemical reaction principles differed widely. For instance four 
different buffer solutions were used in the determination of AP, 
pyridoxal phosohate was or was not present in the assays of ALAT, 
different substrates were used in the analysis of γ-GT, substrate 
concentrations varied etc. 
Participants were asked to transform their results for the control 
serum, using their values for the enzyme standard, according to 
equation (1):
 ( 1 ) γ, = Rs 
ic — * Y .where Y' is the i-th converted 
Y 1С' 1С 
is 
result and Y' is the i-th measured value for the control serum, ic 
Y is the i-th measured value for the enzyme standard and R is is - ' s 
the reference value of the standard for a particular enzyme. 
Participants applying the recommended methods were asked to sub­
mit their measured results for the control serum and the conver­
ted results. Thus three standardization techniques could be stu­
died : 
1) standardization with an enzyme standard. Results were obtained 
from laboratories applying a variety of analytical methods 
measuring at different temperatures. In the text this technique 
will be indicated as 'all methods + enzyme standard' (A.M.+ S) 
2) standardization of methodology. For the investigation of this 
type of standardization non-converted results for the control 
serum of laboratories applying recommended methods were used. 
Description in the text of this technique: 'recommended method' 
(R.M.) 
3) standardization of methodology in combination with an enzyme 
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standard. For this type the converted results of laboratories ap­
plying recommended methods were used. Text description: 'recommen­
ded method + enzyme standard' (R.M. + S) 
STATISTICAL METHODS 
To investigate the results of the three standardization techni­
ques, analyses of variances were performed. Two-way analysis of 
variance (ANOVA) schemes were used, calculating variances a) be­
tween laboratories, b) between weeks, c) interactions and d) re­
sidual. F-values, computed in the schemes, determined the signi­
ficances of the various sources of error. 
Mean squares of the interaction effects are tested against the 
residual variances. Between laboratories and between weeks mean 
squares are tested against the interaction mean squares. 
The partial variances for the various sources of error are compu­
ted from the mean squares. Partial variance between laboratories, 
for instance, is calculated according to equation (2): 
2 2 2 
(2) σ = (MS - σ - η*σ )/(n*w), where MS, is mean square between la­
boratories, σ is the residual variance (=residual mean square), 
2 r 2 2 
σ is variance of interactions (σ = (MS - σ )/η, m which MS is i ι ι r ι 
mean square of interactions), η is the number of results per la­
boratory per week (=5) and w is number of weeks (=8). 
The percentage contribution of the partial variances to the to­
tal variance is calculated also. These calculations are all part 
of the Netherlands coupled external/internal quality control pro­
gram [ 11 ] . 
The partial variances between laboratories, computed for the three 
standardization techniques, are compared to detect possible signi­
ficant differences between them. Fisher tests can be used for 
these comparisons since the correlation coefficients between re­
sults obtained for the three standardization methods did not dif­
fer significantly from zero, that is these results are not corre­
lated. 
To detect differences in quality between control serum and enzyme 
standard, the residual variances for the procedures with the en­
zyme standards are compared with those obtained for the recommen-
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ded methods. These variances can be compared directly since the 
concentration levels of control serum and enzyme standard were 
similar for all enzymes. 
In the cited program also scores are given to the participant 
means [11]. The higher the average participant-mean score, the 
better the interlaboratory companbility. The scoring system is 
based on the difference of participant mean and 'reference' value 
in relation to the 'reference' standard deviation. The 'reference' 
standarddeviation equals the square root of the residual variance. 
Use of the residual variance in the scoring system renders the 
average scores for the three standardization techniques comparable: 
measuring enzyme standard in addition to the control serum intro­
duces an extra error which finds expression m the participant 
means. The scoring system should account for this error therefore. 
Results and Disaussvon 
Although the serum was human, it was reinforced with enzymes of 
animal origin and thus contained a rather complicated enzyme mix­
ture. The standard consisted of a mixture of animal enzymes (only 
alkaline phosphatase was human) originating from the same organs 
as the serum spikes, though the species were different (Table 1). 
Table 1 
Origin of enzymes in enzyme standard and control serum. 
Enzyme enzyme standard human control serum spiked 
with 
AP Human P l a c e n t a Human P l a c e n t a 
CK Ape H e a r t m u s c l e R a b b i t Muscle 
LD Porcine Heart Bovine Heart 
ALAT Porcine Heart Bovine Heart 
γ-GT Porcine kidney Bovine kidney 
A p o s s i b l e i s o e n z y m e e f f e c t may b e m o s t e x p l i c i t f o r t h e c a s e of 
c r e a t i n e k i n a s e . C o n t r o l s e r u m and enzyme s t a n d a r d showed no 
c h a n g e i n a c t i v i t y d u r i n g t h e t r i a l p e r i o d f o r t h e f i v e e n z y m e s , 
a s i n d i c a t e d by t h e n o n - s i g m f l e a n t b e t w e e n - w e e k s c o m p o n e n t s i n 
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Tables 2 and 4-7. Only in the 'recommended method' for the deter­
mination of γ-GT a significant F-value was obtained. The between-
weeks variance however contributes less than 1% to the total va­
riance and no practical consequence can be attached to it. The 
goal of standardization, elimination of interlaboratory variation, 
is not achieved by any of the three techniques in the five assays. 
Highly significant between-laboratory differences are obtained 
even for laboratories applying the recommended methods. Since 
standardization of methodology is considered the best current 
technique, results obtained with the enzyme standard in all me­
thods are compared with values for the 'recommended methods'. 
ALKALINE PHOSPHATASE 
Results for alkaline phosphatase are listed m Table 2. Because 
of the additional measuring error made by assaying both control 
serum and enzyme standard, the residual variance for 'all methods 
+ enzyme standard' (A.M.+ S) 'recommended method + enzyme stan­
dard' (R.M.+ S) are expected to be twice that for 'recommended 
method' (RM). From Table 2 it is seen that the former residual 
variances are not significantly grater than twice the latter, in­
dicating comparable homogeneity and stability for control serum 
and enzyme standard. 
Significant between-laboratory mean squares are obtained (P(F) 
<0.001) for the three standardization procedures (Table 2). Be-
tween-laboratones variance for R.M. equals 244. This value does 
not differ significantly from the between-laboratones variance 
for A.M.+ S (=182) tested with a F-test (a=0.05). Apparently the 
interlaboratory variabilities in the two techniques do not differ, 
despite the various measuring temperatures and the variants m 
the analysis techniques in A.M.+S. Between-laboratones variance 
for R.M.+ S is significantly smaller (a=0.001) than for R.M.. So 
the combination of standardization of methodology and the use of 
an enzyme standard yields the best results for alkaline phospha­
tase. This is also reflected in the contribution of between-labo­
ratones variance to the total variance: 71% and 79% for A.M.+ S 
and R.M. respectively and 42% for R.M.+ S. 
Results listed in Table 3 are also in agreement with these obser-
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vations. The highest average participant-mean score is achieved 
by R.M.+ S. From the scores in this Table it can be seen that the 
Table 2 
Analysis of variance t a b l e s for a l k a l i n e phosphatase 
A = ANOVA for a l l methods + enzyme standard 
В = ANOVA for recommended method 
С = ANOVA for recommended method + enzyme standard 
A between lab. 
between week 
interactions 
residual 
В between lab. 
between week 
interaction 
residual 
С between lab. 
between week 
interaction 
residual 
Sum-Squares 
339581 
778 
36589 
90923 
208037 
1021 
19579 
31232 
34827 
592 
11971 
33359 
d.f.a 
46 
7 
312 
1454 
21 
7 
145 
694 
20 
7 
136 
652 
Mean Square 
7382 
111 
117 
63 
9907 
146 
135 
45 
1741 
84 
88 
51 
F 
6.3 
1.1 
1.9 
73 
1.1 
3.0 
20 
1.0 
1.7 
P(F) 
<0.001 
0.51 
<0.001 
<0.001 
0.4 
<0.001 
<0.001 
0.5 
<0.001 
s\ 
182 
-
11 
244 
-
18 
45 
41 
-
7.6 
51 
< 
of total 
71 
-
4 
25 
79 
-
6 
15 
42 
-
7 
51 
a. degrees of freedom b. p a r t i a l var iance c . percentage cont r ibut ion t o 
t o t a l variance 
u s e of d i f f e r e n t m e t h o d s i n c o m b i n a t i o n w i t h an enzyme s t a n d a r d 
may l e a d t o e v e n b e t t e r r e s u l t s t h a n i n t r o d u c i n g a recommended 
m e t h o d . 
CREATINE KINASE 
R e s u l t s f o r c r e a t i n e k i n a s e a r e l i s t e d i n T a b l e 4 . C o n t r o l s e r u m 
a n d enzyme s t a n d a r d show c o m p a r a b l e h o m o g e n e i t y and s t a b i l i t y , a s 
r e s i d u a l v a r i a n c e s f o r A.M.+ S and R.M.+ S a r e n o t s i g n i f i c a n t l y 
g r e a t e r t h a n t w i c e R . M . ' s r e s i d u a l v a r i a n c e . A s i g n i f i c a n t i n t e r -
l a b o r a t o r y v a r i a b i l i t y i s o b s e r v e d f o r a l l s t a n d a r d i z a t i o n t e c h ­
n i q u e s . P a r t i a l v a r i a n c e b e t w e e n - l a b o r a t o r i e s f o r A.M.+ S d o e s 
n o t d i f f e r s i g n i f i c a n t l y from t h i s v a r i a n c e f o r t h e R . M . , a s was 
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T a b l e 3 
Average part ic ipant-mean scores 
Enzyme 
Standardization techniques 
В 
АР 
CK 
LD 
ALAT 
γ-GT 
6.3 
5.8 
8.2 
5.3 
0.3 
5.2 
6.1 
5.4 
5.8 
0.0 
8.7 
6.2 
5.6 
0.0 
A : all methods + enzyme standard 
В : recommended methods 
С • recommended method + enzyme standard 
Table 4 
Analysis of variance tables for creatine kinase 
A ANOVA for all methods + enzyme standard 
В ANOVA for recommended method 
С ANOVA for recommended method + enzyme standard 
A 
В 
С 
between lab. 
between week 
interaction 
residual 
between lab. 
between week 
interaction 
residual 
between lab. 
between week 
interaction 
residual 
sum square 
3336005 
16969 
372351 
662372 
653752 
2767 
98195 
132002 
926593 
12109 
108813 
228759 
a 
d.f. 
42 
7 
267 
1241 
16 
7 
104 
504 
18 
7 
125 
603 
mean squ; 
79429 
2424 
1395 
534 
40860 
395 
944 
262 
51477 
1730 
871 
379 
are F 
57 
1.7 
2.6 
43.3 
2.4 
3.6 
59.1 
2.0 
2.3 
P(F) 
<0.001 
0.1 
<0.001 
<0.001 
0.3 
<0.001 
<0.001 
0.07 
<0.001 
2 Ь 
σ % of total 
1951 
-
172 
534 
998 
-
137 
262 
1265 
-
98 
379 
73 
-
7 
20 
71 
-
10 
19 
72 
-
6 
22 
a: degrees of freedom partial variance c: percentage contribution to to­
tal variance 
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also the case for alkaline phosphatase, despite the presence of 
different isoenzymes in control serum and enzyme standard. No fur-
ther improvement is achieved when standards are used in combina-
tion with the recommended method: the partial variance between 
laboratories for R.M.+ S does not differ significantly from the 
partial variance for R.M. . The ressemblance of the three techni-
ques is also expressed in the percentages contribution so the to-
tal variance of the between-laboratones variances: 73% for A.M. 
+ S, 71% for R.M. and 72% for R.M.+ S. 
The similarity is demonstrated also in the average participant 
mean scores (Table 3): 5.8, 6.1 and 6.2 respectively. 
LACTATE DEHYDROGENASE 
The residual variances for the two standardization methods apply-
ing the enzyme standard are not significantly greater than twice 
this variance for the recommended method (Table 5). Again, the 
quality of control serum and enzyme standard in respect of lacta-
te dehydrogenase are comparable. Considerable interlaboratory va-
riations remain, despite the standardization, for all three pro-
cedures. Between laboratories variance for R.M. is significantly 
greater than these variances computed for the other two techni-
ques. Thus the use of the enzyme standard yields significantly 
better results than standardization of methodology. The between 
laboratories variances of the two procedures using an enzyme stan-
dard do not differ significantly. The percentages contribution to 
the total variances of the between laboratories variances are in 
agreement with these results: 48% for A.M.+ S, 86% for R.M. and 
35% for R.M.+ S. From these percentages and the average partici-
pant-mean scores (Table 3: 8.2, 5.4 and 8.8 respectively) the 
latter standardization technique seems scarcely better than use 
of the enzyme standard and no standardization of methodoloav. 
ALANINE AMINO TRANSFERASE 
The residual variances of the standardization procedures using 
the enzyme standard are significantly greater than twice the re-
sidual variance of the results of the 'recommended method' (see 
Table 6). Apparently the mtervial variability of the enzyme stan-
dard is larger than of the control serum. Instability may be a 
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T a b l e 5 
Analysis of var iance t a b l e s for l a c t a t e dehydrogenase 
A : ANOVA for a l l methods + enzyme standard 
В ANOVA for recommended method 
С ANOVA for recommended method + enzyme standard 
A 
В 
С 
between lab. 
between week 
interactions 
residual 
between lab. 
between week 
interactions 
residual 
between lab. 
between week 
interactions 
residual 
Sum square 
1778440 
7163 
515934 
1186760 
2986047 
8034 
173216 
280226 
436871 
139883 
204286 
532725 
a 
d.f. 
48 
7 
318 
1478 
17 
7 
116 
561 
18 
7 
121 
583 
mean square F 
37051 
1023 
1622 
803 
175650 
1148 
1493 
500 
24271 
1998 
1688 
914 
22.8 
1.6 
2.0 
117.6 
1.3 
3.0 
14.4 
1.2 
1.9 
Ρ (F) 
<0.001 
0.3 
<0.001 
<0.001 
0.4 
<0.001 
<0.001 
0.4 
<0.001 
2 b 
σ % of total 
886 
-
164 
803 
4354 
-
199 
500 
565 
-
155 
914 
48 
-
9 
43 
86 
-
4 
10 
35 
-
9 
56 
a. degrees of freedom b: par t ia l variance c: percentage contribution to 
the tota l variance 
c o n t r i b u t o r y f a c t o r . The q u a l i t y d i f f e r e n c e in t h e two p r e p a r a ­
t i o n s causes t h e p a r t i a l v a r i a n c e s of t h e enzyme s t a n d a r d - p r o c e ­
d u r e s t o be s i g n i f i c a n t l y h i g h e r t h a n t h o s e of t h e non-enzyme 
s t a n d a r d t e c h n i q u e and t h e s e should not be compared t h e r e f o r e . I f , 
however, use of an enzyme s t a n d a r d does not g ive any r e d u c t i o n in 
m t e r l a b o r a t o r y v a n b i l i t y , t h e v a r i a n c e b e t w e e n - l a b o r a t o n e s for 
' a l l methods + enzyme s t a n d a r d ' i s expected t o be g r e a t e r t h a n 
t h i s v a r i a n c e for 'recommended method + enzyme s t a n d a r d ' , s i n c e 
t h e former i n c l u d e s a g r e a t e r number of c o n t n b u t i n a f a c t o r s t o 
t h i s v a r i a n c e t h a n t h e l a t t e r . The e r r o r i n t r o d u c e d by t h e q u a l i ­
t y d i f f e r e n c e i s e q u a l for b o t h s t a n d a r d i z a t i o n t e c h n i q u e s . 
There fore t h e i r between l a b o r a t o r i e s v a r i a n c e s can be compared. 
This v a r i a n c e f o r ' a l l methods + enzyme s t a n d a r d ' (see Table 6) 
i s not s i g n i f i c a n t l y g r e a t e r t h a n f o r 'recommended method + enzyme 
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standard' (α = 0.05), despite the ontional use of nyndoxal ohos-
phate in A.M.+ S and the obligatory use of it in R.M.+ S. 
All three standardization procedures can be compared, only when 
the partial variances are considered relative to the total vari­
ance. The percentage contribution of between-laboratories variance 
to the total variance are similar for the three methods. The ave­
rage participant-mean score also takes the residual variance into 
account. Therefore the scores of three techniques may be compared; 
they are similar (Table 3). 
Table 6 
Analysis of var iance t a b l e s for a lanine aminotransferase 
A : ANOVA for a l l methods + enzyme standard 
В : ANOVA for recommended method 
С : ANOVA for recommended method + enzyme standard 
A between lab. 
between week 
interactions 
residual 
В between lab. 
between week 
interactions 
residual 
С between lab. 
between week 
interactions 
residual 
Sum squares 
569820 
433 
45153 
44459 
23975 
108 
2254 
5635 
151207 
700 
23225 
20385 
a 
d.f. 
44 
7 
274 
1270 
23 
7 
152 
723 
18 
7 
121 
583 
mean square 
12951 
62 
165 
35 
1042 
15.5 
14.8 
7.8 
8400 
100.0 
192 
35 
F 
78.6 
2.7 
4.7 
70.3 
1.0 
1.9 
43.8 
1.9 
5.5 
p(F) 
<0.001 
0.1 
<0.001 
<0.001 
0.4 
<0.001 
<0.001 
0.2 
<0.001 
„>\ 
320 
-
26 
35 
26 
-
1.4 
7.8 
205 
-
31.4 
35.0 
с 
of total 
84 
0 
7 
9 
74 
0 
4 
22 
76 
0 
11 
13 
a: degrees of freedom b : p a r t i a l var iance 
с : percentage c o n t r i b u t i o n t o 
the t o t a l variance 
γ-GLUTAMYL TRANSFERASE 
R e s u l t s o b t a i n e d f o r γ - g l u t a m y l t r a n s f e r a s e , l i s t e d i n T a b l e s 3 
and 7 , show h i g h l y s i g n i f i c a n t b e t w e e n l a b o r a t o r i e s c o m p o n e n t s 
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for all three standardization procedures. Although the variances 
between laboratories do not differ significantly, no conclusions 
should be drawn from it since the F-values are abnormally high, 
as are the contributions to the total variance. Inspection of the 
distributions of the results for the three procedures disclosed 
the reason. In Figure 3 the distribution histogram of the results 
for 'recommended method' is shown. Clearly two peaks are seen. 
Similar distributions were obtained for the other procedures. 
140 
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110 xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 
100 xxxxxxxxxxxxxxxxxxxxxxxxxxxxxx 
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80 XXXXXXXXXXXXX 
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50 
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Fig. 3 Histogram of the results obtained for the recommended method for the 
determination of γ-glutamyl transferase (one χ represents five results) 
About half of the participants in each procedure measured signi­
ficantly lower than the others. Laboratories that submitted lower 
results appeared to use the substrate Y-glutamyl-3-carboxy-4-nitro-
anilide, rather than Y-glutamyl-4-nitroanilide which is prescribed 
in the recommendation. Use of an enzyme standard should eliminate 
this effect, but it did not. A diverging behaviour towards the 
two substrates between control serum and enzyme standard accounts 
for this phenomenon. Some experiments showed that results obtai­
ned for the control serum using the carboxylated substrate were 
60% lower than values measured using the unsubstituted substrate. 
For the enzyme standard, however, this difference was only 10%. 
Therefore no effect of the enzyme standard can be expected. 
55 
Table 7 
Analysis of variance tables for γ-glutamyl transferase 
A : ANOVA for all methods + enzyme standard 
В ANOVA for recommended method 
С ANOVA recommended method + enzyme standard 
A between lab. 
between week 
interactions 
residual 
В between lab. 
between week 
interactions 
residual 
С between lab. 
between week 
interactions 
residual 
Sum squares 
462922 
122 
7633 
165000 
269611 
467 
2139 
4632 
139802 
85 
1828 
4471 
a 
d.f. 
48 
7 
312 
1448 
17 
7 
115 
556 
17 
7 
114 
551 
mean square 
9644 
17.5 
24.5 
11.4 
15859 
66.7 
18.6 
8.3 
8224 
12.1 
16.0 
8.1 
F 
394 
1.4 
2.2 
853 
3.6 
2.2 
513 
1.3 
2.0 
p(F) 
<0.001 
0.3 
<0.001 
<0.001 
0.002 
<0.001 
<0.001 
0.4 
<0.001 
. * ' , 
241 
-
2.6 
11.4 
396 
0.5 
2.1 
8.3 
205 
-
1.6 
8.1 
t 
i of total 
95 
-
1 
4 
97 
0 
1 
2 
95 
-
1 
4 
a degrees of freedom b: partial variance c· percentage contribution to 
the total variance 
Conaluabons 
In this paper the effect of the use of enzyme standards on the 
mterlaboratory variability, the impact of standardization of ana-
lyte methodology and the results obtained if both standardization 
procedures are combined, have been studied for five enzymes. Data 
were available from a trial of the Netherlands external/internal 
quality control program. The enzymes m control serum and enzyme 
standard came from different species but similar organs, except 
for creatine kinase. Nor control serum nor enzyme standard showed 
continuous increasing or decreasing catalytic activity during the 
trial period for all enzymes studied. 
Use of the enzyme standard in the determination of alkaline phos­
phatase by laboratories applying a variety of analytical methods, 
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resulted in slightly better results than standardization of metho­
dology. The smallest mterlaboratory variation was achieved for 
this enzyme, if standardization of analytical method was combined 
with the use of the enzyme standard. 
Values obtained by the three standardization procedures for crea­
tine kinase were approximately equal. Despite the different ori­
gin of creatine kinase in control serum and standard, the data 
for 'all methods + enzyme standard' did not differ significantly 
from those submitted by laboratories applying a recommended method. 
Using both procedures did not result m further improvement. 
Results for the enzyme standard techniques for lactate dehydroge­
nase were significantly better than values obtained from partici­
pants applying the reconunended method. Combination of both proce­
dures gave slightly better results than the use of an enzyme stan­
dard with different methods. The need of homogeneous and stable 
enzyme standard preparations is demonstrated by the results for 
alanine amino transferase. The poor quality of the standard cau­
sed the partial variances to be unnecessary great. 
Yet values obtained for 'all methods + enzyme standard' are com­
parable to those for 'recommended method + enzyme standard'. If 
the variance introduced by the instability of the standard is ta­
ken into account these values are also similar to results for the 
'recommended method'. 
To prevent matrix effects standardization of substrate is neces­
sary for γ-GT. Results for this enzyme demonstrate a problem to 
be encountered in standardizing methodology: although laboratories 
claimed to apply a recommended method, they wrongly modified it. 
One should take care of generalizing the conclusions which are 
drawn from one trial and one control serum. However results obtai­
ned from a very recently organized trial, in which a control serum 
of different origin and manufacturer was used, seem to be simi­
lar. Many more trials have to be organized using sera and enzyme 
standards of varying isoenzyme composition to investigate the pro­
blems associated with it. In this paper a first attempt has been 
described to reduce mterlaboratory variance using an enzyme stan­
dard and results are encouraging. Standardization of methodology 
creates many problems including new investments by laboratories, 
changes of reference values, inhibition of progress in developing 
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new methods and last but not least the unwillingness of clinical 
chemists to accept methods they cannot adapt at their particular 
circumstances. If a comparable reduction of interlaboratory vari­
ance can be achieved by using enzyme standards, it is to prefer. 
The results of the present investigation indicate this possibility. 
In view of the renewed discussion on the temperature of enzyme re­
actions the preparation of homogeneous and stable standards should 
be urged. 
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CHAPTER 3 
ASSESSMENT OF ROUTINE ANALYTICAL METHODS 
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Chapter 3.1 
APPLICATION OF PATTERN RECOGNITION FOR DISCRIMINATION BETWEEN 
ROUTINE ANALYTICAL METHODS USED IN CLINICAL LABORATORIES 
Rob T.P. Jansen, Frans W. Pijpers and Geert A.J.M, de Valk 
Analytica Chimica Acta, 133 (1981) 1-18 
Computer Techniques and Optimization 
Summary 
Patterns of analytical methods, obtained from the Dutch coupled 
external/internal quality control program for clinical laborato-
ries, can be described by four features: accuracy, precision, ten-
dency to give erroneous results, and tendency to give systemati-
cally different results in different laboratories. The data base 
provided a maximum of six patterns per analytical method for the 
determination of a serum component. Unsupervised pattern recog-
nition revealed clusters formed by the patterns in a four-dimen-
sional space for each of the three serum components considered 
(inorganic phosphate, glucose and cholesterol). The detected clus-
ters were defined as classes. Supervised techniques based on the-
se classes showed that not all descriptors are equally important 
in discriminating between the clusters for different serum com-
ponents. Patterns for a particular analytical method often clus-
tered in the same class. The numerical values of the features of 
the patterns belonging to such a class are measures of the qua-
lity of that class. Pattern recognition provides an objective 
assessment of analytical method used routinely in clinical labo-
ratories . 
Introduction 
In clinical chemistry, the performance of an analytical methods 
must be studied before the method can be applied routinely to spe-
cimens from patients. The selection of a method and the criteria 
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considered in making a decision are therefore of fundamental im-
portance [ 1 ] . 
The features that describe important characteristics of an analy-
tical method are its practicability (speed, cost, technical skill 
requirement, dependability and laboratory safety) and reliability 
(specificity, accuracy, precision and detection limit). Informa-
tion is required about all these features in considering the sui-
tability of a method. Usually information about the practicability 
of a method is readily available and depends on the environment 
of the laboratory. 
Objective information about the reliability (ruggedness) of an 
analytical method is often difficult to obtain. If this informa-
tion is not available, it must be acquired by well-defined proce-
dures m order to make an objective assessment. 
In each trial of the national coupled external/internal quality 
control program in the Netherlands [2], participants submit re-
sults based on the analysis of a number of serum components in a 
lyophilized serum five times per week for eight weeks. To esta-
blish a "reference" overall mean value and a "reference" day-to-
day standard deviation, results are removed if they contribute 
significantly to sources of error detected in a two-way analysis 
of variance with replicates [2]. After this removal, mean values 
for the various analytical methods are computed from the mean va-
lues of the results accepted. The day-to-day standard deviations 
of the analytical methods are computed from the algorithm 
2 2 
s = E¿.s /ΐ,φ . Here s is the standard deviation of method m, φ 
m i ι i m ι 
is the number of accepted results minus 1 for lab ι applying me-
2 
thod m, and s is the variance of the accepted results from lab i. 
Apart from the inaccuracy and imprecision, the percentage of re­
moved results for a particular method is considered as a third 
descriptive feature. Systematic differences between users of the 
same analytical method is considered as a fourth feature. 
Thus the national coupled external/internal program gives infor­
mation about four characteristics of the analytical methods: (1) 
inaccuracy, i.e. the tendency of the method to give results de­
viating systematically from the true value; (2) imprecision, i.e. 
the tendency of the method to give different results for repli­
cate measurements on the same specimen; 
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(3) the tendency of the method to give erroneous 
results, e.g. values increasing or decreasing with time, weekly 
means deviating significantly from the overall mean, an overall 
mean deviating by more than 2.5 "reference" standard deviations 
from the "reference" value, etc. [2]; (4) the tendency of the me-
thod to give systematically different results for different users, 
because of differences in laboratory procedures. 
An analytical method is defined here according to the method codes 
of the Stichting Kwaliteitsbewaking Klinisch Chemische Ziekenhuis 
Laboratoria (Foundation for Quality Control in Clinical Chemistry 
Hospital Laboratories) [3]. Two descriptive parameters are used: 
(a) the principle of the chemical reaction, and (b) the instru-
mental methodology (manual, continuous flow, discrete, centrifu-
gal analyzer, etc.). One of the goals of this National Foundation 
for Quality Control is the objective assessment of analytical me-
thods with regard to reliability. The Foundation should be able 
to recommend, approve or disapprove of analytical methods objec-
tively. Accordingly, the information content of the four featu-
res describing the analytical methods must be investigated. 
Pattern recognition techniques have proved useful tools for sol-
ving multidimensional problems [4]. This suggested their use in 
the detection of different behaviour by analytical methods. For 
this purpose, the coirrouter program ARTHUR [5] was applied to the 
analytical methods that have been described by the four charac-
teristics mentioned. In this investigation, methods for the deter-
mination of three serum components, namely inorganic ohosphate, 
glucose and cholesterol, in use by participants m the above-men-
tioned control program, were studied. Participants in this pro-
gram submit for each trial the results for a lyophilized serum 
assayed five times per week during eight weeks. The results of 
six trials were used to obtain a maximum of six patterns per me-
thod per serum component. Patterns of analytical methods applied 
by less than four oarticipants were not included in the calcula-
tions, because the statistics produce less reliable results. 
Pattern recognition provides information for classification of the 
various patterns, defines the relative importance of the four des-
criptors, and gives numerical correlations between the descriptors. 
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The frequency of appearance of the patterns of an analytical me­
thod in a particular class gives information about the quality of 
that method. This paper presents the procedures applied. 
Experimenta I 
The data base was taken from a previous paper [6]. The pattern 
recognition techniques applied were the Zahn minimal spanning 
tree construction (TREE) [7] and hierarchical or O-mode clustering 
(HIER) [8,9] for unsupervised learning, and the nearest neighbor 
classification (KNN) and linear pattern classification [10-12] 
for supervised learning. The features of the data base were pre-
processed by SCALE [8,9], which is a method for the production 
of unbiased features, CORREL [13], which is a method for the de­
tection of inter-feature correlation, WEIGHT [8,9,14], which 
deals with feature ranking, and KARLOV [15] which calculates 
eigenvalues and eigenvectors based on feature variances. The pat­
terns were projected on a plane defined by the two eigenvectors 
with the highest amounts of information by the plotting routine 
VARVAR for each of the serum components. These methods of calcu­
lation are all part of the ARTHUR program [5] and are denoted by 
the names used there. 
Results and Dvsaussbon 
THE DESCRIPTORS 
Four features were used to describe the patterns (for a more de­
tailed description of the features, see [6]): (1) the mean value 
of a method relative to the "reference" value (RELMV) in a trial 
of the external/internal quality control program [2]; (2) the 
day-to-day standard deviation of a method relative to the "refe­
rence" standard deviation (RELSD) in a trial; (3) the percentage 
of removed values for a method in a trial (PERCREM); (4) the mean 
relative deviation of the mean values of laboratories applying a 
given method from the mean value for that method in a particular 
trial (LABDEV) computed from the formula: 100* ΣΝ , {IX - X I /x }/N, 
i=l ι m m 
where X is the mean value of lab ι applying method m before any 
removal of values; X is the mean value of method m after remo­
ra 
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val of erroneous results; N is the number of laboratories. 
All descriptors X (feature ι of pattern 3) were autoscaled to a 
mean of zero and a normalized standard deviation according to 
X' = (X - Χ )/{σ (Ν - 1)1/2} 
i,J 1,] 1 1 
where x' is the new autoscaled descriptor value of feature 1 
(1 = 1-4) for pattern j , χ is the average value of descriptor 1, 
σ is the standard deviation of the i-th descriptor and N is the 
number of patterns in the training set. The correlation between 
the various features, COR(i,j ), was calculated for the three se­
rum components by the equation 
N
 - - f N - 2 N - 2І1/2 
COR( 1,]) = Σ (X . - X ) (X . - X )/{ Σ (Χ . - Χ ) Σ (Χ . - Χ ) } ' 
k = 1 i-k 1 D,k J l k = 1 i,k 1 k = 1 3,\Í J j 
The correlation coefficients thus obtained are listed in Table 1. 
For glucose and cholesterol, the correlations between the features 
were found to be less than 0.4. For phosphate, PERCREM and LABDEV 
were correlated (COR = 0.6) as were RELMV and RELSD (COR = 0.6). 
However, in order to preserve as much information as possible, 
none of the features was eliminated even when the phosphate data 
were considered. 
UNSUPERVISED CLUSTERING 
The abbreviations used for the various analytical methods are ex-
plained in Table 2. In order to find clusters, the HIER and TREE 
methods were applied in an unsupervised fashion to training sets 
of 22, 40, and 24 patterns of the methods for the determination 
of inorganic phosphate, glucose and cholesterol, respectively. 
Similarity values, s , based on their mutual distances D , are 
i.D i.J 
defined as : S = 1 - D /D . The D are Euclidean distances 1, ] 1, ] max 1, ] 
m the four-dimensional space spanned by the features RELMV, RELSD, 
PERCREM and LABDEV. For each of the three serum components stu-
died, the patterns of the analytical methods were grouped at le-
vels of similarity, s , in HIER, and were linked in branched 
chains based on the distances D in TREE. For all three serum 
if] 
components, TREE could detect only one cluster of patterns. For 
phosphate, HIER calculated three major clusters at similarity le-
vel 0.50 (Table 3). For glucose three major clusters were detec-
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T a b l e 1 
C o r r e l a t i o n s be tween t h e f e a t u r e s f o r t h e d e t e r m i n a t i o n s of i n o r g a n i c p h o s p h a -
t e , g l u c o s e and c h o l e s t e r o l 
RELMV RELSD PERCREM LABDEV 
I n o r g a n i c p h o s p h a t e 
RELMV 
RELSD 
PERCREM 
LABDEV 
0 . 5 7 1 0 . 3 1 2 
0 . 2 2 7 
-
0 .179 
- 0 . 0 2 0 
0 .614 
Glucose 
RELMV 
RELSD 
PERCREM 
LABDEV 
- 0 . 0 2 8 0 . 0 1 9 
0 . 0 4 2 
-
- 0 . 1 3 8 
- 0 . 1 5 3 
0 .314 
C h o l e s t e r o l 
RELMV 
RELSD 
PERCREM 
LABDEV 
-0.178 -0.105 
-0.184 
0.172 
0.056 
0.396 
Table 2 
Abbreviations used for the notation of the patterns of the various methods 
applied in the various trials 
Serum component Abbreviation Principle of the analytical method 
Inorganic phosphate FStn 
FNtn 
MFtn 
MOtn 
FHtn Glucose 
DHtn 
MGtn 
FGtn 
MTtn 
APtn 
FOtn 
automatic, continuous flow system, 
SnCl reduction 
automatic, continuous flow system, 
no reduction 
manual, Fe (II) salt reduction 
manual, organic reducing agent 
automatic, continuous flow system, 
hexokinase 
automatic, discrete, hexokinase 
manual, glucose oxidase 
automatic, continuous flow system, 
glucose oxidase 
manual, o-toluidine 
automatic, Polarographie 
automatic, continuous flow system, 
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serum component A b b r e v i a t i o n s P r i n c i p l e of t h e a n a l y t i c a l method 
o x i d i z i n g a g e n t 
C h o l e s t e r o l FEtn a u t o m a t i c , c o n t i n u o u s f low s y s t e m , 
e n z y m a t i c 
DEtn a u t o m a t i c , d i s c r e t e , e n z y m a t i c 
CEtn a u t o m a t i c , c e n t r i f u g a l f a s t a n a l y ­
s e r , e n z y m a t i c 
MEtn m a n u a l , e n z y m a t i c 
a 
t n = T r i a l number. 
t e d b y H I E R a t s i m i l a r i t y l e v e l 0 . 6 2 ( T a b l e 4 ) . F o r c h o l e s t e r o l 
a l s o t h r e e c l u s t e r s w e r e c a l c u l a t e d a t s i m i l a r i t y l e v e l 0 . 6 0 
( T a b l e 5 ) . 
FEATURE WEIGHTING 
In order to establish the relative importance of the features for 
classification, the autoscaled descriptors were weighted with Fish 
er weighting factors based on the mean values and standard devia­
tions within each class. The Fisher weighting factor W(F) for 
],m,n 
separating class m from class η by means of descriptor j is w(Fl 
= {x' ) - (x' ) }2/(N σ2 + Ν о2п,з), m vhich (x·) denotes 
m j n j m m , ] η J i ] 
the mean value of the autoscaled descriptor 2 1 п class ι, N is 
the number of patterns in class i, and σ . i s the standard devia-
tion of the autoscaled descriptor ] in class i. The Fisher weigh­
ting factor of descriptor j for all linear class seoarations. 
w(F) is w(F) = 2(ΣΜ~!· Σ Μ , w(F) )/{м(м-1)}, in which M denotes D ц m=l η = m + 1 j ,m,n 
the number of classes. 
INITIAL TRAINING SETS 
Based on the results of the hierarchical clustering without suoer-
vision, initial training and evaluation sets were formed for the 
three serum components. The clusters found m Tables 3-5 are now 
defined as classes. Patterns not clearly clustering in a parti­
cular class were put in an evaluation set. 
In order to visualize the classes and possible mtra-class pat­
tern distributions, Karhunen-Loêve transformations were performed, 
which constructed eigenvectors from linear combinations of the 
four descriptors. Fisher-weighted for the various classes of Table 
3-5. These eigenvectors are ranked on the base of their informa-
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tion content. The percentage amounts of information comprised in 
the k-th eigenvector, lnfo(E)k, the eigenvectors and the descrip­
tor weightings are listed m Tables 6-8 for phosphate, glucose 
and cholesterol, respectively. For all three serum components the 
first two eigenvectors yielded more than 90% of all information. 
Figures 1-3 present the projections of the patterns of the trai­
ning and evaluation sets on planes defined by their first two 
Table 3 
Hierarchical clustering of the patterns for inorganic phosphate based on the 
unweighted descriptors. 
Cluil«r defined Paliern Sun lar Ly viluei 
MO04 
FS06 
ΜΟ0Θ 
MF04 
MO02 
MF02 
MF03 
MF05 
MO05 
MFOe 
MO01 
MO03 
FN01 
MF01 
FN02 
FN04 
FSÛ2 
FS01 
FN03 
FS05 
FS03 
FS04 
М б 
іш 
ПР,78 
^ ^ ^ ^ 
10.83 ^ , 7 Э 
Π<),69 
3 59 
η 60 
eigenvectors of W(F) for inorganic phosphate, glucose and cho­
lesterol, respectively. 
For phosphate, Fig. 1 reveals that the classes formed in Table 3 
needed no further adaptation. For glucose, Fig. 2 shows that the 
cluster defined as class 1 in Table 4 is separated into two clas­
ses. Three patterns of class 1 are misclassifled (patterns MG04, 
MG05 and FO04), and two patterns of class 2 are misclassifled 
(patterns FH06, MT06), as is one pattern of class 3 (pattern FG05). 
The patterns of the evaluation set all obviously belong to a dis­
tinct class. Based on this KARLOV projection, a new training set 
and a new evaluation set were formed (Table 9). For cholesterol, 
Fig. 3 reveals that two patterns of the evaluation set and one 
pattern of class 2 do not definitely belong to class 1 or class 
2. All other patterns of the evaluation set classifiy obviously 
in a category. For cholesterol, a new training set and a new evalu-
68 
Table 4 
Hierarchal clustering of the patterns for glucose based on the unweighted descriptors 
Cluster defined 
as class 
Pattern Similarity values 
EMiluation set 
FG01 
FG03 
MG01 
APO 2 
MT04 
MG06 
MG02 
MG05 
MG03 
FG04 
AP03 
AP04 
DH05 
DH06 
DH03 
AP01 
FO01 
FO03 
FO02 
FO05 
FO06 
MT01 
MT06 
MT03 
FH04 
FH06 
FO04 
MG04 
FG06 
FG05 
FH03 
DH04 
AP05 
AP06 
MT06 
FH01 
FG02 
FH02 
FH05 
MT02 
Î0 8 2 
0 75 
0 70 
0 67 
0 65 
- ш и з 
-^HOJ 
0 73 
0 35 
Table 5 
Hierarchical clustering of the patterns for cholesterol based on the unweigh­
ted descriptors d u l l e r dtf ined P i l l e r a 
a i c l u * 
2 MbU4 
ME06 
CE06 
МБ0Б 
D b 0 6 
CE04 
CE01 
C E 0 2 
C E 0 3 
DEO I 
D E 0 3 
OE0J 
D E 0 4 
MEU1 
ME02 
M E 0 3 
P E 0 2 
F E 0 4 
F E 0 5 
FE(16 
FECI 
DEOb 
F E 0 3 
CEOS 
Evalu i l ion ie t 
Evaluation Mt 
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Table 6 
Fisher weightings and eigenfunctions based on the Fisher-weighted features for 
the descriptors of the training set for inorganic phosphate 
Descriptor 
RELMV 
RELSD 
PERCREM 
LABDEV 
Eigenvalues 
WtF)^ 
11.60 
43.39 
34.55 
78.98 
Info(E), (% 
W(F) matrix ],m,n 
X 
of 
i o 2 % of 
total 
6.9 
25.7 
20.5 
46.9 
total) of 
Eigenvector 
(columns) 
0.0296 
0.0084 
0.2897 
0.9566 
71.4 
s of the 
-0.1539 
-0.9543 
-0.2414 
0.0863 
21.4 
W(F) 
] ,m,n 
-0.0085 
-0.2578 
0.9254 
-0.2778 
6.3 
matrix 
-0.9876 
-0.1512 
-0.0383 
-0.0176 
0.9 
Table 7 
Fisher weightings and eigenfunctions based on the Fisher-weighted features for 
descriptors of the initial training set for glucose 
Descriptor W(F) χ 10 % of Eigenvectors of the W(F) matrix 
Ί . 1»m,n 
J
 total (columns) J 
RELMV 
RELSD 
PERCREM 
LABDEV 
36.15 
1.33 
15.99 
8.45 
50.3 0.9705 
1.8 -0.0001 
36.1 -0.2334 
11.8 -0.0600 
Eigenvalues Info(E) (% of total) of 
W(F) matrix 
j ,m.n 
65.6 
0. 
0. 
0. 
0. 
,2400 
.0069 
.9582 
,1555 
-0. 
0. 
0. 
-0. 
.0211 
.0447 
.1654 
.9850 
0. 
0. 
-0. 
-0. 
.0027 
.9990 
.0008 
.0452 
31.8 2.5 0.1 
Table θ 
Fisher weightings and eigenfunctions based on the Fisher-weighted features for 
the descriptors of the initial training set for cholesterol 
Descriptor 
RELMV 
RELSD 
PERCREM 
LABDEV 
Eigenvalues Info 
W(F). matrix ],m,n 
WtF)^ 
62.69 
0.47 
4.96 
72.09 
( E) k (% 
X 
of 
i o 2 % of 
total 
44.7 
0.4 
3.5 
51.4 
total) of 
Eigenvectors of the 
(columns) 
-0.0933 
0.0012 
0.0285 
0.9952 
57.0 
-0.9956 
0.0020 
-0.0059 
-0.0932 
42.Э 
W(F) 
],m,n 
-0.0031 
0.0236 
0.9993 
-0.0289 
0.2 
matrix 
0.0021 
0.9997 
-0.0236 
-0.0003 
0.0 
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Fig. 1. Pro ject ion of the t r a i n i n g s e t for inorganic phosphate on a plane de­
fined by the most important e igenvectors of the Karhunen-Loève t ransformation 
l i s t e d in Table 6. Pa t t e rns are ind ica ted by the abbrev ia t ions defined in 
Table 2. Pa t t e rns of c l a s s e s defined in Table 3 are depicted by the ind ica ted 
symbols. Classes de tec ted in the KARLOV pro jec t ion are depicted by l i n e s . 
Fig. 2. Project ion of the i n i t i a l t r a i n i n g and evaluat ion s e t for glucose on 
a plane defined by the most important e igenvectors of the Karhunen-Loève t r a n s -
formation l i s t e d in Table 7. Pa t t e rns are ind ica ted by the abbrev ia t ions de-
fined in Table 2. Pa t t e rn s of c l a s se s defined in Table 4 are depicted by the 
indicated symbols. Classes dected in the KARLOV pro jec t ions a re depicted by 
l i n e s . 
a t i o n s e t w e r e a l s o fo rmed ( T a b l e 9) 
FINAL TRAINING SETS OF PHOSPHATE, GLUCOSE AND CHOLESTEROL 
The d e s c r i p t o r w e i g h t i n g s f o r t h e f i n a l t r a i n i n g s e t s f o r p h o s -
p h a t e , g l u c o s e and c h o l e s t e r o l a r e l i s t e d i n T a b l e s 6 and 1 0 . Af-
t e r t h e r e l a t i v e i m p o r t a n c e of t h e f e a t u r e s f o r c l a s s i f i c a t i o n 
had b e e n d e t e r m i n e d , t h e c l a s s i f i c a t i o n s b a s e d on t h e h i e r a r c h a l 
c l u s t e r i n g and on t h e m i n i m a l s p a n n i n g t r e e w e r e r e - e v a l u a t e d i n 
a s u p e r v i s e d c a l c u l a t i o n by u s i n g t h e f o u r d e s c r i p t o r s F i s h e r -
w e i g h t e d f o r t h e v a r i o u s c l a s s e s f o r t h e t h r e e s e r u m c o m p o n e n t s . 
The r e s u l t s a r e p r e s e n t e d i n T a b l e s 1 1 - 1 3 f o r HIER, and F i g . 4 
f o r TREE, f o r p h o s p h a t e , g l u c o s e and c h o l e s t e r o l . 
HIER. F o r g l u c o s e ( T a b l e 12) c l a s s 1 i s s e p a r a t e d i n t o two s m a l l -
e r c l a s s e s b o t h c o m b i n e d a t s i m i l a r i t y l e v e l 0 . 7 2 . F o r p h o s p h a t e 
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and cholesterol, the classes are not further subdivided. 
Table 9 
Composition of the classes of the final training set and the evaluation set 
for glucose and cholesterol based on the KARLOV projections of Figs. 2 and 3, 
respectively 
Class Patterns 
Glucose 
Training set 
Evaluation set 
Cholesterol 
Training set 
Evaluation set 
FH01, FH02, FH06, DH03, DH05, DH06, MG01, 
MG02, MG06, MT04 
FH03, FH05, DH04, MG04, MG05, MT02, MT05, 
MT06, AP06, FG06 
FG01, FG02, FG03, FG04, FG05, AP03, AP04, 
MG03 
F001, FO02, FO03, F004, FO05, FO06, MT01, 
MT 03 
FH04, AP01, AP02, AP05 
FE02, FE04, FE05, FE06, ME01, ME02, ME03, 
DE05 
ME05, ME06, CE06, DE06 
CE01, CE02, CE03, CE04, CE05, DE01, DE02, 
DE03, DE04 
FE01, FE03, ME04 
CEOi 
«5 о 
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Fig. 3. Projection of the initial training and evaluation set for cholesterol 
on a plane defined by the most important eigenvectors of the Karhunen-Loève 
transformation listed in Table 8. Patterns are indicated by the abbreviations 
defined in Table 2. Patterns of classes defined in Table 5 are depicted by 
the indicated symbols. Classes detected in the KARLOV projection are depicted 
by lines. 
72 
Table 10 
Fisher weightings and eigenfuntions based on the Fished-weighted features for 
the descriptors of the final training set for glucose and cholesterol 
2 Descriptor W(F) χ 10 % of Eigenvectors of the W(F) matrix 
1
 total (columns) : b m' n 
Glucose 
RELMV 
RELSD 
PFRCREM 
LABDEV 
100.10 
1.83 
53.79 
2.15 
65.6 
1.1 
32.0 
1.3 
0.9999 
0.0017 
-0.0122 
-0.0032 
-0.0122 
0.0021 
-0.9998 
-0.1030 
-0.0035 
0.4377 
0.0127 
-0.08990 
-0.0002 
0.8991 
-0.0039 
0.4377 
Eigenvalues Info (E) (% of total) of 
W(F) matrix ],m,n 80.7 19.3 0.0 0.0 
Cholesterol 
RELMV 
RELSD 
PERCREM 
LABDEV 
58.16 
0.02 
1.53 
64.47 
46. 
0. 
1. 
51, 
.8 
.1 
.2 
.9 
0.3582 
-0.0000 
0.0078 
0.9336 
-0.9337 
0.0001 
0.0077 
0.3581 
-0.0044 
0.0030 
-0.9999 
0.0101 
0.0001 
1.0000 
0.0001 
-0.0001 
Eigenvalues Info (E) (% of total) of 
W(F) matrix 
] .m.n 
56.9 43.1 0.0 0.0 
TREE. For all three constituents the patterns of the analytical 
methods are arranged according to the classes formed. Fig. 4A 
shows the spanning tree for phosphate in which the lengths of the 
interconnecting lines between the patterns represent distances 
D ; in this supervised method, TREE calculated a singel cluster. 
Figure 4B shows the tree for glucose; TREE calculated three clus­
ters combining class 1 and 3. For cholesterol (Fig. 4C) TREE cal­
culated three clusters in accordance with the three classes. 
KARLOV projections. The Karhunen-Loève projections of the patterns 
of the final training set for phosphate have been presented in 
Fig. 1. For glucose and cholesterol the first two eigenvectors 
of the Fisher-weighted data of the respective final training sets 
yield 100% of all information, as can be seen from Table 10. Fi-
gure 5 presents the projections of the patterns of the final trai-
ning sets and the evaluation sets on planes defined by the first 
two eigenvectors for glucose and cholesterol, respectively. The 
results improve the class separation given by HIER and TREE for 
glucose in separating classes 1 and 3, and confirm the classes 
of phosphate and cholesterol. 
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OTHER SUPERVISED CLASSIFICATION METHODS 
Supervised classification methods were applied to the training 
and evaluation sets of the various serum constituents. One of tho­
se methods is based on the nearest neighbour of a Fisher weighted 
pattern vector in the η-dimensional space by using distances D. . 
as previously defined. The results of 1-5 nearest neighbour classi 
fications are considered here. 
Table 11 
Hierarchical clustering of the patterns of the final training set for inorganic 
phosphate based on the Fisher-weighted descriptors 
cu» 
г 
э 
For glucose, DH03 was misclassifled once in class 3. All other 
patterns of phosphate, glucose and cholesterol were unequivocally 
correctly classified by their neighbors. A second classification 
with supervision was based on the binary classifier PLANE, that 
separates all possible pairs of classes by using negative feed­
back training. The classification with PLANE indicates the qua­
lity of the training set because, when one or more class separa­
tions are unsuccessful, the quality of the training set classi­
fication is usually poor and its success as a classifier is limi­
ted. The separation with PLANE was 100% successful for all pairs 
of classes for all three serum components. 
The classification by the various methods of the members of the 
evaluation sets are summarized in Table 14. Even though the clas­
sification of these patterns is not as explicit as the classifi-
Similanly values 
FS04 
FN04 
FN02 
FS02 
FSOS 
FS01 
FN03 
FS03 
MFCS 
MFOe 
MO05 
MF03 
MO01 
MO03 
FN01 
MF01 
MF04 
MO02 
MF02 
MO04 
FS06 
ЧО06 
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cation of the members of the training sets, it can be observed 
that the patterns of the various analytical methods usually are 
classified in the classes where the patterns of the corresponding 
methods of the training sets cluster. 
Table 12 
Hierarchical clustering of the patterns of the final training set for glucose 
based on the Fisher-weighted descriptors. 
FG01 
FG03 
FG02 
MG03 
AP03 
FG05 
MG01 
FH01 
DH03 
FG04 
AP04 
FH02 
DH06 
MG02 
FH06 
DH05 
MG06 
MT04 
MT02 
MT05 
FHOS 
MG05 
DH04 
MT06 
AP06 
MG04 
FG06 
FH03 
MT01 
FO05 
FO06 
F004 
FH03 
FO01 
FO02 
FO03 
Similarity values 
1 0 
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Table 13 
Hierarchical clustering of the patterns of the final training set for choleste­
rol based on the Fisher-weighted descriptors 
Claa 
3 
2 
Pattern 
СЕОЭ 
DE01 
CE02 
DE03 
DE04 
CE04 
DE02 
CE01 
CE05 
ME06 
CE06 
DE06 
ME05 
FE02 
ME02 
ME01 
FE05 
FE06 
FE04 
DE05 
ME03 
Similarity value! 
1 0 
^ 1 0 92 
^ 0 90 
53 
-1097 
-1 10 90 . 
— , 0 95 
— [ 0 9 5 
— Г - | 0 92 
1 
ι 
0 5 
0 78 
0 78 
In TT 
0 55 
0 
0 7 5 
"Vi ττ 
Οββ 
5 
0 42 
p j 
0 0 
Conclusions 
From the results presented, it can be concluded that the strategy 
followed in applying the various pattern recognition techniques 
can be successful for discrimination between analytical methods 
that are described by the four features used above. The detected 
clusters, defined as classes, often contain a majority of the pat­
terns of one single method or are formed by patterns of analyti­
cal methods based on similar techniques (see Tables 3 and 9 in 
combination with Table 2). Another merit of the pattern recogni­
tion techniques is the revelation that, for different serum com­
ponents, the four features alternately are of importance in dis­
criminating between the clusters. The feature values of the vari­
ous classes are measures of the quality of these classes. The fre­
quency of appearance of the patterns of an analytical method in a 
particular class can be correlated with the performance of that 
method. If most of the patterns of an analytical method cluster 
in the class with the best feature values, this analytical method 
can be recommended. If the patterns of an analytical method belong 
to many different classes or to no class at all, the method can be 
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disapproved. Other analytical methods can be approved, if neces-
sary, with annotations concerning the feature values to be expec-
ted. Thus pattern recognition offers the possibility of assessing 
analytical methods objectively. 
The number of patterns is still limited, but as a practical exam-
ple, the following recommendations can be made tentatively for 
glucose. Both automatic hexokinase techniques considered can be 
recommended as the majority of their patterns classify in the 
best category (category 1: no bias; lowest PERCREM values). The 
continuous flow-glucose oxidase techniques can also be approved, 
is well as the automatic Polarographie techniques; both would have 
the annotation: slight negative bias. The continuous flow-aspeci-
fic oxidizing agent techniques should be approved also (annotation: 
positive bias). Both manual techniques should be disapproved be-
cause the patterns considered are classified in three categories. 
Fig. 4. Zahn minimal spanning tree of the final training set patterns based 
on Euclidean distances and Fisher-weighted descriptors. (-) cluster calcula-
ted by TREE; ( ) class defined in Tables 3 and 9. (A) Inorganic phosphate; 
(B) glucose; (C) cholesterol. 
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Fig. 5 Projection of the final training set and evaluation set for (A) glucose 
and (B) cholesterol, on a plane defined by the most important eigenvectors of 
the Karhunen-Loève transformation listed in Table 10. Patterns are indicated 
by the abbreviations defined in Table 2. Patterns of classes defined in Table 
9 are depicted by the indicated symbols. Classes detected in the KARLOV pro-
jection are depicted by lines. 
Table 14 
Classification of te members of the evaluation sets for glucose and choleste-
rol by various classification methods 
Pattern KARLOV 
projection 1-2 
KNN PLANE 
Glucose 
Cholesterol 
FH04 
AP01 
AP02 
AP05 
FE01 
FE03 
ME04 
1(4) 
3(1) 
3(1) 
2(3) 
1(2) 
1(2) 
1(2) 
1(4) 
3 
3(1) 
3(2) 
1 
1 
1(2) 
4 
3 
3 
3 
1(2) 
1 
1 
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Chapter 3.2 
A TECHNIQUE FOR THE OBJECTIVE ASSESSMENT OF ROUTINE ANALYTICAL 
METHODS IN CLINICAL LABORATORIES USING PATTERN RECOGNITION 
Rob T.P. Jansen, Frans W. Pijpers and Geert A.J.M, de Valk 
Annals of Clinical Biochemistry, 18 (1981) 218-225 
Summary 
A technique is presented to assess objectively the reliability of 
analytical methods used routinely in clinical laboratories. From 
the Netherlands National Coupled External/Internal Ouality Control 
Program information can be gathered about the oerformance of rou-
tine analytical methods. The performance of a method in a trial 
is described by four 'features': the accuracy of a method; its 
day-to-day precision; its susceptibility to give erroneous results 
(eg, extreme bias, drift, extreme week-to-week variations); and 
its susceptibility to give systematic errors for different labo-
ratories. These four features obtained in a trial for a given 
analytical method determine the position of a 'pattern' in the 
four-dimensional space. The results of six trials discussed in 
this paper orovided six 'patterns' per analytical method. Using 
pattern recognition techniques, clusters of patterns were detected 
in the four-dimensional space. A weighting procedure revealed the 
relative importance of the various features for discrimination be-
tween the detected clusters. For various blood components, differ-
ent features are of importance for this discrimination. Patterns 
belonging to the same clusters appeared to be patterns of the same 
(or comparable) analytical methods; thus analytical methods could 
be distinguished from each other. The means of the feature values 
of the patterns in a cluster determine the quality of that cluster. 
Thus the quality of an analytical method can be objectively asses-
sed. Some tentative conclusions on the validity of analytical 
methods are given. 
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Introduction 
A major problem in clinical laboratories is the objective assess-
ment of analytical methods for routine use. The selection of a 
method and the criteria used in making this choice are of funda-
mental importance [1]. The expert panel on 'nomenclature and prin-
ciples of quality control in clinical chemistry' of the IFCC sta-
ted that, in considering the suitability of an analytical method, 
information should be obtained about the practicability (speed, 
cost, technical skill requirements, dependability, and laboratory 
safety) and its reliability (specificity, accuracy, precision, 
and detectability) [1]. In practice, objective information about 
the reliability of an analytical method is difficult to obtain. 
In this paper a technique is described for the objective assess-
ment of the reliability of analytical methods. 
Information about this reliability is obtained from the 'Nether-
lands national coupled external/internal quality control program' 
[2]. In this program each participant analyses a lyophylised se-
rum sample five times a week during eight consecutive weeks for 11 
serum components. Statistical analysis of the results encompasses 
an analysis of variance. This analysis of variance allows detec-
tion of sources of error which contribute to the total variance 
of all the results obtained for a given serum component. These 
sources of error include: systematic mterlaboratory errors; time 
effects in the results of a large group of laboratories (for in-
stance, caused by instability of a control serum sample); and 
time effects in the results of individual laboratories (eg, re-
sults increasing or decreasing with time, significant week-to-
week variability, and significant within-week variances). 
The results contributing significantly to sources of error detec-
ted in the analysis of variance are removed from the computations 
in a second and third computer run. In the final run a 'reference' 
value and a 'reference' day-to-day standard deviation (SD) are 
computed [2]. This'reference' SD equals the square root of the 
residual variance computed in the analysis of variance of the fi-
nal run. The 'reference' value is computed from the accepted re-
sults as an overall mean value corrected for systematic mterla-
boratory and time effects. It has proved to agree well with the 
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true value [2]. In the final computer run mean values and day-to-
day SDs are also computed for the various analytical methods. 
These values are calculated from the mean values and day-to-day 
SDs of the laboratories using these methods. An assumption under-
lying analysis of variance is a normal distribution of data. For 
cholesterol this distribution is not normal if the chemical me-
thods and the enzymatic methods are considered together. For this 
reason separate procedures are followed for the two analysis prin-
ciples . 
The method means and method SDs should meet the criteria set by 
the 'reference' value and 'reference' SD. Thus the method mean 
relative to the 'reference' value and the method SD relative to 
the 'reference' SD can be considered as two 'features' describing 
the performance of an analytical method in a trial. In the final 
computer run results are removed from the computations that con-
tributed significantly to a source of error in the analysis of 
variance of the previous runs. The percentage results removed for 
a given analytical method is also considered as a 'feature' that 
describes performance. Although the method mean possibly shows no 
bias with respect to the 'reference' value, the laboratory means 
of the individual participants using a particular analytical me-
thod can. This laboratory bias is considered as a fourth descrip-
tive 'feature'. 
In summary, four parameters derived from the coupled external/in-
ternal quality control scheme are used to describe the various 
methods : 
1. accuracy or susceptibility of a method to give results in 
agreement with the 'reference' value; 
2. precision or susceptibility of a method to day-to-day variation; 
3. susceptibility of a method to 'removal of results' caused by 
significant between-weeks variability, significant within-
week variability, drifting values, extreme bias in the results 
of participants applying the method as detected in the analysis 
of variance; [2] 
4. susceptibility of a method to give systematically different 
results for different users. 
The vector formed by these four features defines the position of 
a point for that method in the four-dimensional space. Such a 
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point is called a 'pattern'. The results of six trials discussed 
in this paper provided a maximum of six patterns per analytical 
method. 
For practical reasons it was decided that at least four partici-
pants should apply an analytical method before it could be incor-
porated in the study. To detect clusters of patterns in the four-
dimensional space, pattern recognition techniques were applied. 
Inability to detect separate clusters would indicate that the 
analytical methods all perform equally well (or badly). Detection 
of more than one cluster would indicate a different behaviour of 
patterns. To de-
monstrate a constant behaviour of an analytical method in the 
various trials the patterns of that method should be found in the 
same cluster. Also a pattern of that method obtained from a fu-
ture trial should be found in the cluster to which the majority 
of the patterns of that method belong. To detect possible sensi-
tivity of analytical methods to the serum matrix (ie, the milieu 
in which the analyte is present) lyophylised serum preparations 
from different manufacturers were used in the various trials. Hu-
man, bovine, as well as horse serum preparations were employed. 
If patterns of a method belong to many different clusters, sensi-
tivity to serum matrix of the method could be the cause. 
Analytical methods were defined according to the method codes of 
the Stichting Kwaliteitsbewaking Klinisch Chemische Ziekenhuis 
Laboratoria (Foundation for Quality Control in Clinical Chemistry 
Hospital Laboratories) [3] in which two descriptive parameters 
are used: the chemical reaction principle, and the instrumental 
methodology (manual, continuous-flow, discrete, centrifugal, etc.). 
The aims of the Foundation are the ability to recommend, approve, 
or disapprove analytical methods objectively. In this investiga-
tion the possibility is indicated of obtaining objective informa-
tion about the reliability of analytical methods. 
As examples, the results for various analytical methods for the 
determination of inorganic phosphate, glucose, and cholesterol 
(only enzymatic methods) are given. The three examples given 
illustrate the varying importance of the features in discrimina-
ting between the analytical methods for different analytes. They 
also demonstrate that manual and automatic techniques can be dis-
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tinguished for one analyte but not for another. 
General approach to the problem and results 
STARTING DATA 
Pattern recognition techniques, which are part of the computing 
program ARTHUR, were applied to the results of six eight-week 
trials of the external/internal program in order to reveal whether 
analytical methods defined as m the Introduction could be dis-
tinguished from each other by the information content of the four 
descriptive features mentioned. In each trial a different lyophy-
lised serum preparation was used to detect possible sensitivity 
for matrix effects of analytical methods. From the results of the 
trials it appeared that none of the six samples used was non-ho-
mogeneous or unstable for the duration of the trial period. In 
Table 1 the abbreviations used for the various analytical methods 
are listed. The number of participants for each method in the va-
rious trials is summarised in Table 2. The descriptive features 
Table 1 
Abbrpviations used for the notation of the patterns of the various methods 
applied in the various trials 
Serum component abbreviation Principle of the analytical method 
Inorganic phosphate 
FStn* Automatic, continuous-flow system, 
SnCl reduction 
FNtn Automatic, continuous-flow system, 
no reduction 
MFtn Manual, Fe(II)-salt reduction 
MOtn Manual, organic reduction reagents 
Glucose 
FHtn Automatic, continuous-flow system, 
hexokmase 
DHtn Automatic, discrete, hexokmase 
MGtn Manual, glucose oxidase 
FGtn Automatic, continuous-flow system, 
o-toluidine 
APtn Automatic, Polarographie 
FOtn Automatic, continuous-flow system, 
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Serum component 
Cholesterol 
abbreviation Principle of the analytical method 
non-specific oxidating reagents 
FEtn 
DEtn 
CEtn 
MEtn 
Automatic, continuous-flow system, 
enzymatic 
Automatic, centrifugal fast analyser, 
enzymatic 
Automatic, centrifugal fast analyser, 
enzymatic 
manual, enzymatic 
*tn = Trial Number 
Table 2 
Number of participants applying a particular method in a particular trial 
Method Trial 01 Trial 02 Trial 03 Trial 04 Trial 05 Trial 06 
Inorganic phosphate 
FS 
FN 
MF 
MO 
Glucose 
FH 
DH 
MG 
FG 
MT 
AP 
FO 
Cholesterol 
(enzymatic ι 
FE 
DE 
CE 
ME 
7 
4 
20 
8 
4 
--
5 
8 
5 
5 
11 
rcethods) 
7 
5 
8 
6 
8 
4 
21 
7 
4 
— 
6 
7 
4 
7 
11 
10 
5 
7 
7 
9 
4 
21 
7 
4 
4 
5 
8 
4 
6 
9 
10 
6 
7 
6 
10 
4 
21 
7 
5 
4 
5 
9 
4 
5 
12 
6 
7 
8 
10 
20 
7 
4 
4 
9 
4 
5 
9 
11 
6 
7 
7 
21 
7 
4 
4 
4 
8 
4 
5 
8 
11 
6 
8 
6 
of each pattern as defined in the Introduction are computed with 
the following algorithms: 
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feature_l: mean value of a particular method relative to the "re­
ference" value (RELMV): 
X - X -
_!B ΈΕ1 * 100% 
ref 
where X is the mean value of the method computed after exclusion 
of erroneous results [2] in a particular trial 
X , is the "reference" value [2] in that trial 
ref 
feature_2: day to day standarddeviation relative to the "reference" 
standarddeviation (RELSD): 
m 
SD , 
ref 
where SD is the standarddeviation of the method computed from 
the standarddeviations of the laboratories applying it after ex­
clusion of results contributing significantly to a source of va­
riance in the analysis of variance of [2] a particular trial. 
SD , is the "reference" standarddeviation [2] in that trial 
£§Ё£У£Ё_3: Percentage removals (PERCREM) 
R 
rem 
* 100% 
Rtot 
where R is the number of removed results of laboratories using 
rem ^ 
a particular method in a particular trial [2] 
R. . is the total number results for that method in that tot 
trial. 
feature_4: Mean relative deviation of the mean values of labora­
tories applying a particular method from the method 
mean (LABDEV): 
Г N |X - X | ι 
100 * Σ — ì nL 
'•1 = 1 X J 
/N 
where X is the mean value of each laboratory (where ι = 1 ...N) 
using the method in a particular trial before any removal of re­
sults [2] 
X is the mean value of that method in that trial after re­in 
moval of erroneous results [2] 
N is the number of laboratories applying that method in the 
86 
trial under investigation. 
Tables 3, 4, and 5 give the numerical values of the various fea-
tures for the patterns of inorganic phosphate, glucose, and cho-
lesterol (enzymatic methods) respectively. 
PATTERN RECOGNITION STRATEGY 
A detailed descriotion of the pattern recognition techniques 
Table 3 
Original non-autoscaled numerical values of the four descriptive features for 
the patterns of inorganic phosphate 
Pattern RELMV* RELSD PERCREM LABDEV 
FS01 
02 
03 
04 
05 
06 
FN01 
02 
03 
04 
MF01 
02 
03 
04 
05 
06 
MO01 
02 
03 
04 
05 
06 
-2.37 
-3.54 
-0.63 
0.0 
-1.23 
-0.91 
0.0 
-3.45 
-1.26 
-2.92 
0.59 
0.88 
0.63 
0.73 
0.0 
1.82 
-1.18 
0.0 
0.0 
-0.73 
0.0 
-2.73 
0.75 
1.00 
0.75 
1.00 
1.00 
1.00 
1.50 
1.00 
0.75 
1.00 
1.25 
1.33 
1.25 
1.33 
1.33 
1.33 
1.50 
1.33 
1.50 
1.00 
1.33 
1.00 
0.0 
12.5 
11.1 
0.0 
15.0 
34.7 
0.0 
0.0 
0.0 
0.0 
50.0 
19.1 
23.8 
23.8 
20.6 
22.6 
12.5 
28.6 
14.3 
42.9 
30.4 
28.6 
2.68 
2.41 
1.48 
2.55 
2.00 
4.49 
2.22 
1.83 
2.97 
2.26 
1.44 
4.93 
2.14 
3.93 
2.50 
2.72 
1.65 
4.42 
1.71 
4.71 
2.47 
3.34 
*See text for abbreviations 
Table 4 
Original non-autoscaled numerical values of the four descriptive features for 
the patterns of glucose 
Pattern RELMV* RELSD PERCREM LABDEV 
FH01 -1.42 1.06 0.0 5.18 
02 0.37 0.83 0.0 4.10 
03 -0.80 0.87 33.3 5.07 
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Pattern RELMV* RELSD PERCREM LABDEV 
FH04 
05 
06 
DH03 
04 
05 
06 
MG01 
02 
03 
04 
05 
06 
FG01 
02 
03 
04 
05 
06 
MT01 
02 
03 
04 
05 
06 
AP01 
02 
03 
04 
05 
06 
FOOI 
02 
03 
04 
05 
06 
2.28 
1.65 
0.94 
-2.25 
0.0 
0.73 
0.31 
-1.73 
0.19 
-2.09 
-1.05 
-0.37 
-0.63 
-2.36 
-2.62 
-2.09 
-3.34 
-2.19 
-1.25 
3.46 
2.24 
4.49 
-0.35 
1.Θ3 
0.63 
-3.93 
-3.18 
-2.09 
-4.22 
-2.93 
0.63 
4.40 
5.61 
5.30 
3.34 
3.29 
3.60 
1.00 
0.50 
0.93 
1.25 
0.80 
1.21 
1.33 
1.06 
1.00 
1.19 
1.00 
1.14 
1.13 
1.00 
0.94 
1.00 
1.27 
1.07 
1.07 
1.35 
1.33 
1.38 
1.13 
1.00 
1.27 
1.41 
1.17 
1.31 
1.27 
1.29 
1.27 
1.06 
1.28 
1.00 
1.13 
1.21 
1.20 
0.0 
25.0 
0.0 
0.0 
25.0 
0.0 
0.0 
0.0 
0.0 
20.0 
40.0 
25.0 
3.1 
12.5 
14.3 
12.5 
11.1 
26.4 
37.5 
20.0 
50.0 
0.0 
0.0 
50.0 
25.0 
0.0 
0.0 
16.7 
20.0 
45.0 
40.0 
9.1 
9.1 
11.1 
0.0 
15.3 
25.0 
2.47 
2.88 
1.36 
0.71 
2.72 
1.50 
1.68 
1.95 
3.26 
2.75 
3.02 
2.71 
3.15 
2.07 
6.61 
2.60 
3.47 
4.30 
2.65 
1.31 
7.95 
0.96 
2.65 
1.17 
1.52 
2.45 
2.68 
3.04 
1.58 
2.75 
4.45 
3.23 
3.56 
2.05 
0.89 
2.62 
1.94 
'See text for abbreviations 
aoülied to these patterns has been published elsewhere [4]. 
For each serum component the problem was approached with the same 
strategy: 
a. Patterns, each representing results of a particular method of 
individual trials, are positioned in the four dimensional soace 
spanned by the four autoscaled and unweighted features. An auto-
scaling procedure is performed to obtain comparable axes for 
the four features. The features are each scaled to a mean of 
zero and SD of l/v/n(n = number of patterns). 
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Table 5 
Original non-autoscaled numerical values of the four descriptive features for 
the patterns of cholesterol (enzymatic methods) 
Pattern 
FE01 
02 
03 
04 
05 
06 
DE01 
02 
03 
04 
05 
06 
CE01 
02 
03 
04 
05 
06 
ME01 
02 
03 
04 
05 
06 
RELMV* 
3.59 
0.92 
1.19 
1.03 
-0.98 
-0.67 
-0.90 
-1.53 
-0.60 
-0.77 
1.96 
3.34 
-2.10 
-0.31 
-0.99 
-1.80 
-3.91 
1.67 
1.20 
0.61 
0.0 
0.77 
2.93 
2.01 
RELSD 
1.00 
1.20 
2.08 
1.40 
1.07 
1.00 
0.85 
0.60 
1.17 
0.80 
0.71 
0.90 
1.46 
1.20 
1.42 
1.40 
1.64 
1.40 
1.08 
1.40 
1.33 
1.30 
1.00 
1.30 
PERCREM 
28.6 
40.0 
10.0 
41.7 
37.5 
27.3 
0.0 
40.0 
0.0 
33.3 
50.0 
2.1 
12.5 
14.3 
14.3 
28.6 
42.9 
35.9 
16.7 
0.0 
16.7 
25.0 
19.6 
18.8 
LABDEV 
5.90 
5.20 
4.55 
6.61 
6.04 
5.42 
1.99 
3.24 
2.72 
2.86 
6.91 
3.58 
3.82 
2.07 
2.42 
3.22 
4.33 
3.17 
5.47 
5.08 
7.52 
3.93 
2.00 
3.11 
*See text for abbreviations 
b. Detection of clusters of patterns with similar numerical fea-
ture values in that four-dimensional space applying the hier-
archical clustering [5] and the Zahn minimal spanning tree [6] 
techniques; 
c. defining these clusters as classes; 
d. ranking of the relative importance of the various features for 
the discrimination between the classes by means of the Fisher 
weighting procedure; [7] 
e. control of the classification by various supervised classifi-
cation techniques: Karhunen-Loêve projections [8], nearest 
neighbour classification [7], and linear pattern classification 
by negative feedback training [9]; 
f. interpretation: after the classification has been confirmed and 
the weighting procedure has revealed the most important dis-
criminating features, the composition of the classes is studied 
to check whether patterns of corresponding analytical methods 
89 
have been clustered. The quality of the various classes was asses-
sed by comparison of the original non-autoscaled numerical values 
of the most important discriminating features of the patterns 
clustering in these classes. With this procedure very well sepa-
rated clusters of patterns were detected for inorganic phosphate 
as well as for glucose and cholesterol (enzymatic methods)[4]. 
This indicated that for all three analytes groups of patterns were 
found which behaved differently. The weighting procedures in com-
bination with Karhunen-Loëve projections [4] revealed that for 
different serum components the ranking of features for discrimin-
ation between the clusters was different. 
ResuIts 
Table 6 shows the relative percentage contribution to the total 
information of the various features for the three analytes. From 
this table it can be seen that for inorganic phosphate three fea-
Table 6 
Relative percentage contribution to the total information of the various fea-
tures for discrimination between the clusters 
RELMV* 
RELSD 
PERCREM 
LABDEV 
inorganic 
Phosphate 
6.9% 
25.7% 
20.5% 
46.9% 
Glucose 
65.6% 
1.1% 
32.0% 
1.3% 
Cholesterol 
(enzymatic methods) 
46.8% 
0.1% 
1.2% 
51.9% 
:See text for abbreviation 
tures are of importance for the discrimination between the clus-
ters: the relative mean value hardly contributes. For glucose two 
features contain 97% of all information for discrimination between 
the clusters. For this analyte the relative mean value is the 
most important discriminatory feature in contrast to its contri-
bution for inorganic phosphate. Also the percentage of removed 
values is of importance for glucose. For cholesterol (enzymatic 
methods) the relative mean value is an important discriminator 
but here the percentage of removed values hardly contributes; 
LABDEV is of importance. For both glucose and cholesterol it 
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appeared that the relative SD is not of importance in discrimina-
ting between the clusters. 
In Tables 7, 8, and 9 the mean values and the ranges of the origi-
nal numerical values of the most important discriminating features 
are listed for the various detected clusters for inorganic phos-
phate, glucose, and cholesterol respectively. 
Table 7 
D e t e c t e d c l u s t e r s w i t h o r i g i n a l mean v a l u e s and n u m e r i c a l r a n g e s of t h e most 
i m p o r t a n t d i s c r i m i n a t i n g f e a t u r e s f o r i n o r g a n i c p h o s p h a t e 
C l u s t e r P a t t e r n F e a t u r e Mean Range 
Class 1 
Class 2 
Class 3 
FSOl 
FS02 
FS03 
FSÛ4 
FS05 
FN02 
FN03 
FN04 
MF01 
MF03 
MF05 
MF06 
MO01 
MO03 
MO05 
FN01 
MF02 
MF04 
MOO 2 
MO04 
MO06 
FS06 
LABDEV* 
RELSD 
PERCREM 
LABDEV 
RELSD 
PERCREM 
LABDEV 
RELSD 
PERCREM 
2.3 
0.9 
4.8 
2.1 
1.4 
21.θ 
4.3 
1.2 
29.6 
1.5 -
0.8 · 
0.0 · 
1.4 -
1.3 -
0.0 · 
3.3 -
1.0 -
19.1 • 
- 3.0 
- 1.0 
- 15.0 
- 2.7 
- 1.5 
- 50.0 
- 4.9 
• 1.3 
- 42.9 
*See t e x t for abbrev ia t ions 
For i n o r g a n i c p h o s p h a t e (Table 7) t h r e e c l u s t e r s have been d e t e c ­
t e d . C l a s s 1 c o n s i s t s e x c l u s i v e l y of p a t t e r n s of c o n t i n u o u s - f l o w 
methods: f i v e o u t of s i x p a t t e r n s of t h e ' c o n t i n u o u s - f l o w SnCl 2 
r e d u c t i o n ' t e c h n i q u e s be long t o t h i s c l a s s , and t h r e e o u t of four 
p a t t e r n s of t h e ' c o n t i n u o u s - f l o w no r e d u c t i o n ' t e c h n i q u e s . The 
mean va lue for LABDEV in t h i s c l a s s i s s i m i l a r t o t h a t of c l a s s 
2 but t h e v a l u e s of PERCREM and RELSD for c l a s s 1 a r e b e t t e r than 
in t h e o t h e r c l a s s e s . C l a s s 2 c o n s i s t s mainly of p a t t e r n s of ma­
nua l t e c h n i q u e s : four o u t of s i x p a t t e r n s of t h e manual F e - s a l t 
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Table 8 
D e t e c t e d c l u s t e r s w i t h o r i g i n a l mean v a l u e s a n d n u m e r i c a l r a n g e s o f t h e m o s t 
i m p o r t a n t d i s c r i m i n a t i n g f e a t u r e s f o r g l u c o s e 
C l u s t e r P a t t e r n F e a t u r e Mean R a n g e 
C l a s s 1 
C l a s s 2 
C l a s s 3 
C l a s s 4 
FH01 
FH02 
FH04 
FH06 
DH03 
DH05 
DH06 
MG01 
MG02 
MG06 
MT04 
FH03 
FH05 
DH04 
MG04 
MG05 
MT02 
MT05 
MT06 
FG06 
AP06 
FG01 
FG02 
FG03 
FG04 
FG05 
AP01 
AP02 
fiP03 
AP04 
AP05 
MG03 
FO01 
FO02 
FO03 
FO04 
FO05 
FO06 
MT01 
MT03 
RELMV* 
RELMV 
RELMV 
RELMV 
- 0 . 1 - 2 . 3 - 2 . 3 
PERCREM 0 . 3 0 . 0 - 3 . 1 
0 . 4 - 1 . 3 - 2 . 2 
PERCREM 3 5 . 1 2 5 . 0 - 5 0 . 0 
- 2 . 8 - 2 . 1 - - 4 . 2 
PERCREM 1 6 . 2 0 . 0 - 4 5 . 0 
4 . 2 3 . 3 - 5 . 6 
PERCREM 1 1 . 2 0 . 0 - 2 5 . 0 
*See text for abbreviation 
r e d u c t i o n methods, t h r e e out of s i x p a t t e r n s of t he manual orga-
n i c r e d u c t i o n r e a g e n t s t e c h n i q u e s , and one out of four p a t t e r n s 
of t h e c o n t i n u o u s - f l o w n o n - r e d u c t i o n methods . C la s s 3 a l s o con-
s i s t s mainly of p a t t e r n s of manual t e c h n i q u e s : two out of s i x 
92 
Table 9 
Detected clusters with original mean values and numerical ranges of the most 
important discriminating features for cholesterol (enzymatic methods) 
Cluster 
Class 1 
Class 2 
Class 3 
Pattern 
CE01 
CE02 
CE03 
CE04 
CE05 
DE01 
DE02 
DE03 
DE04 
ME05 
ME06 
CE06 
DE06 
FE01 
FE02 
FE03 
FE04 
FE05 
FE06 
ME01 
ME02 
ME03 
ME04 
DE05 
Feature 
LABDEV* 
RELMV 
LÄBDEV 
RELMV 
LABDEV 
RELMV 
Mean 
3.0 
-1.4 
3.0 
2.5 
5.7 
0.9 
Range 
2.0 - 4.3 
-0.3 - -3.9 
2.0 - 3.6 
1.7 - 3.3 
3.9 - 7.5 
-1.0 - 3.6 
*See text for abbreviations 
patterns of the manual Fe-salt reduction and three out of six pat-
terns of the manual organic reduction reagents techniques cluster 
in this class as does one of the six patterns of the continuous-
flow SnCl2 reduction techniques. For inorganic phosphate continu-
ous-flow and manual techniques are clearly separated. 
For glucose (Table 8) four clusters were detected. In class 1 
mainly patterns of automatic hexokmase techniques and manual glu-
cose oxidase techniques are found. The patterns of this class show 
practically no bias and have the lowest PERCREM values. Class 2, a 
second class with almost no bias, is additionally characterised 
by high PERCREM values. This class contains the patterns of vari-
ous analytical methods but oarticularly the remaining patterns of 
the automatic hexokmase techniques belong to it. Class 3 is main-
ly formed by patterns of the continuous-flow glucose oxidase and 
the automatic Polarographie techniques. This class is characteri-
93 
sed by a negative bias and a mean PERCREM value of about 16% (com-
pare class 1: 0.3%). 
All patterns of the continuous-flow non-specific oxidating rea-
gents methods are found in class 4, which is characterised by a 
positive bias and a mean PERCREM value of 11%. 
For the enzymatic determination of cholesterol (Table 9) three 
clusters were detected. The majority of the patterns of the dis-
crete and the centrifugal analyser techniques classify in class 1. 
This class for cholesterol is characterised by a mean LABDEV va-
lue of 3% and a slight negative bias. Class 2 is formed by pat-
terns of various techniques and has a mean LABDEV value of 3% and 
a positive bias. Class 3 consists mainly of patterns of contmu-
ous-flovf and manual techniques. This class is characterised by 
high LABDEV values (a mean of about 6%) and a slight positive 
bias. 
Discussion 
In this investigation the results of 45 laboratories participa-
ting in six trials of the coupled external/internal quality con-
trol program have been used. To ensure reliable statistics based 
upon a sufficient number of patterns, a minimum of four partici-
pants per analytical method was set. In order to test whether a 
feature described a particular analytical method, and not a par-
ticular laboratory applying that method, it was checked whether 
a single laboratory was responsible for the value of a feature 
for a particular method in all six trials or in most of them. For 
all features it was found that no laboratory had dominating in-
fluence on the value of a feature in more than one trial. For in-
stance, for glucose four different participants were responsible 
for the values of PERCREM of the manual ortho-toluidine techni-
ques m the various trials (see Table 4); for cholesterol the main 
causes of the high values of LABDEV for the continuous-flow tech-
niques in the various trials (Table 5) were nine different labo-
ratories. The results for inorganic phosphate, glucose, and cho-
lesterol (enzymatic methods) are presented as examples to illu-
strate the application of pattern recognition techniques for the 
objective assessment of analytical methods. Similar results were 
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obtained for other serum constituents. Table 6 demonstrates that 
the biases and the day-to-day SD of analytical methods are not al-
ways of importance in the discrimination between clusters of pat-
terns of those methods. This implies also the necessity of descri-
bing analytical methods with more than these two usually conside-
red features. 
From Tables 7, 8, and 9 it appears that the various patterns of 
a particular analytical method are similar as far as their values 
of the most important discriminating features are concerned, since 
in general they cluster in the same class. The patterns of a few 
analytical methods belong to three or more classes or to no class 
at all. This might indicate a sensitivity for matrix effects as 
the patterns are described by feature values from trials in which 
control preparations of different origin were used. 
From the algorithms for the computation of the original non-auto-
scaled numerical values of the features it can be seen that the 
closer to zero the better feature values are. An analytical me-
thod can be recommended objectively when the large majority of 
its patterns fits into the class characterised by discriminating 
feature values closest to zero. When more methods satisfy these 
criteria, that method should be chosen where the other features 
have values closest to zero. It should be realised that in this 
recommendation only those analytical methods are considered which 
are used routinely by participants of the quality control program. 
A method can be disapproved if its patterns do not mainly pertain 
to one class but instead classify in three or more classes or in 
no class at all. Other analytical methods can be approved. This 
approval should be accompanied by annotations such as: constant 
positive bias, etc. 
Conolusions 
From the results of the Dutch external/internal quality control 
program four features describing the patterns of an analytical 
method can be obtained. 
Pattern recognition techniques applied to patterns of analytical 
methods revealed that, for different serum components, features 
describing these patterns rank differently in their contribution 
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to discrimination between clusters formed by the patterns. It was 
observed that method bias and method day-to-day SD are sometimes 
unimportant features for this discrimination. The majority of the 
patterns of a particular analytical method often cluster in the 
same category. From the mean values of the important discrimin-
ating features in a class, conclusions can be drawn about the qua-
lity of the patterns belonging to this class. 
1. An analytical method can be recommended as the best method 
applied in the quality control trials, from the results of which 
the feature values for the various patterns were calculated, if 
the majority of the patterns of that method fits into a class cha-
racterised by feature values nearest to zero as compared with the 
feature values of the other classes. 
2. An analytical method can be approved when the patterns of that 
method fit into a class characterised by feature values close to 
the feature values of the best class. The approval should be ac-
companied by details about the feature values. 
3. A method can be disapproved for routine use if the patterns of 
that method belong to many different classes or to no class at 
all. 
Realising that the number of patterns upon which the recommenda-
tions are based is limited, considering the results of this inves-
tigation, the following recommendations could be made tentatively: 
The methods using continuous-flow systems with or without reduc-
tion should be recommended for the determination of inorganic 
phosphate. Both manual techniques considered should be approved 
with the following limitations: standard deviation and suscepti-
bility to give systematically different results for different 
users are about 1.5 times the values for these features for the 
recommended techniques; susceptibility to give erroneous results 
is about 5 times this feature value for the recommended techni-
ques. 
For the determination of glucose both automatic hexokinase tech-
niques considered should be recommended. The continuous-flow glu-
cose oxidase techniques should be approved as are the automatic 
Polarographie techniques both with the annotation of a slight ne-
gative bias. The continuous-flow non-specific oxidating reagent 
techniques should be approved also with the annotation of a posi-
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tive bias. The manual techniques should be disapproved, since the 
majority of the patterns of both methods considered does not fit 
into one class. Instead the patterns of these methods are disper-
sed between three categories. 
For the enzymatic determination of cholesterol the centrifugal 
fast analyser techniques should be recommended. The continuous-
flow and the manual techniques should be approved with the note 
that it has a susceptibility to give systematically different re-
sults for different users at about twice the value of this fea-
ture for the recommended method. The discrete techniques should 
at present be approved since the large majority of patterns oer-
tam to the best class. However caution is appropriate since one 
pattern of the discrete techniques fits into class 1 and one into 
class 2. More patterns are needed to decide whether these techni-
ques really are susceptible to serum matrix effects or belong to 
the best class. 
This investigation will be continued by considering the results 
of future trials. These will be put into 'evaluation sets' [4] to 
reveal into which classes they fit. 
This investigation offers the participant laboratories the possi-
bility for objective recommendation approvals or disapprovals of 
analytical methods applied in the trials of the external/internal 
quality control program. 
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Chapter 3.3 
COMPARISON OF ROUTINE ANALYTICAL METHODS IN THE NETHERLANDS FOR 
SEVEN SERUM CONSTITUENTS USING PATTERN RECOGNITION 
Rob T.P. Jansen. Accepted for publication in Annals of Clinical 
Biochemistry, 1982 
Summary 
Routine analytical methods for seven serum analytes (calcium, chic-
ride, cholesterol, glucose, inorganic phosphate, urate and urea) 
are assessed using data of the Netherlands coupled external/inter-
nal quality control scheme. From the results of a trial each me-
thod can be described by four features, respectively measures of 
bias, between day precision, tendency to give erroneous results, 
interlaboratory variance. These four features each trial deter-
mine a vectorpoint in the four dimensional space for a particular 
method. From twelve trials a maximum of twelve vectorpoints per 
analytical method was obtained. Pattern recognition techniques 
allowed detection of clusters of vectorpoints. 
Analytical methods having vectorpoints classifying in different 
clusters perform differently. The mean feature values of the vec-
torpoints forming a cluster determine the quality of that cluster. 
A weighting procedure revéales the importancy of the respective 
features for discrimination between the clusters. For all of the 
seven analytes clusters of vectorpoints were found. Different fea-
tures appeared to contain discriminatory power for different ana-
lytes . 
For six analytes (calcium, chloride, cholesterol, glucose, inor-
ganic phosphate and urea) an analytical method was found to clas-
sify predominantly in the qualitative best cluster. 
One analytical method for the determination of chloride and one 
for glucose, inorganic phosphate and urea respectively did not 
cluster at all. 
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Introductzon 
The performance of an analytical method is usually ¡judged by com-
paring results obtained for a series of specimens with results ac-
quired with a competitive method. These experiments generally are 
performed in the optimal or suboptimal conditions of a 'research 
environment' [1]. To assess the performance of analytical methods 
used routinely, however, larger data sets are needed. Such data 
sets may be found in Quality Control Surveys. 
The American College of Pathology periodically reports results 
obtained for various serum analytes [1,6]. These and other [7,8] 
state of the art publications give an impression of the perfor-
mance of routine analytical methods. In most of these reports in-
formation is given on method bias, interlaboratory variation and 
short term intralaboratory variation. 
Recently a technique has been presented for the assessment of rou-
tine analytical methods in which four descriptive features of a 
method can be studied in a four dimensional space using pattern 
recognition [9,10]. Data sets to which the technique can be ap-
plied are obtained from the Netherlands Coupled External/Internal 
Quality Control Program [11]. In the trials of this program par-
ticipants analyse a lyophilized control serum forty times (daily 
for eight weeks five times a week). Statistical analysis of the 
results is based on an analysis of variance. Four sources of va-
riance are considered: a) between laboratory variance or syste-
matic interlaboratory differences; b) between week variance or 
systematic effects in time in the results of a large group of par-
ticipants (e.g. instability of the control serum); c) interaction 
effects or systematic time effects in the results of individual 
laboratories; d) residual effects. 
Results of laboratories that cause one of the first three sources 
of variance to contribute significantly to the total variance of 
the data, are removed from the computations in a second and third 
computer run to detect underlying errors. In the final computer 
run a 'reference' mean value and a 'reference' between-day stan-
dard deviation are computed that are influenced only by residual 
factors. Mean values and between-day standard deviations for the 
various analytical methods are computed also. From the results of 
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a trial for each method four descriptive features can be obtained 
[9,10]: 
1) the relative mean value (RELMV) i.e. the method mean in the fi­
nal computer run (after removal of erroneous values) relative to 
the 'reference' mean value. A RELMV of e.g. 1.0 signifies a devia­
tion of 1.0% from the 'reference' mean. RELMV is thus a measure 
of the bias of a method. 
2) the relative between-day standard deviation (RELSD) i.e. the 
method between-day standard deviation as computed in the final com­
puter run (after the removals) relative to the 'reference' between-
day standard deviation. A RELSD value of e.g. 1.5 signifies a be­
tween-day SD of 1.5 times the 'reference' between-day SD. RELSD 
expresses the imprecision of a method. 
3) the percentage removed results (PERCREM). A PERCREM value of 
e.g. 10 signifies a removal of 10% of the data obtained for the 
method from the computations in the final computer run. PERCREM 
gives an indication of all type of errors (systematic, random and 
trends) made with a certain method. 
4) the average laboratory deviation from its method mean (LABDEV) 
before any removals:
 T ,„„„,, inn* r rl I/ \ л, v u LABDEV = 100* Σ {χ -χ /χ }/Ν in which χ = 
, ι m
1
 m ι 
ι=1 
mean value of laboratory ι before any removals, χ = method mean 
after removals, N = number of laboratories applying method m. 
A LABDEV value of e.g. 2.0 signifies an average deviation of the 
laboratory mean values of 2% from their method mean. LABDEV illu­
strates the performance of a method in different laboratories. 
These four features are considered to be equally important charac­
teristics of the performance of a method m a trial. Therefore, 
they are not weighted initially m the pattern recognition proce­
dure . 
The four features, computed from the results for a particular me­
thod in a trial, determine a vectorpomt in the four dimensional 
space for that method. 
The vectorpoints of several trials of a constant performing method 
will cluster together. Other methods giving the same results will 
have vectorpoints fitting in the same cluster. A method giving 
constant but different results will classify in a different clus-
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ter. The mean feature values of the vectorpomts forming a clus-
ter determine the quality of that cluster. The relative importan-
ce of the various features for discrimination between the clusters 
can be determined. Thus analytical methods can be distinguished 
from one another, the most important discriminating features for 
the analyte of concern can be determined and herewith the quality 
of the analytical methods can be assessed. Results of 12 trials 
organized between January 1979 and December 1980 will be discus-
sed for seven serum constituents: calcium, chloride, cholesterol, 
glucose, inorganic phosphate, urate and urea. 
For cholesterol only the enzymatic methods were considered. 
No data are given for sodium, potassium, creatinine and total pro-
tein as too few different methods were used in the analysis of 
these constituents. 
Materials and Methods 
In the twelve trials of this investigation twelve control sera of 
different manufactures were used. Human, horse as well as bovine 
sera were analysed. About 65 laboratories participated in the 
trials and each submitted 40 results per serum constituent per 
trial. Only analytical methods applied by at least four partici-
pants per trial were taken in consideration. The statistical tech-
niques used in the external/internal quality control program have 
been described [11]. 
The pattern recognition techniques used to detect clusters of vec-
torpomts in the four dimensional space spanned by the four fea-
tures mentioned have been published also [9,10]. In summary they 
include: 
- an autoscaling procedure to obtain comparable axes for the va-
rious features: Feature values are scaled to a mean of zero and 
a standard deviation of l/\/N (N is the number of vectorpomts) 
- detection of clusters of vectorpomts by the Q-mode or hierar-
chial clustering technique. In this technique the similarity of 
two vectorpomts is determined by the Euclidean distance between 
them in the four dimensional space. Combining the two vector-
points yields a new point. The similarity of this new point 
and another vectorpoint is determined and so on. Vectorpomts 
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with high similarity form clusters 
- definition of the detected clusters as classes 
- determination of the relative importance of the various features 
for discrimination between the classes using the Fisher weigh-
ting procedure. The larger the differences between the cluster 
mean values of a feature relative to the within cluster varian-
ces the more important is this feature for dicnmination between 
the clusters. Subsequently the feature values of all vectorpoints 
are weighted according to the differences in discrimination po-
wer 
- confirmation of the classes and possible replacement of vector-
points using various supervised classification techniques: 
Karhunen-Loëve projections: In this technique a new set of ortho-
gonal axes in the four dimensional space is defined. The 
first axis (eigenvector) is drawn in the direction of the 
largest variation of the data, the second orthogonal on 
the first one in the direction of the second largest va-
riation etc. Thus a large percentage of the total infor-
mation content of the four dimensional space is maintai-
ned in two axes, the two dimensional space spanned by 
the first. Vectorpoints are projected on a plane defined 
by the two eigenvectors with the largest information con-
tent constructed from linear combinations of the Fisher 
weighted feature values. 
K-nearest neighbour classification: the three nearest neighbours 
of each autoscaled and Fisher weighted vectorpomt are 
found based on Euclidean distances. These three neighbour 
vectorpoints should belong to the same class as the vec-
torpomt of interest to confirm the defined classes. 
A binary classifier that separates all possible pairs of classes 
using negative feedback training. A plane is computed 
which separates two classes of vectorpoints optimally. 
All of the vectorpoints belonging to one class should lie 
on one side of the plane and the vectorpoints of the se-
cond class should lie on the other side of it for a 100% 
separation of the classes. The percentage of vectorpoints 
correctly classified by the technique is a measure of the 
distinction between the classes. 
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All these techniques are part of the computing program ARTHUR*. 
The Figures presented to elucidate the results are Karhunen-Loëve 
projections of the vectorpoints Fisher weighted for the various 
classes. 
Results and Dzscussion 
Information gained from the Netherlands coupled external/internal 
quality control program includes data about stability and homoge-
neity of the control serum. The homogeneity and stability during 
the eight-week trial periods were satisfying and comparable for 
the twelve control sera as appeared from the distribution curves 
of the submitted results and the non significant contribution of 
the time component in the analyses of variance. Sera from diffe-
rent manufactures and of different origin were used a) to prevent 
habituation of technicians to results, b) to be able to test la-
boratory and method performances at various concentration levels 
and c) to test possible matrix effects [12] of the various ana-
lytical methods. Table 1 lists the 'reference' values and 'refe-
rence' between-day standard deviations for the seven analytes in 
the twelve trials. From the results of a trial one vectorpoint, 
determined by the four descriptive features, is obtained for each 
analytical method, applied by at least four participants. Thus a 
vectorpoint is based upon at least 160 measurements. A maximum of 
twelve vectorpoints per analytical method was obtained from the 
twelve surveys organized in 1979-1980. In this investigation the 
four features are considered to be equally important: the accura-
cy of a method is regarded as important as the between-day preci-
sion, the between laboratory variance and the tendency to give 
erroneous results (which are removed from the final computations 
m the external/internal program). Clusters of vectorpoints were 
detected for all seven serum constituents investigated and defi-
ned as classes. The importance of the four features for discrimin-
ation between the classes was assessed applying the Fisher weigh-
ting procedure. 
*Duewer D.L., Kosklnen J.R., Kowalski B.R. Documentation for ARTHUR. Available 
from B.R. Kowalski, Laboratory for Chemometncs, Department of Chemistry BG-10, 
University of Washington, Seattle, Washington USA. 
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Table 1 "Reference" values and "reference" between day SD's 
of the twelve control sera. 
Analyte mmol/1 trial trial trial trial trial trial trial trial trial trial trial trial 
1 2 3 4 5 6 7 8 9 10 11 12 
calcium 
chloride 
cholesterol 
glucose 
inorganic 
phosphate 
urate 
urea 
2
-
2 3 b 
0.04 
104.30 
1.34 
3.34 
0.13 
6.36 
0.17 
1.69 
0.04 
0.45 
0.01 
12.08 
0.30 
2.31 
0.04 
113.08 
1.39 
3.26 
0.10 
5.35 
0.18 
1.13 
0.03 
0.38 
0.01 
7.17 
0.19 
2.16 
0.03 
102.08 
1.14 
5.04 
0.12 
6.23 
0.16 
1.59 
0.04 
0.43 
0.01 
9.98 
0.22 
2.43 
0.04 
102.22 
1.16 
3.88 
0.10 
5.69 
0.15 
1.37 
0.03 
0.31 
0.01 
8.20 
0.18 
2.50 
0.04 
93.54 
1.14 
4.09 
0.14 
5.47 
0.14 
1.62 
0.03 
0.30 
0.01 
9.68 
0.22 
2.04 
0.03 
96.36 
1.10 
2.99 
0.10 
6.39 
0.15 
1.10 
0.03 
0.306 
0.012 
8.52 
0.21 
2.61 
0.04 
110.18 
1.23 
2.31 
0.10 
6.98 
0.17 
1.13 
0.03 
0.448 
0.014 
11.69 
0.25 
2.57 
0.04 
97.14 
1.10 
3.91 
0.12 
5.12 
0.15 
1.65 
0.03 
0.290 
0.012 
9.11 
0.23 
2.08 
0.03 
90.40 
1.07 
2.00 
0.08 
4.98 
0.14 
1.44 
0.03 
0.211 
0.009 
5.78 
0.15 
2.52 
0.03 
101.10 
1.07 
4.64 
0.11 
5.03 
0.13 
1.47 
0.03 
0.293 
0.011 
7.97 
0.18 
2.67 
0.03 
110.23 
1.17 
5.52 
0.13 
9.00 
0.19 
2.53 
0.05 
0.541 
0.016 
28.48 
0.61 
2.44 
0.04 
104.82 
1.12 
3.37 
0.09 
6.35 
0.16 
1.59 
0.03 
0.454 
0.012 
12.11 
0.25 
a) "reference" value b) "reference" between day SD 
Table 2 lists these importances expressed in percentages of the 
sum of the four weighting factors for the seven analytes. It is 
seen that for each constituent two features contain more infor-
mation for discrimination between the classes that the other two 
(for urea three features are of importance). Table 2 also demon-
strates the varying importance of the features for different se-
rum components. As the highest correlation observed between two 
features was 0.6 (data not shown) Table 2 demonstrates the neces-
sity of considering more features than ]ust precision and accu-
racy for discrimination between routine analytical methods. 
For all constituents the composition of the classes was confirmed 
by the nearest neighbour technique: all Fisher weighted vector-
points were correctly classified by their three nearest neigh-
bours. The classifications were also 100% confirmed by the binary 
classification technique. 
Table 2 
Fisher weightings for discrimination between classes expressed in percentages 
of their sum. 
calcium 
chloride 
cholesterol 
glucose 
inorganic phosphate 
urate 
urea 
RELMV 
59.0 
0.4 
0.7 
60.8 
0.7 
85.3 
12.5 
RELSD 
39.2 
56.0 
42.4 
0.1 
0.9 
1.4 
1.1 
PERCREM 
0.3 
39.9 
2.4 
37.2 
87.1 
2.2 
41.5 
LABDEV 
1.5 
3.7 
54.5 
1.9 
11.3 
11.1 
44.9 
In Figures 1-7 Karhunen-Loève projections of the vectorpoints ob-
tained for the seven serum components are presented. Boundary li-
nes are drawn around the classes that could be distinguished vi-
sually and in addition were confirmed by the nearest neighbour 
and the binary classifier techniques. The observed clustering of 
vectorpoints could have been caused by a matrix effect of the con-
trol sera used: the vectorpoints of all analytical methods obtai-
ned in one trial might have formed a cluster as might have the 
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vectorpoints obtained in a second trial. This appeared not to be 
the case. The majority of the clusters are composed of vector-
points of one or two analytical methods. If two methods classify 
in different clusters their performances differ. Methods classi­
fying in clusters characterized by the better feature values per­
form better than methods which do not cluster or classify in clas­
ses of inferior quality. Thus conclusions may be drawn about dif­
ferences in analytic quality of routinely used methods m the 
trials of the Netherlands external/internal quality control pro­
gram. 
СаЪогит 
Four analytical methods for the determination of serum calcium 
were studied: A: atomic absorption spectrophotometry (average 
number of participants per trial N = 6) B: automatic titration 
(N = 24) C: colorimetrie methods using continuous flow systems 
(N = 13) D: colorimetrie manual methods (N = 8) 
The first two eigenvectors constructed from linear combinations 
of the features Fisher weighted for the various classes for cal­
cium contained 100% of the total information. The projection of 
the vectorpoints on a plane defined by these eigenvectors is shown 
in Fig. 1. Four clusters of vectorpoints were detected by visual 
inspection of the Karhunen-Loève plots, 100% confirmed by the nea-
rest neighbour and binary classification techniques and defined 
as classes. From table 2 it is seen that for calcium the most im-
portant features for discrimination between the classes are RELMV 
(measure of the inaccuracy) and RELSD (measure of the between day 
imprecision). 
Apparently the differences between the vectorpoints in the PERCREM 
and LABDEV values are much smaller than the divergences with re-
gard to RELMV and RELSD. So if one is interested in the analyti-
cal differences existing between the methods in this dataset, one 
should take in consideration the latter two features. 
The cluster named class 1 is characterized by an average RELMV 
value of 0.2 (i.e. an average deviation of 0.2% from the 'refe-
rence' value) and a mean RELSD value of 1.05 (i.e. a between day 
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Fig. 1 Karhunen-Loève projection of vectorpoints obtained for calcium on the 
plane defined by the first two eigenvectors (information content 100%). 
class 1 2 3 4 
average RELMV 0.2 -1.1 1.2 0.4 
average RELSD 1.05 1.09 0.97 1.34 
SD 1.05 times the 'reference' SD). This class is composed of four 
vectorpoints of the automatic titration method, three of the 'con-
tinuous flow colorimetrie' techniques and two vectorpoints of the 
'manual colorimetrie' method. No vectorpoint of the atomic absor-
tion spectrophotometry classifies in this class 1. 
Classes 2 and 3 are characterized by RELSD values comparable to 
that of class 1 (means of 1.09 and 0.97 respectively) and by ave-
rage RELMV values of respectively -1.1 and +1.2 indicating slight 
negative and positive bias. As six vectorpoints of the 'continu-
ous flow system colorimetrie' method classify in class 3 this me-
thod appears to show a slight positive bias. One vectorpoint of 
this method classifies in class 2, one in class 4 and one is pro-
jected between classes 1 and 2. Six vectorpoints of the atomic 
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absorption method classify in class 4 which is characterized by 
practically no bias (mean RELMV value of 0.4) and comparatively 
high between day standard deviations (mean RELSD of 1.34). One 
vectorpomt of this method fits in class 3, one is projected be-
tween classes 2 and 4 and four points are located at large distan-
ces of the clusters characterized by high RELSD values whereas one 
in addition to this has a high positive bias. Only six vector-
points were obtained for the manual colorimetrie method as in the 
first six trials less than four laboratories applied it. This me-
thod seems to perform comparable to the atomic absorption techni-
que giving relatively high RELSD values (three vectorpomts clas-
sifying in class 4, one between classes 2 and 4) although two 
points fit in class 1. Eight vectorpomts of the automatic titra-
tion method classify in class 2 whereas the other four fit in 
class 1. This method shows the most constant performance. It has 
a slight negative bias (-1% from the 'reference' values). The be-
tween day SD however is small. From these results the automatic 
titration techniques appear to be the most constant performing 
showing slight negative bias and good between day precision. The 
'continuous flow colorimetrie' method shows a slight positive bias 
(+1%) and also has good between day precision. It seems more sen-
sitive towards matrix effects than the automatic titration as 
three vectorpomts do not cluster with the other. 
The atomic absorption spectrophotometry shows practically no bias 
but has higher RELSD values. This method performs less constantly 
than the automatic titration and the continuous flow colorimetrie 
methods, since four vectorpomts do not classify at all and one 
is positioned between classes 2 and 4. 
Chloride 
Three basic analytical methods for the determination of serum 
chloride were considered: A: automatic argentometric amperometnc 
methods (chlorocounter etc.) (N = 34) B: colorimetrie methods ba-
sed on continuous flow systems (N = 9) C: manual titnmetric me-
thods (N = 6) 
Fig. 2 shows the projection of the vectorpomts on a plane defi-
ned by two eigenvectors which contain 99.8% of the total infor-
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Fig. 2 Karhunen-Loève projection of vectorpoints obtained for chloride on the 
plane defined by the first two eigenvectors (information content 99.8%). 
class 1 2 3 4 5 
average RELSD 0.99 1.18 0.92 1.40 1.31 
average PERCREM 4.2 6.6 27.3 14.7 37.6 
mation. The most important discriminating features for the five 
detected clusters are RELSD and PERCREM the percentage removed re-
sults (see Table 2). In contrast to results for calcium practi-
cally no contribution to the observed distinction between the 
clusters is obtained from RELMV. The cluster named class 1 is cha-
racterized by a mean RELSD value of 0.99 and an average PERCREM 
value of 4.2. This class is exclusively formed by (six) vector-
points of the continuous flow system colorimetrie techniques. Four 
more vectorpoints of this method classify in a second class with 
low RELSD values (mean of 0.92). This class 3 however is additio-
nally characterized by higher PERCREM values (mean of 27.3). One 
vectorpoint classifies in class 2 and one in class 4. 
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Class 2 is mainly composed of vectorpoints of the automatic argen-
tometric method (10 points) having an average RELSD value of 1.18 
and low PERCREM values (mean of 6.6). One vectorpomt of this me-
thod classifies in class 3 and one is projected between classes 
2 and 3; it is however assigned to class 2 by the nearest neigh-
bour and the binary linear classifier pattern recognition techni-
ques. Although an evident distinction is demonstrated between the 
argentometric and continuous flow methods, both methods classify 
predominantly in clusters characterized by qualitatively good fea-
ture values. The manual colorimetrie method does not perform con-
stantly: three vectorpoints do not cluster at all, one vectorpomt 
classifies in class 3 and one in class 2. The other vectorpoints 
of this method fit in classes 4 or 5 which have high RELSD values 
(averages of 1.40 and 1.31 respectively) and moderate to high 
PERCREM values (averages of 14.7 and 37.6). The performance of 
the manual methods differs from the behaviour of the other methods 
considered, and is less good. 
Geisinger et al. observed in their study [3] a statistically sig-
nificant negative bias for the electrometric method and a positi-
ve for the colorimetrie methods. They also observed differences 
in the interlaboratory coefficients of variation (without outlier 
exclusion) between the four basic methods considered by them. Al-
though in the present investigation a slight negative bias was ob-
served for the electrometric method and a comparable positive 
bias for the colorimetrie method RELMV and LABDEV appeared not im-
portant for discrimination between the methods. 
Instead the two features not extensively studied by Geisinger et 
al. RELSD and PERCREM proved to have discriminatory power. The 
ionselective electrode method was not taken in consideration in 
this investigation since too few laboratories applied it in the 
studied period. 
Cholesterol 
Large systematical differences can be expected between enzymatic 
methods and non-enzymatic methods for the determination of serum 
cholesterol as no extraction step is involved in the chemical me-
thods [7]. A distribution curve with two peaks will be obtained. 
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Since a normal d i s t r i b u t i o n i s assumed i n t h e computa t iona l p roce-
d u r e s of t h e e x t e r n a l / i n t e r n a l program t h e d e t e r m i n a t i o n of cho -
l e s t e r o l w i th enzymat ic t e c h n i q u e s i s t r e a t e d s e p a r a t e l y from t h e 
non -ênzyma t i c . 
Only t h e enzymat ic c h o l e s t e r o l d e t e r m i n a t i o n s a r e i n v e s t i g a t e d in 
t h e p r e s e n t s tudy s i n c e t h e m a j o r i t y of t h e p a r t i c i p a n t s t o t he 
program a p p l i e s an enzymat ic p r o c e d u r e . 
Four i n s t r u m e n t a l methodolog ies a r e d i s t i n g u i s h e d : A: c e n t r i f u g a l 
f a s t a n a l y s e r system (N = 9) B: con t inuous flow system (N = 11) 
C: d i s c r e t e systeem (Ν = 7) D: manual (N = 13) 
F i g . 3 shows t h e Karhunen-Loêve p r o j e c t i o n of t h e v e c t o r p o i n t s . 
The two e i g e n v e c t o r s d e f i n i n g t h e p l ane c o n t a i n 99.9% of t he t o -
t a l i n f o r m a t i o n . Three c l u s t e r s have been d e t e c t e d and de f ined as 
c l a s s e s . The most im por t an t d i s c r i m i n a t i n g f e a t u r e s a r e LABDEV 
Fig . 3 Karhunen-Loève p ro jec t ion of vec to rpo in t s obtained for cho les t e ro l on 
the plane defined by the f i r s t two e igenvectors (information content 
c l a s s 1 2 3 99.9%). 
average LABDEV 2.8 3.3 5.2 
average RELSD 0.83 1.29 1.14 
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and RELSD (Table 2) . 
The vectorpoints of class 1 have a mean LABDEV value of 2.8 and 
an average RELSD value of 0.83. Seven vectorpoints of the discre-
te procedures belong to this class. Two points of this method 
classify in class 2 which is characterized by LABDEV values of a-
bout 3.3 and RELSD values of 1.29. Two more vectorpoints of the 
discrete method fit in class 3, a class with the highest LABDEV 
values (mean of 5.2) and a mean RELSD value of 1.14. The twelfth 
point of this method does not cla^sifv at all. 
Six vectorpoints of the continuous flow systems classify in class 
3 indicating that although a rather good between day precision is 
obtained with this method it shows comparatively large mterlabo-
ratory bias. 
Three vectorpoints fit in class two; one is projected between 
classes 1 and 3 and two points do not classify. 
The centrifugal analysers give rise to moderate mterlaboratory 
bias and comparatively high RELSD values classifying five times 
in class 2 and twice in the neighbourhood of this class (both 
points are assigned to it by the nearest neighbour and the binary 
classifier techniques). Two vectorpoints are positioned in class 
3 whereas two more points, projected between classes 1 and 3, are 
not univocally assigned to one of these classes by these pattern 
recognition techniques. One more point of this method does not 
classify at all. The manual techniques also cluster mainly in 
class 2 (six points). Three vectorpoints belong to class 3, one 
to class 1 and two points do not classify. None of the methods stu-
died shows a really constant performance, although for all four 
methods a (small) majority of the vectorpoints fits in a particu-
lar class. From the results the discrete method shows the most 
constant performance, has the lowest between day imprecision and 
the smallest mterlaboratory variability. The centrifugal analy-
ser and the manual methods have higher between day SD's but show 
less variability between laboratories than the continuous flow 
techniques. 
The finding that RELMV was unimportant for discrimination between 
the classes is in agreement with results of Haeckel et al. [7] 
who observed no significant differences between means of methods 
for the enzymatic determination of cholesterol. 
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Glucose 
Routine analytical methods for the determination of serum glucose 
were categorized according to instrumental methodology and chemi-
cal reaction principle. 
Seven methods were distinguished applied by at least four partici-
pants: A: continuous flow system, glucose oxidase (N = 11) B: con-
tinuous flow system, hexokmase (N = 6) C: continuous flow system, 
non specific oxidation (N = 8) D: discrete, automatic, hexokmase 
(N = 5) E: manual, glucose oxidase (N = 9) F: manual, ortho-tolui-
dine (N = 4) G: Polarographie, automatic (N = 6) 
The two eigenvectors defining the plane at which the vectorpomts 
obtaine4 for the glucose determination are projected (Fig. 4) con-
tain 99.9% of the total information. Six clusters of vectorpomts 
could be discerned for this analyte. The most important features 
for discrimination between these clusters are RELMV and PERCREM 
(see Table 2). 
The cluster named class 1 is characterized by a slight positive 
bias (average RELMV value of 1.0) and a low percentage removed re-
sults (mean PERCREM value of 2.0). This class is predominantly 
formed by vectorpomts of hexokmase methods: five points out of 
twelve of the continuous flow hexokmase method and six points 
out of ten of the discrete method. Five more vectorpomts of the 
continuous flow hexokmase procedure cluster in class 2 which has 
practically no bias (average RELMV value of 0.4) and higher PER-
CREM values (mean of 23.2). Two vectorpomts of the discrete tech-
nique also fit in class 2. The automatic hexokmase methods ap-
pear to be more accurate than the other methods. Since the discre-
te technique yields lower PERCREM values than the continuous flow 
method the former is probably more reliable. 
Nine of the twelve vectorpomts obtained for the continuous flow 
glucose oxidase method fit in class 3 showing negative bias and 
moderate PERCREM values. The manual glucose oxidase technique twi-
ce classifies in this class, twice in class 2 and six times in 
class 6 thus showing negative bias also (though less than the con-
tinuous flow techniques) but higher PERCREM values. The observed 
negative bias is in agreement with results obtained by Björkhem 
et al. [8] but m contradiction with results obtained by Sheiko 
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Fig. 4 Karhunen-Loève pro jec t ion of vec torpo in t s obtained for glucose on the 
plane defined by the f i r s t two eigenvectors (information content 99.9%) . 
c l a s s 1 2 3 4 5 6 
average RELMV 1.0 0.4 -2 .3 4.θ 3.6 -1.2 
average PERCREM 2.0 23.2 10.6 7.1 27.1 38.8 
e t a l . [ 4 ] who o b s e r v e d a s l i g h t p o s i t i v e b i a s f o r t h e i r ' o v e r a l l 
g l u c o s e o x i d a s e m e t h o d s ' (a n e g a t i v e b i a s was f o u n d o n l y f o r t h e 
g l u c o s e o x i d a s e o x y g e n r a t e m e t h o d ) . 
The l a r g e m a j o r i t y of t h e v e c t o r p o i n t s o b t a i n e d f o r t h e a u t o m a t i c 
P o l a r o g r a p h i e m e t h o d shows s i m i l a r b e h a v i o u r a s t h o s e o f t h e c o n ­
t i n u o u s f low g l u c o s e o x i d a s e m e t h o d and c l u s t e r s i n c l a s s 3 . 
The c o n t i n u o u s f l o w non s p e c i f i c o x i d a t i o n m e t h o d s showed p o s i t i ­
ve b i a s a s e x p e c t e d , c l a s s i f y i n g t h r e e t i m e s i n c l a s s 4 (mean 
RELMV of 4 . 8 , mean PERCREM of 7 . 1 ) a n d f i v e t i m e s i n c l a s s 5 ( a v e ­
r a g e RELMV of 3 . 6 , mean PERCREM v a l u e of 2 7 . 1 ) and m o d e r a t e t o 
h i g h PERCREM v a l u e s . T h r e e v e c t o r p o i n t s of t h i s m e t h o d d i d n o t 
c l a s s i f y a t a l l . 
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The manual ortho-toluidine method is probably susceptible to ma-
trix effects as the vectorpomts of this method do not mainly 
cluster in one class. 
Inorganic Phosphate 
Four basic methods for the determination of inorganic phosphate 
were investigated: A: continuous flow system, no reduction (N = 5) 
B: continuous flow system, S n C ^ reduction (N = 9) C: manual, 
Fe-II-salt reduction (N = 21) D: manual, organic reducing reagent 
(N = 9) 
Fig. 5 (information content of 100%) shows the plot of the vector-
points projected on the plane defined by the first two eigenvec-
tors of the features. Four clusters of vectorpomts have been de-
X 1 KflBL 
Fig. 5 Karhunen-Loève projection of vectorpomts obtained for inorganic phos-
phate on the plane defined by the first two eigenvectors (information 
class 1 2 3 4 content 100%) 
average PERCREM 0.5 13.2 22.2 34.0 
average LABDEV 2.2 1.8 2.2 3.9 
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tected. From Table 2 the most important discriminating feature 
appears to be PERCREM whereas LABDEV contributes to a lesser ex­
tent . 
The cluster named class 1 is mainly characterized by very low PER­
CREM values (mean of 0.5) and a mean LABDEV value of 2.2. Eight 
out of ten vectorpoints obtained for the 'continuous flow system, 
no reduction' method fit into this class. Although a slight ne­
gative bias (-1%) could be demonstrated for the 'continuous flow 
system, no reduction' method (data not shown), which is in agree­
ment with results of Burkhardt et al. [5], the method bias appear­
ed to be comparatively unimportant for discrimination between the 
clusters found (see Table 2). 
The 'continuous flow system, SnCl-, reduction' method yields slight­
ly higher PERCREM values and slightly lower LABDEV values classi­
fying four times in class 1 and five times in class 2. The manual 
Fe-II-salt reduction method gives rise to still higher PERCREM 
values clustering five times in class 2 and four times in class 3 
which has higher PERCREM values than class 2 (mean of 22.2) and 
LABDEV values comparable to those of class 1. The 'manual, organic 
reducing reagent' method shows the least constant behaviour and 
seems less reliable than the other methods considered classifying 
four times in class 4 which is characterized by the highest PER­
CREM and LABDEV values (means of 34.0 and 3.9 respectively), three 
times into class 2, twice in class 3 whereas three vectorpoints 
do not cluster. 
Urate 
Six analytical methods for the determination of serum urate were 
studied: A: centrifugal fast analyser, enzymatic, UV (N = 6) B: 
continuous flow system, colorimetrie (Ν = 10) С: discrete, enzy­
matic, colorimetrie and UV (Ν = 8) D: manual, colorimetrie (Ν = 8) 
E: manual, enzymatic, colorimetrie (Ν = 14) F: manual, enzymatic, 
UV (Ν = 4) 
From Fig. 6 (information content 99.9%) it can be seen that four 
clusters of vectorpoints have been detected for urate. The most 
important discriminating feature is RELMV (see Table 2). LABDEV 
discriminates to a lesser extent. Although five vectorpoints of 
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Fig . 6 Karhunen-Loève p ro jec t ion of vec to rpo in t s obtained for urate on the 
plane defined by the f i r s t two e igenvectors (information content 99.9%). 
c l a s s 1 2 3 4 
average RELMV 0.2 -0 .5 -2 .7 3.3 
average LABDEV 2.7 4.9 3.7 3.0 
the d i s c r e t e enzymatic method and four out of nine of the c e n t r i -
fugal analyser-enzymatic method c lass i fy in c lass 1 which i s cha-
rac te r i zed by absence of b ias (mean RELMV of 0.2) and the lowest 
LABDEV values (mean of 2 .7 ) , both methods tend to inconstant per-
formance as the other points do not c l u s t e r very wel l . The manual 
co lor imetr ie method i s the l e a s t constant performing method as 
four vectorpoints of t h i s method are posi t ioned wide away from 
the r e s t . I t a lso shows the l a rges t LABDEV values c lass i fy ing f i -
ve times in c lass 2. The 'manual, enzymatically, co lor imet r ie ' me-
thod and the 'continuous flow system, co lo r imet r i e ' method perform 
more cons tan t ly . Class 3, which has negative bias (average RELMV 
of -2.7) and moderate to high LABDEV values (mean of 3.7) i s main-
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ly formed by vectorpoints of the 'manual, enzymatic, colorimetrie' 
method of which seven out of twelve points fit in this class whe-
reas two more points of this method were assigned to it by the 
nearest neighbour and binary classifier techniques. Three vector-
points of this manual procedure classify in class 1. All twelve 
vectorpoints of the 'continuous flow system, colorimetrie' method 
cluster in class 4 characterized by a positive bias (average RELMV 
of 3.3) and a mean LABDEV of 3.0. Only six vectorpoints were ob-
tained for the 'manual enzymatic UV' method. These did not clus-
ter in a particular class. The observation of Geismger et al.(l) 
that the manual phosphotungstic acid method produced consistently 
lower results than the automated phosphotungstic acid procedures 
was confirmed as was their observation of a similar tendency for 
the uncase methods. 
Uvea 
The analytical methods for the determination of serum urea inves-
tigated in the present study are: A: centrifugal fast analyser, 
urease-glutamate dehydrogenase (N = 5) B: continuous flow system, 
diacetylmonoxime (N = 21) C: continuous flow system, urease-fenol-
hypochlonte (N = 11) D: discrete system, urease-glutamate dehy-
drogenase (N = 5) E: manual, urease-fenol-hypochlonte (N = 12) 
Three clusters of vectorpoints were detected as can be seen in 
Fig. 7 (information content of 97%). The most important features 
for discrimination between the clusters are LABDEV, PERCREM and 
to a lesser extent RELMV (see Table 2). The between-day precision 
appeared to be not important for discrimination which is in agree-
ment with results of Passey et al. [6] who compared continuous 
flow system-diacetylmonoxime methods with a centrifugal fast ana-
lyser-urease glutamate dehydronenase technique and a urease con-
ductivity method. 
The cluster named class 1 has the lowest LABDEV and PERCREM values 
(averages of respectively 2.4 and 15.7) and does not show bias 
(average RELMV of -0.08). All twelve vectorpoints of the continu-
ous flow diacetylmonoxime method fit in this class as do nine vec-
torpmts of the manual urease-fenol-hypochlonte method. The con-
tinuous flow urease-f enol-hypochlonte method probably is inferior 
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Fig. 7 Karhunen-Loève projection of vectorpoints obtained for urea on the 
plane defined by the first two eigenvectors (information content 97.0%), 
class 1 2 3 
average LABDEV 2.4 5.1 "3.8 
average PERCREM 15.7 31.1 59.2 
average RELMV -0.1 0.5 -2.9 
to the manual technique since only five vectorpoints classify in 
class 1 and four points cluster in class 2 which is characterized 
by high LABDEV values (mean of 5.1), moderate to high PERCREM va-
lues (mean of 31.1) and practically no bias (mean RELMV value of 
0.5). One more vectorpoint is assigned to class 2 by the binary 
classifier technique. Two points do not cluster at all. The vec-
torpoints of the 'centrifugal analyser urease-glutamate dehydro-
genase' method mainly cluster in class 2 (six points). The posi-
tive bias found for this method by Passey et al. [6] was not con-
firmed. Only two points of method A fit in class 1 and two in 
class 3 characterized by moderate LABDEV values (mean of 3.8), 
high PERCREM values (mean of 59.2) and negative bias (average 
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RELMV of -2.9). For the discrete urease glutamate dehydrogenase 
method only two vectorpomts were obtained and no conclusions can 
be drawn therefore. The positive bias found by B^órkhem et al. 
[8] for the urease methods was not confirmed. 
Concluszons 
In this investigation routine analytical methods for the determin-
ation of seven serum constituents applied by at least four parti-
cipants in the Netherlands external/internal quality control pro-
gram were studied. From the quality control data no information 
was obtained about possible drug interference and no recovery ex-
periments could be incorporated. However the results do provide 
information about differences in the routine performance of ana-
lytical methods with respect to bias, between day precision, sus-
ceptibility to give erroneous results and interlaboratory varia-
bility (respectively from RELMV, RELSD, PERCREM and LABDEV). From 
the results of a trial vectorpomts were constructed using the 
four features to characterize the performance of analytical me-
thods in that trial. A vectorpomt is based upon at least 160 
measurements. Pattern recognition techniques were used to detect 
possible clusters of vectorpomts in a four dimensional space. 
Advantages of the use of pattern recognition techniques are the 
ability to consider several features at a time m a multi dimen-
sional space. If clusters are found, significant differences exist 
between groups of vectorpomts. The relative importance of the 
features for discrimination between the clusters can be assessed: 
If there exist differences between the analytical methods in the 
data set, the Fisher weighting orocedure reveals obnectivelv which 
features are responsible for it. Results presented m this paper 
demonstrate that vectorpomts each representing results of an ana-
lytical method m a particular trial formed clusters in the four 
dimensional space spanned by the four features. Vectorpomts of 
the same or comparable methods appeared to cluster often m the 
same class. Non-clustermg of vectorpomts of a method may indi-
cate sensitivity towards matrix effects as different sera were 
used in different trials. The Fisher weighting procedure revealed 
that for most of the analytes studied two features were more im-
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portant for discrimination than the other two. For different se-
rum components different features were important. As bias and be-
tween day precision not always contained discriminatory power the 
importance of considering more than these two features has been 
demonstrated. The average feature values of the vectorpoints in a 
class determine the quality of that class. 
For six analytes (calcium, chloride, cholesterol, glucose, inor-
ganic phosphate and urea) one method was found to classify main-
ly in the best class for that analyte. Only for urate this was 
not the case. Other methods predominantly fitted into classes cha-
racterized by relatively less good feature values. One analytical 
method for the determination of chloride and one for the determin-
ation of glucose, inorganic phosphate, urate and urea respective-
ly did not cluster at all. 
Although sodium, potassium, creatinine and total protein are also 
part of the control program, the large majority of participants 
applied methods grouped in the same method code. Too few labora-
tories used different coded methods in the studied period to be 
able to investigate them. 
Only since the end of 1980 seven participants apply ion selective 
electrodes for the determination of sodium and potassium, and on-
ly two use this method for the determination of chloride. 
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VARIANCE REDUCTION IN ANALYTICAL PROCESSES 
124 
Chapter 4.1 
VARIANCE REDUCTION IN ANALYTICAL PROCESSES IN THE CLINICAL LABO-
RATORY BY DIGITAL FILTERING 
R.T.P. Jansen and P.J.M. Bonants. Accepted for publication m 
Annals of Clinical Biochemistry, 1982 
Summary 
A model is postulated describing the fluctuations in analytical 
chemical processes in the clinical laboratory. In this model the 
process variations are described by a non-stationary stochastic 
process with a significant time-varying mean value. Experiments 
demonstrate a short term variance within a run and a long term va-
riance between runs determined by the time-varying mean value. 
For four different analytic systems used for determining six se-
rum analytes between-run variance was demonstrated to be signifi-
cantly greater than within-run variance. Based on the model a di-
gital filtering procedure is presented which in each run estima-
tes the process mean and subsequently corrects serum samples for 
its deviation. Thus significant variance reductions are obtained. 
The filtering procedure was tested for the determination of inor-
ganic phosphate with a continuous flow system in an experimental 
environment. A variance reduction of about 50% was achieved. The 
filter was also tested for five routine analytical methods. Vari-
ance reductions amounted to 46% for ASAT determined with a centri-
fugal fast analyser, 14% for chloride (automatic argentometric), 
25% for cholesterol (enzymatically, centrifugal fast analyser), 
35% for creatinine (continuous flow system) and 74% for LD (auto-
matically discrete system). Characteristics of the low pass fil-
ter are presented. 
IntiOduatton 
The issue of requirements for analytic variation in the clinical 
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laboratory has been argued by many authors [1-5]. Most of these 
define serum-concentration ranges of clinical interest and suggest 
percentages of analytic error appropriate to these ranges. Atten-
tion has been paid to the problem of measuring the practical sig-
nificance of reduction in existing levels of within laboratory 
variance [6]. This significance depends on the purpose of the test 
Laboratory tests are used in population surveys to detect speci-
fic diseases. For this type of use improvement of laboratory pre-
cision seems not necessary for some analytes (e.g. urea, glucose, 
cholesterol) as the intenndividual biological variation is much 
greater than the analytic error. For other analytes (chloride, so-
dium, calcium) improvement may be necessary for this type of pur-
pose. 
Laboratory tests are also used to record a change in the condition 
of a patient. In this context reduction of laboratory variability 
will matter, particularly in the elucidation of short term intra 
individual trends. Finally laboratory tests are used to detect 
whether individual test values exceed some alarm point. In this 
situation relevant sources of variation are short term intra in-
dividual variation and short and longer term within laboratory va-
riation. Improvement of the analytic precision for this type of 
use leads to increased sensitivity and specificity of the test for 
several serum constituents [5,6]. It was concluded by Harris [6] 
that even the slightest reductions in measurement error will be 
valuable and have their greatest impact on clinical decision con-
cerning individual patients. 
However factors that cause the error of an analytical method for 
determining a constituent to be unacceptably large are often hard 
to detect. They may be method dependent, but even a method measu-
ring precisely in one laboratory may fail in the hands of another. 
If increased variability is method dependent, high costs of in-
stalling a different method may be prohibitive for improving la-
boratory performance. 
For these reasons an investigation was started to the use of a di-
gital filtering procedure to effect variance reduction in analyti-
cal processes. A "process" here is considered as the analytical 
system or actions necessary to assay a sample, including the pre-
paration of reagents and standards and eventual regression calcu-
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lations by technicians, but excluding the collection of the sample. 
A "digital filter" aimes to improve the signal/noise ratio by ma­
thematical techniques. In digital filtering the information con­
tent of process measurements is used to estimate process parame­
ters describing its fluctuations and trends. Subsequently these 
estimates are used to correct measurements thus obtaining better 
estimates of the orocess input. 
In this paper a technique is presented to reduce the within labo­
ratory variance applying such a procedure. 
Stattstiaal methods 
In this section the model describing the analytical process is 
postulated. The methods to confirm the postulation and the filte­
ring procedure to reduce the variance are presented. 
THE MODEL 
Analytical processes can show various kinds of variation. The er­
rors can be random or deterministic. Random errors include impre-
dictible fluctuations (white noise) and correlated more or less 
predictible fluctuations (coloured noise) . 
If the processes are considered to be stationary stochastic, they 
are assumed to have a constant mean value and variance. If they 
are assumed to be mstationary stochastic two types of mstatio-
nanties may appear: a varying mean value and a varying variance. 
A model is postulated in which the process is described as an in-
stationary stochastic orocess with constant variance and time va­
rying mean value. The following two equations describe this model: 
У = χ + w + a 
t - -
*• a = E (a) + b 
where Y. is the measurement at time t, χ is the true value, w is 
a normally distributed stochast with a mean value 0 and variance 
2 
σ , a,_ is the term describing the time varying mean value, which 
w —t -• J 
is supposed to be a normally distributed random variable with an 
2 
expected value E(a) and variance σ . The fast fluctuating varia­
ble w is considered to be the within run variance. The long term 
variance determining the time varying mean value is assumed to be 
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the between run variance. Here a run is defined as a series of 
ten to twenty samples consisting of standards, control and patient 
sera. 
To test the model analysis of variance (ANOVA) was performed on 
a series of measurements on control samples assayed in a number 
of runs, several times a run. 
A one way ANOVA was used to establish whether the between run va-
riance was significantly greater than the within run variance 
which would support the choice of the proposed model as a first 
approximation. 
Control sera were applied of such concentration levels to cover 
the range of the analytical method. To be able to combine the re-
sults of these sera in the ANOVA the relationship between concen-
tration and standard deviation for the constituent of concern was 
investigated. Since linear relationships were found calculations 
were performed using values relative to the reference concentra-
tion values of the sera (see materials and methods). 
THE ESTIMATING FILTER 
If between run variance in the ANOVA is significantly greater 
than within run variance, a.Idescribing the time varying process-
mean in the model,must take different values in various runs. Es-
timation of the value of a. in a particular run and subsequent 
correction of the samples in that run for it should lead to re-
duction of the between run variance. 
To estimate the varying process-mean control samples of known 
concentration are needed. The mean of the relative deviations 
from the reference values of the control samples m a run is cal-
culated. This mean value is an estimate of the process mean a. 
(expressed as a percentage). However if only a few control sam-
ples are used the influence of within run variance on the estim-
ate might be considerable and should be diminished (for instance 
a possible outlier will produce an erroneous estimate). 
A recursive low pass filter is introduced therefore. In such fil-
ters fast process fluctuations are suppressed, whereas low fre-
quent variations are maintained. This is done by multiplication 
of a new measurement and all preceding measurements by weighting 
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factors that become smaller as the information is older [7]. In 
this case the filter weights each mean value by an exponential 
factor characterized by a filter-time constant T. 
The term a. (expressed as a percentage deviation) for a particu­
lar run is estimated from the weighted preceding estimate plus 
the weighted mean in the recursive algorithm: 
(1) S = as , + (l-a)D 
r r-1 r 
-1/T 
with a = e , τ is a filter time constant, S is the estimate in 
run r, S , is the estimate in run r-1, D is the mean relative 
' r-1 ' r 
deviation of the control sera from their reference values in run 
r. The estimate S is used to correct the remaining patient sam­
ples in run r according to formula 2: 
(2) z' = ζ - ζ *s 
ir ir ir r 
where ζ1 is the corrected value for sample ι of run r, ζ is the 
ir Γ ir 
measured value for sample ι of run r. 
To assess whether a significant variance reduction is obtainable 
by this procedure, additional control sera, which were not used 
for estimation of the varying process mean, were placed in the 
runs. 
A simple F-test could not be used in comparing the variances of 
the corrected and not-corrected values obtained for these sera, 
since the two variances are correlated. A test derived by Pitman 
[8] was used therefore. In this test the statistic r _ is compu­
ted from: 
r
n c
 = (F-D/ / {(F-l)2-4r2F} where F = s2/s2, s 2 is v a n ­
os
 2 η с η 
ance of the not-corrected values, s is variance of the corrected 
с 
values, r is the correlation between not-corrected and corrected 
values. The probability function of correlation coefficients 
with N-2 degrees of freedom (N= number of runs) is tabulated in 
many textbooks e.g. [9]. 
Matevzals and Methods 
The postulated model was tested on a continuous flow system for 
the determination of serum phosphate as described by Baadenhuij-
sen e.a. [10]. 
During a period of 25 days each day 10 runs were assayed. 
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The runs c o n s i s t e d of 5 aqueous s t a n d a r d s , 8 c o n t r o l s e r a and 7 
randomly chosen f r e sh p a t i e n t s e r a . Con t ro l and p a t i e n t s e r a were 
p o s i t i o n e d randomly m t h e run . The c o n t r o l s e r a had been a s s a y -
ed in t r i a l s of t h e e x t e r n a l q u a l i t y c o n t r o l program of the Neth-
e r l a n d s [11] and t h e consensus v a l u e s were used as r e f e r e n c e va -
l u e s (Table 1 ) . 
Table 1 
Reference values of the cont ro l sera for inorganic phosphate and five ana ly tes 
assayed by rout ine a n a l y t i c a l methods. 
Control serum 
inorganic phosphate 1.14 1.49 2.40 1.13 1.13 1.14 1.49 2.42 
(mmol/1) 
ASAT ((U/l) 52.9 119.9 31.8 
Chloride (mmol/1) 89.3 116.2 105.6 
Cholesterol (mmol/1) 3.22 5.72 3.90 
Creatinine (umol/l) 82.6 160.2 167.0 
LD (U/l) 223.4 418.2 438.3 
The hypothesis was also tested on routine analytical methods: 
1. a centrifugal fast analyser application for the determination 
of aspartate aminotransferase (ASAT) according to the direc-
tives proposed by the Netherlands [12] and Scandinavian [13] 
committees on enzymes. 
2. the automatic argentometric method for the determination of 
chloride [14]. 
3. a centrifugal fast analyser application for the enzymatic de-
termination of cholesterol [15]. 
4. a continuous flow method for the determination of creatinine 
[16]. 
5. an automatic discrete method for the determination of lactate 
dehydrogenase [LD] according to directives of the Netherlands 
[12] and Scandinavian [13] committees on enzymes. 
Only three control sera could be incorporated m the runs for the-
se routine analytical methods because of the additional workload. 
For the various methods the definition of a run differed: 
ASAT: one run consisted of 3 control sera and on the average 10 
patient sera.Control sera were positioned randomly between 
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the patient sera. 
chloride: one run consisted of 1 aqueous standard, 3 control sera 
and on the average 10 patient sera. Control sera, were posi-
tioned randomly between the patient sera. 
cholesterol: one run consisted of 1 standard serum, 3 control se-
ra and on the average 10 patient sera. Control sera were po-
sitioned randomly between the patient sera. 
creatinine: one run consisted of 5 aqueous standards, 3 control 
sera and about 10 patient sera. Control and patient sera we-
re randomly positioned. 
LD: one run consisted of 3 control sera and 7 patient sera. Con-
trols were randomly placed in the run. 
The means of at least 100 assays of the control sera for the en-
zymes and cholesterol were used as reference values. For the other 
constituents consensus values obtained in trials of the cited pro-
gram were used. They are listed in Table 1. 
Results and Dzsausszon 
INORGANIC PHOSPHATE 
Inorganic phosphate was assayed on a continuous flow system in a 
experimental environment. For each of the eight control sera used 
250 results were obtained. Since the coefficients of variation 
for the various concentration levels were constant, results were 
transformed according to equation 3: 
(3) Y' = (Y - R )/R where Y' is the i-th transformed value 
ID ID D D ID 
of control serum j , Y IS the i-th measured value of control se-
1] 
rum -} and R is the reference value for control serum 3 . 
The transformed results for sera 6, 7 and 8 (Table 1) were statis-
tically analysed in a one way ANOVA. Table 2 shows that the be-
tween run variance is significantly greater than the within-run 
variance. Therefore the model seems a reasonable first approxima-
tion of the real process. To obtain an estimate of the process 
mean a. for each run, control sera 1 and 2 were used in the digi-
tal filtering procedure described in section statistical methods. 
The mean D of the transformed results Y' for these sera in each 
r ID 
run, was used in the recursive algorithm (1). Starting value Sn 
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Table 2 
Analysis of variance table of the transformed results for inorganic phosphate 
of sera 6, 7 and 8 
source sum-squares degrees of freedom mean square F P(F) 
between runs 
within runs 
total 
0.1517 
0.0490 
0.2007 
249 
500 
749 
0.000609 
0.000098 
6.21 <<0.001 
was set to 0. To establish the filter time constant Τ determining 
the weighting factor a, it was varied. For various values of Τ 
the estimation of a in each run was computed. The measured values 
of control sera 6, 7 and 8 were corrected for this estimate accor­
ding to equation (2). The total variance of the not-corrected and 
the corrected results were calculated. The estimated variance re­
duction is defined: 
(4) VR = 100% _c * 100% 
2 
2 2 
where s is the variance of the corrected results and s is the 
с η 
variance of the not-corrected results. 
The variance reductions achieved for sera 6, 7 and 8 at various 
Τ values are plotted versus this filter time constant in Figure 
1. 
INORGANIC PHOSPHATE 
Ζ CORRECTION-SERA 
T-VALUE 
Fig. 1 Variance reduction versus T-values for inorganic phosphate of sera 6, 
7 and 8 using sera 1 and 2 in the estimating filter. 
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For t h e t h r e e c o n t r o l a maximal r e d u c t i o n m v a r i a n c e was o b t a i n ­
ed a t a Τ v a l u e of about 0 . 5 . V a r i a n c e r e d u c t i o n amounted t o 57% 
for serum 7, 49% for serum 6 and 37% for serum 8. Pi tmans t e s t 
r e v e a l e d t h a t t h e s e r e d u c t i o n s a r e s i g n i f i c a n t w i t h p ( r ) <0.001 
as can be seen from Table 3. 
Table 3 
Pitmans test for comparison of the variances in the not corrected and correc­
ted results for inorganic phosphate of sera 6, 7 and 8 applying two control 
sera in the estimating f i l t e r with Τ = 0.5 
_ _ _ ___ _ 
serum S S r F degrees of freedom r „ p ( r ) 
η с DS DS 
6 0.000377 0.000193 0.614 1.95 248 0.397 <0.001 
7 0.000620 0.000267 0.579 2.3 248 0.469 <0.001 
8 0.001387 0.000870 0.534 1.59 248 0.268 <0.001 
See t e x t for explanation of symbols 
The v a r i a n c e r e d u c t i o n s of t h e t h r e e s e r a d i f f e r . T h i s may b e c a u ­
s e d by t h e d i f f e r i n g p o s i t i o n s i n t h e r u n i n w h i c h c a s e t h e m o d e l 
i n s u f f i c i e n t l y d e s c r i b e s t h e o r o c e s s c h a r a c t e r i s t i c s w i t h i n r u n s . 
I n d i c a t i o n s of t h i s p o s s i b i l i t y w e r e o b t a i n e d ( r e s u l t s n o t s h o w n ) . 
I t may a l s o b e c a u s e d by t h e d i f f e r e n t o r i g i n of t h e s e r a : t h e y 
w e r e p u r c h a s e d f rom d i f f e r e n t m a n u f a c t u r e r s . 
I n t h e p r o p o s e d f i l t e r i n g p r o c e d u r e t h e m i n i m a l a c h i e v a b l e v a r i ­
a n c e i s t h e w i t h i n r u n v a r i a n c e . I f , i n t h e ANOVA, b e t w e e n r u n 
mean s q u a r e i s n o t s i g n i f i c a n t l y g r e a t e r t h a n w i t h i n r u n mean 
s q u a r e no i m p r o v e m e n t i s t o b e e x p e c t e d . The m a x i m a l o b t a i n a b l e 
v a r i a n c e r e d u c t i o n i s : 
MS (5) VR = 100°. - w * 100% w h e r e MS i s mean 
max —x- w 
s 
tot 
2 
square within run and s is the total variance (Table 2: sum 
tot 
squares total/degrees of freedom total). VR computed for serum 
max 
6, 7 and 8 was 64%. 
Using more than two control sera in the estimating filter should 
lead to better estimates of the terms a . In figures 2 and 3 the 
variance reductions obtained for sera 6, 7 and 8 are plotted ver­
sus Τ when three respectively five sera were used in the filter. 
It is seen from figures 1-3 that increase of the number of control 
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INORGANIC FHOSPHATF 
3 CORRECTION-SERA 
T-VALUE 
Fig. 2 Variance reduction versus T-values for inorganic phosphate of sera 6, 
7 and θ using sera 1, 2 and 3 in the estimating filter. 
IMOHCANIC PHOSPHATE 
5 CORRECTION-SERA 
> T-VALUE 
Fig . 3 Variance reduction versus T-values for inorganic phosphate of sera 6, 
7 and Э using sera 1, 2, 3, 4 and 5 in the es t imat ing f i l t e r . 
sera in the f i l t e r causes a decrease of the T-value at which a 
maximal variance reduction i s obtained: the mean of the deviat ion 
of two contro l s from t h e i r reference values i s a less accurate 
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estimation of the time varying process mean than the mean of more 
sera. So in equation (1) α tends to zero with increasing number 
of control sera. 
Figures 1-3 show a slightly increasing variance reduction for an 
increasing number of controls as expected. To minimize the addi­
tional workload, however, use of two control sera suffices to a-
chieve substantial reductions. The quality of the estimating fil­
ters applying 2, 3 or 5 sera can be seen in figure 4. The relati­
ve deviation of 8 sera from their reference values in ten runs 
ШЛОЛН PHOSPHATE 
Fig. 4 Process f l u c t u a t i o n s in 10 runs of the continuous flow system for the 
determinat ion of inorganic phosphate measured by 8 c o n t r o l s e r a . 
The d e t e r m i n i s t i c fac tors est imated by the f i l t e r using 2, 3 and 5 
c o n t r o l sera are i n d i c a t e d . 
+ es t imates obtained using 2 sera in the f i l t e r 
χ es t imates obtained using 3 sera in the f i l t e r 
о es t imates obtained using 5 sera in the f i l t e r 
a r e i n d i c a t e d t o g e t h e r w i t h t h e e s t i m a t e s of t h e t i m e v a r y i n g p r o ­
c e s s mean o b t a i n e d from t h e d i g i t a l f i l t e r s . The e s t i m a t o r s a p ­
p e a r t o f o l l o w t h e p r o c e s s i n s t a t i o n a n t i e s q u i t e w e l l . 
ROUTINE ANALYTICAL METHODS 
F o r t h e d e t e r m i n a t i o n of i n o r g a n i c p h o s p h a t e w i t h a c o n t i n u o u s 
f l o w s y s t e m i n an e x p e r i m e n t a l e n v i r o n m e n t v a r i a n c e r e d u c t i o n s 
w e r e o b t a i n e d of a b o u t 50%. F i v e a n a l y t i c a l m e t h o d s w e r e s e l e c t e d 
t o t e s t w h e t h e r t h e f i l t e r i n g p r o c e d u r e c o u l d a l s o b e a p p l i e d t o 
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other systems which in addition were used in the daily routine of 
a laboratory. 
Two applications of a centrifugal fast analyser for the determin­
ation of ASAT and cholesterol respectively were investigated. The 
automatic argentometric determination of chloride was studied as 
well as a continuous flow system for creatinine and an automatic 
discrete sytem for LD. Since all of these methods were routinely 
used only three additional control sera could be incorporated in 
the daily runs. Equation 3 was used to transform the results sin­
ce a constant coefficient of variation was obtained for the con­
centration ranges of concern for the five methods. 
The results of the analyses of variances oerformed on the trans­
formed values of three control sera in a number of runs for the 
five methods are presented in Table 4. 
Table 4 
Analysis of variance tables for the transformed results for ASAT chloride 
cholesterol creatinine and LD of sera 1, 2 and 3. 
Analyte 
ASAT 
Chloride 
Cholesterol 
Creatinine 
LD 
ΞΞ: sum-squares 
source 
between runs 
within runs 
total 
between 
within 
total 
between 
within 
total 
between 
within 
total 
between 
within 
total 
d.f.: degrees 
SS 
0.5753 
0.2046 
0.7798 
0.0150 
0.0172 
0.0322 
0.0672 
0.0643 
0.1316 
0.2550 
0.1619 
0.4169 
1.6497 
0.3227 
1.9724 
d.f. 
128 
258 
386 
106 
214 
320 
38 
116 
151 
304 
455 
191 
384 
575 
of freedom MS : 
MS 
0.00449 
0.00079 
0.00014 
0.00008 
0.00177 
0.00082 
0.00169 
0.00053 
0.00864 
0.00084 
mean square 
F 
5.67 
1.76 
2.15 
3.17 
10.28 
p(F) 
«0.001 
O.OOl 
0.001 
<<0.001 
<<0.001 
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Between-runs mean square is significantly greater than within runs 
mean square for all of the methods. The level of significance how­
ever is different. The F-values indicate that the largest varian­
ce reduction is to be expected for LD. A large reduction should 
be obtained also for ASAT, a smaller for creatinine and choleste­
rol and still smaller for chloride. Results of control sera 1 and 
2 (Table 1) were used in the estimating filter. 
Measured values of serum 3 were corrected for the estimates of the 
terms a in each run according to equation 2. Variance reductions 
for sera 3 were computed according to equation 4 at various Τ va­
lues. A plot of the variance reduction versus Τ for ASAT is given 
in Figure 5. 
1 2 3 1 
-> T-VALUE 
Fig. 5 Variance reduct ion versus T-values for ASAT of serum 3 using serum 1 
and 2 in the es t imat ing f i l t e r . 
S i m i l a r p l o t s were o b t a i n e d for t h e o t h e r a s s a y s c o n s i d e r e d . For 
each of t h e f i v e a n a l y t i c a l methods an i n s e n s i t i v e maximum i s 
found for t h e r e d u c t i o n a t T-va lues v a r y i n g between 1 and 2 . 5 . 
The s i g n i f i c a n c e s of t h e r e d u c t i o n s , a t t h e T-va lues a t which t h e 
v a r i a n c e i s maximal r e d u c e d , a r e l i s t e d in Table 5. The r a n k i n g 
of t h e v a r i a n c e r e d u c t i o n s for t h e v a r i o u s a n a l y t e s i s a s expec­
t e d . 
Es t imated r e d u c t i o n s of 46%, 35% and 74% a r e o b t a i n e d for ASAT, 
c r e a t i n i n e and LD r e s p e c t i v e l y (see Table 5). For c h l o r i d e and cho-
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Table 5 
Pitmans test for comparison of the variances in the not corrected and the cor­
rected and the corrected results for 5 analytes of sera 3 applying sera 1 and 
2 in the estimating filter. 
analyte 
ASAT 
Chloride 
Cholesterol 
Creatinine 
LD 
Τ 
1.25 
2.50 
1.50 
1.25 
1.00 
s
2 
с 
2.18 
1.15 
0.022 
24.03 
599.9 
s
2 
с 
1.19 
0.99 
0.0166 
15.63 
152.7 
VR 
46% 
14% 
25% 
35% 
74% 
г 
0.616 
0.934 
0.929 
0.766 
0.384 
F 
.83 
.16 
,33 
.54 
.93 
d.f. 
127 
105 
37 
150 
190 
rDS 
0.755 
0.202 
0.362 
0.320 
0.625 
P^DS' 
<0.001 
0.02 
0.02 
<0.001 
<0.001 
See text for symbols d.f. degrees of freedom 
lesterol these percentages amounted to 14% and 251 respectively. 
The percentages are in agreement with the maximum achievable re­
ductions computed according to equation (5) from Table 4: VR 
= 61% for ASAT, 20% for chloride, 27% for cholesterol, 42% for 
creatinine and 74% for LD. 
The value of Τ at which the maximal variance reduction is obtai­
ned depends on the number of control sera used in the estimating 
filter as was demonstrated for inorganic phosphate. 
Conelusions 
Results obtained for the continuous flow system for the determin­
ation of inorganic phosphate indicate that the postulated model 
describes the process at least approximately. Applying the propo­
sed digital filtering technique highly significant reductions in 
variance were obtained for this assay. These reductions are cau­
sed entirely by removal of the between run variance from the re­
sults. The explanation of the presence of this variance is hard 
to give. The use of one set of standards for each run certainly 
contributes [17] . 
Although between-days variance was larger than between-run vari­
ance (results not shown) no attention was paid to it as it disap­
peared together with between-run variance in the filtering proce­
dure. 
The generality of the model for analytical processes in clinical 
138 
laboratories was demonstrated by the results obtained for five 
routine analytical methods tested. Although the definition of a 
run differed from method to method again the variance between-runs 
was significantly greater than within-runs. Significant reductions 
of variance were obtained for all analytes. The more significant 
the variance ratio between-runs/withm-runs, the more significant 
was the variance reduction. 
Achieved reductions varied with the filter time constant. 
Maximal reductions for the various analytes were obtained at T-
values between 0.5 and 2.5 when two sera were used m the estima-
ting filter. Apparently use of only two sera necessitates weigh-
ting the new and the old estimate. 
The minimal obtainable variance equals the within run variance. 
The achieved variance reductions closely aoproximated the maximal 
obtainable. If the performance of an analytical method is insuf-
ficient and the within-run variance exceeds the criteria set, the 
benefit of the filtering procedure will be limited. If between-
run variance is not significantly greater than within-run no im-
provement at all can be expected. 
In many oapers concerning goals in clinical chemistry reduction 
of between day and between run variability is urged. The only way 
to achieve this seemed to 'install and operate the best current 
method' [6] in the laboratory. In this paper a digital procedure 
is presented that is easy to implement on the desktop calculator 
or microcomputer every laboratory nowadays will have to its dis-
posal. One should take care of the control sera to be used for 
enzyme assays. A basic assumption underlying the estimating fil-
ter technique is commutability of control and patient sera. The 
use of two control sera of different concentration and manufac-
turer is recommended. This will diminish the occurence of wrong 
estimates caused by matrix effects. 
To detect a significant difference between the two control sera 
in a run in deviating from their reference values, a Shewhart 
range control procedure should be implemented for instance one as 
proposed by Westgard and Groth [17]. If such a significant diffe-
rence occurs the run should be disapproved. In this manner inter-
nal quality assessment is combined with quality improvement. 
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T h i s p a p e r i s i n t e n d e d t o s t i m u l a t e t h e i n t r o d u c t i o n of d i g i t a l 
f i l t e r s i n c l i n i c a l l a b o r a t o r i e s . More s o p h i s t i c a t e d f i l t e r a l g o -
r i t h m s , a l l o w i n g f o r i n s t a n c e e s t i m a t i o n of p o s s i b l e w i t h i n r u n 
d r i f t p a r a m e t e r s , c a n p o s s i b l e b e a d a p t e d o r d e v e l o p e d f o r a n a l y -
t i c a l p r o c e s s e s i n c l i n i c a l l a b o r a t o r i e s . 
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Chapter 4.2 
REDUCTION OF ANALYTICAL VARIANCE USING DISCRETE-TIME DATA WEIGH-
TING FILTERING FOR ESTIMATION OF ABRUPT CHANGES IN BATCH-TYPE 
PROCESSES. I Theory. 
Hennie N.J. Poulisse and Rob T.P. Jansen 
Analytica Chimica Acta, 1982, submitted for publication 
Summary 
A discrete time state-space model is proposed in this paper which 
describes the behaviour of analytical methods in which the samples 
are investigated in batches (runs). 
A characteristic of this type of analysis is that the quantity 
describing the behaviour of such processes may undergo an abrupt 
change (jump) when the analysis of a new batch is started. A modi-
fied Kalman filter is formulated which estimates the state of the 
batch-type analysis model. This finally leads to a procedure which 
is claimed to reduce the analytical variance in the measurements 
of the unknown samples in the batches. The performance of the pro-
posed procedure in a real situation is discussed in a separate pa-
per. 
Introdustion 
In many routine analyses, oarticularly in clinical chemistry, ana-
lytical samples are investigated in batches (runs). Like all mea-
surement experiments, these batch analyses are subject to distur-
bances. The disturbances eventually appear as deviation in the 
quantity to be estimated, usually the concentration. However in 
many batch analyses the deviation in the estimated quantities can-
not be explained by the uncertainties introduced by the measure-
ment noise only [1]. Limonard [2] has suggested a model which 
would explain the behaviour of the analytical processes in the cli-
nical laboratory. It is argued in the present paper that an impor-
tant disadvantage of Limonard's method is that it actually ignores 
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the characteristic batch situation. In particular it is impossible 
to explain the presence of a significant between-run analytical 
variance which is typical for this type of analysis [1]. There-
fore, an alternative model is proposed which is believed to give 
an adequate description of batch analysis. Specifically the quan-
tity characterising the behaviour of such analysis, called the 
state [3], may undergo abrupt changes (jumps) when the analysis 
of a new run of samples is started. Subsequently the state is es-
timated by a Kalman filter [3] which processes measured quanti-
ties of the control samples in each batch. It is known that the 
standard Kalman filter cannot be used in the investigated situa-
tion. Therefore, a modified Kalman filter is proposed. The main 
feature of this modified Kalman filter is that it forgets infor-
mation from the past, which is no longer relevant for the present. 
Using state estimates, a procedure originally proposed by Jansen 
[4] is described to reduce the analytical variance in the measure-
ments of unknown analytical samples in each run. The performance 
of the proposed methods when applied to practical situations is 
described in a companion paper [5]. 
Theory 
Consider the situation where analytical samples are investigated 
in batches. To explain the deviations in the estimated quantities 
which have been observed in practice for batch analysis [1], Limo-
nard [2] suggested that the measurements cannon be regarded as in-
dépendant random variables [6], but instead the measurement pro-
cess should be treated as a time series. He assumed that such a 
process can be described as a first order, stationary autoregres-
sive time series [7]: 
У(Э) = a y(]-l) + b(:) (1) 
In equation (1) j is the measurement or sample number, y(]) the 
measured value of the ]-th control sample relative to its known 
reference value ζ (]) i.e. y(]) = (z(:)-z
 f(:))/z ,(]), where ztj) 
is the measured value of sample ]; b(j) is discrete-time white noi­
se [3] with constant variance, disturbing the signal caused by 
the 3-th sample. The coefficient a is unknown but constant. 
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Limonarci estimated the parameter a by first calculating the quan-
titiy (2) : 
ф(к) = φ (к) /ф(0) (2) 
! n t" k 
where φ (к) = — — Σ {(у U+k)-у) (у (i)-у) } (3) 
к = 0,1,2, . 
η 
у = -^- ΐ yd) 
t i=l 
(η is the total number of measurements) and then fitting an ex­
ponential curve of the form exp (-ak) through the pairs {(ф(к),к)}; 
from the quantity α an estimate of a can be obtained. This proce­
dure is based upon the fact that the normalised autocorrelation 
function ф*(к) of a stationairy first order autoregressive pro­
cess is given by [7]: 
ψ (к) = alkl = exp{|k| Ina} ; к = 0, + 1, + 2 (5) while 
the quantity given by (2) is an estimate of the normalised auto­
correlation function, assuming that the process {у(])} is ergodic 
rather than stationary [6]. Having estimated the parameter a,using 
control sample measurements, Limonard proposed a correction pro­
cedure for the measurements of the unknown samples [2]. Applying 
this procedure, however, the batch character of the processes is 
ignored. It is well known that these batch methods exhibit a sig­
nificant between-run variance as follows from analysis of varian­
ce experiments [1,4]. This leads to the conclusion that the quan­
tity, which determines the behaviour of the batch processes under­
goes sudden changes (jumps) every time a new run is analysed. 
If the coefficient of variation of measured values of samples 
having varying concentration levels, is constant, the relative 
measurement у(з), defined by 
y(D) = (z(]) - ζ .(]))/z (D) (6) 
ref ref 
where z(]) is the measured value of the j-th control sample and 
ζ (]) is its reference value, may be used as a measurement of 
the quantity which determines the behaviour of the process. The 
above given verbal description of the batch process, can be trans­
lated mathematically m the following way: 
x(D) = x(j-l) + u(3)6(:,rm+l) + w(j) (7) 
У(3) = x(]) + (з) (8) 
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3 = 1,2 , η.m, г = 0,1,2... .(η-1), <5(i,k)=l if i=k 
<5(i,k)=0 if i^ k 
In (7) and (8) χ(j) represents the quantity which determines the 
behaviour of the process. u(]) is an unknown deterministic, impuls-
like disturbance. The integer : is again the sample number; η is 
the number of runs (batches) and m is the number of control sam­
ples per run. w(]) is discrete-time white noise; it accounts for 
uncertainties m the description of the process. Indeed, in many 
cases w(]) should be regarded as "fictitious noise" L3]. The quan­
tity v(]) represents discrete-time measurement noise. The following 
assumptions are made with respect to the noise sequences {w(j)} 
and {v(]) } : 
E{v(])} = E{w(;j)} = 0 for all : (9) 
Е{ (з)v(k)} = σ^ δ(j,k) (10) 
E{w(:)w(k)} = σ2 6(D,k) (11) 
W 
E{v(])w(k)} = 0 for all ],k (12) 
The quantity x(]) is called the state and (7,8) is called a dis­
crete-time state space model [3]. Specifically m this terminolo­
gy (7) is called the dynamic state equation, (8) the measurement 
equation and w(]) the system noise. 
Returning to Limonard's method, it is of course possible to cal­
culate a quantity as defined in (2), based upon the relative mea­
surements у(э) as defined in (6) and subsequently fitting an ex­
ponential curve through the pairs {(ф(к), к)}, but if the process 
is described by the state space model (7,8) the results will be 
meaningless. 
Instead an estimator is sought for the state x(j). An outstanding 
method to estimate the state x(]) based upon the relative measure­
ments {y(])} is the Kalman filter [3]. However, the performance of 
the Kalman filter will generally be unacceptable if the impuls-
like disturbances u(j) are ignored. To clarify this statement, the 
Kalman filter equation will be given, ignoring in the first in­
stance the unknown disturbances u(j) [3]: 
x(3/]) = x(D-l/]-l) + K(])V(D) (13) 
v(]) = y(;)) - х(з-1/з-1) (14) 
Klj) = P(]/]-l) {P(D/D-1) + σ^}-! (15) 
PtD/j-l) = Ptj-l/n-l) + a2 (16) 
145 
P(j/j) = {1-К(з)} P ( D / 3 - 1 ) (17) 
initial estimates χ (0/0) and Ρ (0/0) (18) 
3 = 1>2, , η.m 
where χ(./.) is an estimate of the state x(.) and P(./.) may be 
regarded as an estimate of the variance in the state estimate. 
In the notation (i,k), the first symbol ι refers to the sample 
number, and the second symbol k refers to the number of measure­
ments upon which the estimate is based; e.g. χ ( j/ ] ) is the esti­
mate of x(]) at sample number j and based upon the measurements 
{y(l), , y (j) } . к(з) is the Kalman g a m . An heuristic expla­
nation of the quantities in the Kalman filter can be found in re­
ference [8]. From equations (15-17) it follows that: 
Р(3/3-1) = a2p(j-i/D-2){Р(]-1/з-2) + σ2}-1 + σ^ (19) 
It is well known that the quantity р(з/з-1) in the Kalman filter 
(13-18), which is based upon the scalar state space model (7,8) 
with constant system- and statistical parameters and ignoring the 
disturbances и(з), converges to a limit ρ [3]. This limit readily 
follows from (19): 
P = h {a2 + {oh + 4 σ 2 σ 2 } 1 5 } (20) 
W W W V 
From (19) and (15) it follows that the limit of the Kalman gain 
is: 
ІС = PCP + O 2 } " 1 (21) 
V 
and hence L = (l-io = σ 2{Ρ+σ 2}" 1 (22) 
Note that 0<K<1 (23) 
0<L<1 (24) 
Define the true estimation error: 
x(3/3) = x(3) - *<3/3> (25) 
It follows from (7,8,13,14) that 
x(D/j) = (1-К(з)){х(з-1/з-1)+6(3,rm+l)u(3)+w(3)} 
-К(з) (з) (26) 
Hence 
х(з/з)=Е{х(з-1/з-1)+6(3.rm+l)u(j)+w(3) }-К (з) (27) 
if 3 is sufficiently large. From (27) it follows that 
|x(3/3)| <L{ |x(3-l/j-l) | +δ (3 ,rm+l) |u(3) | + |w(3) I }+ к| (з) I (28) 
It will be assumed that the realisation of the noise processes 
w(3) and (з) as well as the impuls-like disturbances и(з) are 
bounded, i.e. 
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I w(]) I < W for all J 
|ν (3 ) | < V for all : (29) 
|u ( ] ) ] < U for all j 
So the true estimation errors x(]/]) are majorized by a solution 
of the difference equation (30) [9]: 
S(D) - I s(]-l) + L{<5 (j , rm. 1) U + W} + KV (30) 
Alternatively 
s(3+k) = Lk s(j) + Σ {Lk{δ(],rm+1)U+w}+Lk~1KV} (31) 
к = 1,2 
Every time the processing of a new batch of analytical samples is 
started, the Kronecker delta function 6(з,гт+1) equals 1, and the 
-majorized- estimation error is subject to an impul-like change. 
Note that it follows from (31) that the estimation errors will al­
ways be bounded, but that if L = l-ε, where ε is a very small real 
number and U is relatively large, the bound in the estimation er­
ror can be very large. The relative measurements contain informa­
tion about the disturbances {u(j)} but the Kalman filter, which 
is used to process these measurements, does not. So there is a 
discrepancy between the true model and the model on which the Kal­
man filter is based. Generally this will lead to divergence of 
the Kalman filter. 
Divergence is said to occur when the actual errors in the estima­
tes become totally inconsistent with the covariance as given by 
the Kalman filter equations: the quantity P(:/]). Many modifica­
tions of the standard Kalman filter equations have been suggested 
[9-17] to cope with the divergence problem. In general the propo­
sed modifications try to prevent, in a more or less sophisticated 
way, the Kalman gain κ(]) from becoming too small too soon. In 
these modifications the information content of the past measure­
ments is forgotten at a quicker rate than in the standard Kalman 
filter. Kalman filters in which the past is exnonentially fast for­
gotten have particularly proved to be useful [11,13]. This is in­
tuitively appealing: since there is a discrepancy between the true 
model and the model assumed in the Kalman filter design, the past 
is no longer representative for the behaviour of the system and 
hence should be forgotten as quickly as possible. A disadvantage 
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of most of the proposed schemes is that the modification is ad 
hoc, at least not dictated by the data. An exception are the adap­
tive estimation schemes, where an increase in the error variance 
-and hence m κ(])- is accomplished by an increase of the varian­
ce of the system noise (see equation (16)) by lettmq the innova­
tion sequence {ν ( ц) } dictate its magnitude. An estimation scheme 
of some fame in this connection is Jazwinski's adaptive filter 
[18]. However the adaptive feature generally increases the com­
plexity of the filter considerable. In this paper a modified Kal­
man filter is proposed, which takes full advantage of the batch-
type situation. The increase in the error variance P(]/:) IS dic­
tated by the data. Nevertheless the modified filter has the same 
degree of complexity as the standard Kalman filter: 
X C J / J ) = x ( D - l / ] - l ) + К ( : ) ( з ) ( 3 2 ) 
V(j) = у ( ] ) - x U - l / D - l ) ( 3 3 ) 
-i m 
P ( j / a - 1 ) = {-{ Σ , ί γ ί ι ι - Ι + ι ) - x ( : - l / j - l ) } 2 } + σ 2 } 6 (j , r m + l ) 
r m ι — l w 
( 3 4 a ) 
r = 0 , 1 , , ( n - l ) , a = 1 , , m 
P U / a - 1 ) = { P t j - l / a - 1 ) + σ 2 } 6 ( j , r m + i ) ( 3 4 b ) 
τ τ w 
ι = 2 , ,m , a = 2 , ,m 
r 
K ( D ) = P ( ] / a
r
- l ) { p ( 3 / a r - l ) + σ 2 } - 1 ( 3 5 ) 
P ( D / a
r
) = ( 1 - К ( з ) ) Р ( : / а
г
- 1 ) ( 3 6 ) 
where ] = 1,2, , n.m. It follows from equation (34a) 
that each time a new batch of data will be analysed, The calcula­
tion of the error variance is restarted. As the measurements in 
each batch have to be collected first, regarding equation (34a), 
the algorithm (32-36) is strictly speaking, not a filter, but ac­
tually a batch processer. The symbol a in equations (34a-36) in­
dicates that the calculation of the variances, and hence also of 
the Kalman gam, always is based upon the current information; 
the past is abruptly forgotten, being no longer representative 
for the behaviour of the process, because of the impuls-like dis­
turbances u(j). This periodic restarting of the Kalman gain calcu­
lations is certainly not new and dates at least back to Battm and 
Levin [19]. 
There is still another approach possible to attack the impuls-like 
disturbance problem. An important contribution in this area has 
been made by Willsky and Jones [¿0] and Willsky [21]. Basically 
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in this approach the impulses u(ц) are estimated and the state es­
timate and error covarlance matrix are adapted [21]. In the prac­
tical situation investigated in a companion paper [5] initially 
Willsky's approach has been used, but it turned out to be unsatis­
factory. This is probably due to the fact that Willsky's procedu­
re is more suited for situations where the impulses only occur ve­
ry infrequently [21]. 
Having estimated the state χ(j) in run r using control samples, 
the measurements of unknown (patient) samples in this run may be 
corrected for it [4,5]: 
z
c
(i) = z(i) - z(i) χ (J/J) (37) 
1 = 1,2, Ξ ; ]=r.m ; r ε {1,2, ,n} 
where с means "is an element of", ζ (ι) is the corrected measure-
c 
ment of the i-th unknown sample in the r-th run and z(i) is the 
uncorrected measurement; s is the number of unknown samples in the 
r-th batch; χ (υ/;)) is the final estimate of the state χ ( ц ) , given 
by equation (7), in the r-th run, produced by the data weighting 
algorithm (32-36) using m control samples. By placing additional 
control samples, which are not processed by the algorithm (32-36), 
in the runs, the achieved variance reduction may be estimated from 
(38) : 
VR = {1-σ2/σ?}* 100?, ( 38) 
с η 
where σ2 is the estimated variance in the corrected measurements 
с 
ζ of an additional control sample, and a2 is the estimated vari-
c
 r
 η 
ance in the non-corrected measurements of it. In a companion pa­
per [5] the succesful application of the proposed procedure to a 
practical situation is described. The choise of the statistical 
parameters a2 and σ?, as well as the initial condition χ (0/0) is 
V w 
discussed in this paper [5] also. 
Finally it is noted that the algorithm (32-36) can be readily ex­
tended to more general situations, in particular when the measu­
rements in each run are, apart from noise, also disturbed by drift. 
Such an extension, however, will probably be made at the expense 
of placing additional control sera in the batches. 
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Conclusions 
A discrete-time state space model has been given which describes 
the behaviour of analytical systems in which the samples are ana­
lysed in batches. Estimates of the state of the model, characte­
rizing the analytical batch-type system, are produced by a data 
weighting Kalman filter using the control samples in each run. The 
modified Kalman filter takes full advantage of the batch type si­
tuation. The proposed filter is placed in the proper theoretical 
context. 
It is claimed that the estimates of the state can be used to cor­
rect the measurements of unknown samples which leads to a reduc­
tion of the analytical variance. 
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Chapter 4.3 
REDUCTION OF ANALYTICAL VARIANCE USING DISCRETE-TI4E DATA WEIGH-
TING FILTERING FOR ESTIMATION OF ABRUPT CHANGES IN BATCH-TYPE 
PROCESSES. II Applications. 
R.T.P. Jansen and H.N.J. Poulisse 
Analytica Chimica Acta, 1982, submitted for publication 
Summary 
A well known characteristic of analytical methods in clinical la-
boratories is the presence of a significant between-batch analy-
tical variance component. This is confirmed by an analysis of va-
riance of data obtained for the determination of inorganic phos-
phate in blood serum with a continuous flow system. Based on a 
4 
model, describing the process fluctuations, a discrete-time digi-
tal filter algorithm is presented which estimates abrupt changes 
in the process values, occurring between two runs of samples. 
Subsequent correction of control sera data for these estimates 
leads in the example to a reduction of the analytical variance of 
about 50%. 
Similar results are obtained for various other analytical methods 
including a centrifugal fast analyser, an automatic discrete sys-
tem and a semi-automatic coulometric titration. 
Introduation 
The efforts to reduce the analytical variance of assays in the 
clinical laboratory mainly concentrate on the introduction of ana-
lytical methods measuring more precisely than current techniques. 
Relatively little attention has been paid to mathematical tech-
niques like digital filtering procedures [1]. Such filter algo-
rithms are based on models describing the system dynamics of the 
analytical processes. The filter produces estimates of quantities 
such as the concentration of a constituent, and aims to improve 
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the signal/noise ratio of the process. 
A well known feature of most analytical methods in clinical labor-
atories is the presence of a significant between-run (batch) va-
riance m addition to a within-run variance component. In this pa-
per the model presented in a previous paper [2] will be used to 
describe some practical situations. A discrete-time recursive da-
ta weighting filter algorithm based on this model is used to es-
timate the process fluctuations. 
The theoretical details of this filter have been given [2]. In or-
der to reduce the analytical variance measurements are corrected 
for the estimated deviations. As an example results obtained for 
the determination of inorganic phosphate in blood serum with a 
continuous flow analyser in 250 runs, each composed of standards, 
patient sera and control sera, are presented. 
Experimental 
The results of 250 runs of samples assayed with a continuous flow 
system for the determination of inorganic phosphate in blood se-
rum [3] are used to investigate whether reduction of analytical 
variance may be obtained by digital filtering. During a period of 
25 days 10 runs a day were assayed. The runs were composed of 5 
aqueous standards, 6 control sera and 9 randomly chosen fresh pa-
tient sera. The standards were positioned at the start of each 
run. The control sera were placed at fixed positions randomly be-
tween the patient sera. The six control sera are lyophilized sera 
of varying origin (human, bovine, equine) and cover the concentra-
tion range of medical interest (see Table 1). 
Though not discussed extensively here, the filtering procedure 
was also applied to four other analytical methods used in the dai-
ly routine; a centrifugal fast analyser method for the determin-
ation of cholesterol; an automatic discrete system for the deter-
mination of lactate dehydrogenase; a continuous flow system for 
the determination of creatinine; a semi-automatic amperometnc ti-
tration method for the determination of chloride. Since these me-
thods were used routinely only three control sera could be imple-
mented in the runs to avoid excessive additional work load. 
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Table 1 
Mean values, standard deviations and coefficients of variation of the six con­
trol sera. 
control serum χ sd vc(%) N 
1 1.136 0.019 1.67 250 
2 1.491 0.024 1.61 250 
3 2.404 0.036 1.50 250 
4 1.137 0.019 1.67 250 
5 1.496 0.025 1.67 250 
6 2.420 0.037 1.53 250 
Statistieal Methods 
In the concentration range covered by the six control sera no dif­
ferences can be demonstrated between the coefficients of varia­
tion in F-tests at a = 0.01 (see Table 1). 
Therefore results of the control sera relative to their mean va­
lues (equation 1) may be compared and used in an analysis of va­
riance . 
(1) y = (ζ - ζ J/z . in which ζ is the measured value of a 
ref ref 
control serum in mmol/1 and ζ
 c
 is its reference value for which 
ref 
the mean value of 250 results was used. The relative measurements 
y are used in the model describing the process fluctuations [2]: (2) χ = x , + u δ(τ, rm + 1) + w 
3 D-i : 3 
δ ( ] , r m + 1 ) = l i f ] = r m + l and 6 ( j , rra + 1) = 0 
i f J ^ r m + 1 
(3) y = χ + ν 
3 3 3 
(4) E{v } = E{w } = 0 tí-] 
3 3 
(5) E{v v. } = σ 26(],k) 
j к ν 
(6) E{W W, } = σ 26(],k) 
J к w 
(7) E{V w, } = 0 tí],к 
3 к 
where у is the relative value of control sample ]; j = 1,2,.. 
n.m; η is the number of runs, m is the number of control sera per 
run; r = 0, 1 , 2 , ... (n-1) , u is an impulse-like disturbance m run 
r acting upon the term χ . The quantity χ , called the state 
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[2], is assumed to be constant if no such disturbance occurs, ν 
represents the measurement noise. The noise term w is called the 
system noise; it accounts for the uncertainty of the model [2]. 
Equation (2) is called the state equation; equation (3) is called 
the measurement equation. Equations (2,3) constitute a so called 
state-space description of a system in which abrupt chanqes occur 
at known instances [2]. 
A one way analysis of variance is performed using the values of 
the six control sera transformed accordinq to equation (1). If be-
tween-runs variance is significantly larger than within-run vari­
ance support is obtained for the model (2,3) . 
The algorithm used to estimate the terms χ which represent the 
between-run mstationanties is presented in equations 8-12 [2]: 
(8) X(J/J) = x(j-l/]-l) + Ktj) v(]) 
(9) v(j) = y(D) - x(]-l/]-l) 
(10a) P(]/a -1) = {- Σ, {y(]-l+i) - x(]-l/]-l}2 + a;>}6(],rra +1) 
r m i=l w 
r = 0,1/ (n-1) , a - 1, m 
r 
(10b) P( j/a -1) = {РСз-І/а -1) + а 2 } о ( з , г т + ι) 
Γ ΐ w 
ι = 2,....m; a = 2 , ... .m 
(11) Kt]) = Ρ (u/a -l)/{P(j/a -1) + σ2} 
r r ν 
(12) Р(]/а
г
) = {l-K(D)}P(j/a -1) 
where j = 1,2,....η.m 
In equation (10a) r = 0 (n-l) since P(1/0) is estimated from the 
deviation of the measurements in run 1 from χ(0/0), therefore an 
initial estimate is needed for x(0/0) but not for P(0/0). 
In each run three control sera (sera 1,2 and 3, see Table 1) are 
used to compute the estimate xij/j) . Hence m = 3. 
The estimate obtained after the third control sample in each run 
is used to correct the measurements of the remaining three samples 
in the run. So the measurements ζ of these remaining samples in 
1 
each run are not processed with the algorithm (8-12) but instead 
they are corrected according to the following equation: 
(13) z^  = z i - ZIX(]/D) 
J = r-m, r = 1, 2 , . . . . ,n 
where ζ is the measured value of a control serum ι in run r which 
ι 
has not been processed by the discrete-time filter (8-12) . For 
each of the three additional control sera the variance reduction 
obtained by correcting the measured values, is computed accor-155 
between runs 
within runs 
total 
0. 
0. 
0. 
,265 
.129 
,393 
ding to equation (14): j 
(14) VR = {l--|-}x 100% 
ση 
In (14) σ2 is the variance in the corrected results z' and 
с ι 
the variance in the non-corrected results ζ . 
Results and Discussion 
Analysis of variance of the relative values for inorganic phospha­
te of the six control sera measured in 250 runs, revealed a high­
ly significant between-runs variance component (Table 2). 
Table 2 
Analysis of var iance of the r e l a t i v e values of the s ix c o n t r o l sera . 
Source of e r r o r Sum Squares degrees of freedom Mean Squares F ρ(F) 
249 0.001063 10.3 <0.001 
1250 0.000103 
1499 0.000262 
I n t h e m o d e l d e s c r i b i n g t h e p r o c e s s f l u c t u a t i o n s ( e q u a t i o n s 2-7) 
σ
2
 a c c o u n t s f o r t h e w i t h i n - r u n v a r i a n c e a n d u f o r t h e b e t w e e n -
v D 
r u n i n s t a t i o n a r i t i e s . The a l g o r i t h m f o r t h e d e t e c t i o n of t h e s e i n -
s t a t i o n a r i t i e s i s o f a r e c u r s i v e n a t u r e . T h e r e f o r e i n i t i a l e s t i ­
m a t e s a r e n e e d e d . The i n i t i a l v a l u e s c h o s e n a r e : x(0/0)=0 a n d , i f 
i n e q u a t i o n (10a) r = l , (n-1) , P(0/0) = σ2 ; i n t h e e x a m p l e , how­
e v e r , r may t a k e t h e v a l u e s 0, (n-1) s i n c e t h e i n i t i a l e s t i m a t e 
f o r x(0/0) i s a r a t h e r good o n e , n a m e l y t h e e x p e c t e d v a l u e f o r 
X(D/D) (=0) ; t h e r e f o r e no i n i t i a l e s t i m a t e i s n e e d e d f o r P(0/0). 
σ
2
 = 1 χ 10 (= w i t h i n - r u n v a r i a n c e , s e e T a b l e 2 ) . V a l u e s f o r σ2 
V ' w 
a r e v a r i e d t o i n v e s t i g a t e i t s i n f l u e n c e on t h e v a r i a n c e r e d u c t i o n s 
o b t a i n e d . In Table 3 t h e v a r i a n c e r e d u c t i o n s achieved f o r t h e 
t h r e e c o n t r o l s e r a not p r o c e s s e d by t h e f i l t e r a l g o r i t h m a r e p r e ­
s e n t e d for v a r i o u s σ2 v a l u e s . The maximal o b t a i n a b l e v a r i a n c e r e -
w 
a u c t i o n may be e s t i m a t e d from t h e r e s u l t s of Table 2: 
σ
2 
( 1 5 ) VR = { 1 - — }x 100% 
max
 σ
7 
i n w h i c h σ 2 d e n o t e s t h e w i t h i n - r u n v a r i a n c e and σ 2 t h e t o t a l v a -
wr t 
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riance. VR is 60% for the inorganic phosphate determination max ^ f f 
of the sample. The average variance reduction obtained for the 
three control sera at a σ2 value of 1 χ 10 
w 
d u c t i o n achieved i n d i c a t e s t h a t t h e f i l t e r e s t i m a t e s fo l low t h e 
i s 49%. The l a r g e r e -
Table 3 
Variance reductions (5) obtained for sera 4, 5 and 6 at various σ2 values. 
^^ w 
σ
2 
control serum IxlO"1 lxl0~2 lxl0~3 Ixicf4 lxl0~5 Ixicf Ixicf lxl0~ 
4 
5 
6 
13.7 
36.2 
2 2 . 8 
14 .3 
36 .7 
2 3 . 3 
18 .8 
4 0 . 6 
2 7 . 3 
3 4 . 5 
5 3 . 3 
3 9 . 5 
4 3 . 8 
59.2 
43 .4 
4 4 . 8 
59.4 
4 3 . 0 
4 4 . 9 
5 9 . 4 
4 2 . 9 
4 4 . 9 
5 9 . 4 
4 2 . 9 
t h e p r o c e s s f l u c t u a t i o n s q u i t e w e l l . A t y p i c a l example of t h e e s ­
t i m a t e s and t h e p r o c e s s v a r i a t i o n s i n r e l a t i v e u n i t s i s g iven in 
F i g u r e 1. 
20 
о 
<oo 
>-i o-
Fig. 1 Relative values (·) of the six control sera in 13 runs and the estima­
tes x(3/3) produced by the f i l t e r algorithm (+). 
Exact ly the same f i l t e r i n g p r o c e d u r e was a p p l i e d t o r e s u l t s ob­
t a i n e d from t h e d e t e r m i n a t i o n of four o t h e r serum components u-
s i n g v a r i o u s i n s t r u m e n t s (see M a t e r i a l and Methods) . For t h r e e 
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routine analytical methods two control sera were used in the fil­
ter algorithm and one additional serum was used to estimate the 
variance reduction obtained. Maximal obtainable variance reduc­
tions computed according to equation (15) amounted to 27% for the 
determination of cholesterol, 74% for lactate dehydrogenase, 42% 
for creatinine and 20% for chloride. Estimated variance reduc­
tions achieved applying the filter algorithm amounted to 27%, 72%, 
29% and 12% for the determination of cholesterol, lactate dehy­
drogenase, creatinine and chloride respectively. 
Cone іивгоп'; 
A well known feature of analytical methods in clinical laborato­
ries is the presence of a significant between batch variance com­
ponent. The method for the determination of inorganic phosphate 
used in this investigation exhibits this behaviour as is eviden­
ced by the analysis of variance shown in Table 2. 
A model describing such a process forms the basis of a discrete-
time recursive filter algorithm [2] which estimates the between-
run instationanties. The estimates made by the filter appear to 
follow the process fluctuations quite well. Application of the 
filter algorithm leads to a variance reduction of about 50% of 
the original value for this determination. 
In the algorithm values of the control sera were used relative 
to their respective reference values. If, for instance, the stan­
dard deviation does not vary with concentrations, absolute values 
should be used in the computations. To apply the algorithm ini­
tial values are needed. A good estimation of σ2 may be obtained 
from the withm-run variance of the analytic system as computed 
in an analysis of variance. The value of σ2 must be determined 
w 
experimentally. For the example investigated here a value of 0.01 
χ σ
2
 or less appeared to be satisfactory (Table 3). The filter 
algorithm is applicable to analytic systems characterized by the 
presence of a significant between-run (batch) variance component. 
The larger the contribution of this variance to the total varian­
ce, as compared with the within-run variance, the larger the ob­
tainable reductions are. In the example a reduction of 50% is 
achieved. Though not presented here extensively similar results 
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w e r e o b t a i n e d f o r d e t e r m i n a t i o n s of o t h e r s e r u m c o m p o n e n t s a p p l y ­
i n g v a r y i n g a n a l y t i c a l i n s t r u m e n t a t i o n . 
An a d d i t i o n a l a d v a n t a g e of t h e a l g o r i t h m i s t h e p o s s i b i l i t y t o 
e x t e n d i t t o e s t i m a t e p o s s i b l e w i t h m - r u n d r i f t p a r a m e t e r s [ 2 ] . 
However s u c h an e x t e n s i o n w i l l p r o b a b l y b e made a t t h e e x p e n c e 
of t h e number o f p a t i e n t s e r a p e r r u n , s i n c e a d d i t i o n a l c o n t r o l 
s e r a w i l l b e n e e d e d . 
Aoknowledgement 
The a u t h o r s t h a n k M i s s M a d e l e i n e J a n s e n f o r p e r f o r m i n g many com­
p u t a t i o n s . 
References 
1. R.T.P. Jansen, P.J.M. Bonants. Variance reduct ion in a n a l y t i c a l processes 
in the c l i n i c a l laboratory by d i g i t a l f i l t e r i n g . 
Ann. Cl in. Biochem. (1962) accepted for p u b l i c a t i o n 
2. H.J.N. Poul i s se , R.T.P. Jansen. Reduction of a n a l y t i c a l variance using 
d i s c r e t e - t i m e data weighting f i l t e r i n g for es t imat ion of abrupt changes 
in batch-type processes . I Theory. 
Anal. Chim. Acta (19Θ2) Submitted for p u b l i c a t i o n 
3. H. Baadenhuysen, H.E.M. Seuren-Jacobs and A.P. Jansen. Continuous flow de-
determinat ion of serum inorganic phosphate with a s ing le reagent - the 
vanado - molybdate method re-evaluated. 
Cl in. Chem. (1977) 23, 1275-1280 
159 
CHAPTER 5 
GENERAL CONCLUSIONS AND FUTURE PERSPECTIVES 
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The major goals of this investigation have been to provide methods 
assessing laboratory performance and techniques to improve it if 
necessary. Performances within as well as between laboratories 
have been taken in consideration. 
From the results of Chanters 2, 3 and 4 it can be concluded that 
these goals have been achieved. The quality assessment program 
described in Chapter 2 forms the basis of the investigation. In 
the program both interlaboratory and intralaboratory proficiency 
can be assessed. Indications of analytical method performance can 
be obtained from it also. The accuracy of the "reference" values 
computed has been demonstrated confirming the importance and use­
fulness of consensus values. Each trial period a lyophilized con­
trol serum of different origin and/or manufacturer is used. This 
prevents habituation of technicians to results and offers the 
ability to detect matrix susceptibility of analytical methods. 
A possible solution of the problem of the extreme interlaboratory 
variance in results for serum enzymes is given in Chapter 2.2. 
The use of enzyme standards has many advantages compared to stan­
dardization of analytical technology. For example no investments 
have to be done for new equipment, the ever continuing discussion 
on the choice of reaction temperature for standardized methods 
comes to an end, and progress is not inhibited since new and bet­
ter analytical methods can be installed without delay. A problem 
to be resolved is the production of stable and homogeneous enzyme 
preparations. The influence of possible isoenzyme effects has to 
be investigated further although the results obtained for creatine 
kinase are hopefull. If use of enzyme standards is introduced, 
for some enzyme determinations (ASAT, γ-GT) standardisation of 
reagents still may be necessary. 
A large interlaboratory variance observed in the coupled external/ 
internal program for other serum analytes may be caused by inaccu­
rate methods. Such methods and methods causing other kinds of dis­
satisfying inter- and intralaboratory performance should be re­
cognized and disapproved for routine use. A technique for the ob­
jective assessment of routine analytical methods has been descri­
bed in Chapter 3. Recommendations for analytical methods for the 
determination of seven serum constituents are given using results 
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of twelve trials of the external/internal program. 
The importance of change of control serum each trial period to 
detect matrix susceptibility of methods has been demonstrated. 
Further work has to be done to assess routine analytical methods 
for the determination of these and other analytes using results of 
future trials to increase the confidence level of the recommenda-
tions. Perhaps additional features describing methods can be in-
corporated. For instance the percentage removed erroneous results 
may be separated into two or more components to discriminate be-
tween the various kinds of error. If the performance of a labora-
tory is dissatisfying because of a badly performing analytical 
method it should replace it by a better one. If the analytic pre-
cision of a laboratory is insufficient although it applies a well 
classifying method improvement of performance is hardly possible 
at present. The introduction of digital filtering procedures is 
a solution to this problem and may have far reaching consequen-
ces for analytical precision in clinical laboratories. Highly sig-
nificant variance reductions are obtained with the procedure des-
cribed in Chapter 4.1. The more sophisticated filter presented 
in Chapter 4.2 and 4.3 yields comparable results. This filter, 
however, can be adapted to less simple models describing the ana-
lytical processes. For instance, in addition to the between run 
mstationarities, within run drift parameters may be estimated 
and be accounted for. The digital filtering procedures described 
improve analytical precision applying the same equipment but uti-
lizing the information content of control materials more effi-
ciently. 
In conclusion the techniques presented in this investigation offer 
the possibility to assess the quality of clinical laboratory per-
formance and, once this is done, to control it by feedback pro-
cedures . 
Much work has yet to be done particularly in the field of funda-
mental research to statistical techniques applicable to problems 
in the clinical laboratory. The steps set in this thesis stress 
the necessity of such techniques and demonstrate the great im-
pact they may have on analytical performance. 
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Summary 
Quality control is a mam topic in clinical chemistry. Intralabo-
ratory quality control procedures govern actions to keep process 
fluctuations under control. In mterlaboratory quality assessment 
programs,results among laboratories are compared and the efficien-
cy of their internal control programs is tested. Aspects and pro-
blems associated to both type of program are discussed in Chapter 
1. The main conclusion is that analytical variability within as 
well as between laboratories need improvement. Indications are gi-
ven to effectuate such improvements. 
In Chapter 2.1 a coupled external/internal quality assessment pro-
gram which is introduced in the Netherlands by the Stichting Kwa-
liteitsbewaking Klinisch Chemische Ziekenhuislaboratoria is pre-
sented. The program offers the possibility to assess the quality 
of the internal control programs of the participants. The 'refe-
rence' values calculated are demonstrated to approximate true va-
lues very close. 'Reference' between-day standard deviations are 
computed which are influenced by neither mterlaboratory nor sys-
tematical time effects. The scoring systems used to valúate par-
ticipants means and standard deviations are described. 
The problem of extreme mterlaboratory variation in serum enzyme 
determination is attacked in Chapter 2.2. In a special trial of 
the coupled external/internal program the usefulness of enzyme 
standards is demonstrated. The assay of five serum enzymes is con-
sidered: alkaline phosphatase, creatine kinase, lactate dehydro-
genase, alanine aminotransferase and γ-glutamyl transferase, it 
is concluded that use of enzyme standards can lead to results 
which are at least comparable with values obtained when methodo­
logy is standardized. Combination of both standardization proce­
dures gives the best results. For γ-glutamyl transferase standar­
dization of the aoplied substrate is necessary. 
Solutions to the problem of dissatisfying inter- and intralabora-
tory performance are presented in Chapters 3 and 4. Significant 
mterlaboratory bias may be caused by inaccurate analytical me­
thods. Similarly, insufficient analytic precision within a labor­
atory may arise from a badly performing method. Recognition of 
such methods is therefore most important. Equally important is 
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the validation of other methods and the recognition of the best 
current method. A technique for the objective assessment of rou-
tine analytical methods is presented in Chapter 3. Vectorpoints 
describing the performance of analytical methods are obtained from 
trials of the external/internal program. Patterns recognition tech-
niques allowed detection of clusters of vectorpoints in a four 
dimensional space. The quality of the analytic performance of the 
vectorpoints in the various clusters was determined. One analyti-
cal method classifying in the qualitatively best cluster was found 
for each of six analytes (calcium, chloride, cholesterol, glucose, 
inorganic phosphate and urea). Analytical methods clustering in 
qualitatively poor clusters or not classifying were demonstrated 
for chloride, glucose, inorganic phosphate, urate and urea respec-
tively. 
Costs may prohibit replacement of a badly performing method in a 
laboratory. Conversely installation of the best current method is 
no guarantee for a satisfying performance. Moreover it is conclu-
ded in Chapter 1 that reduction in analytic variance, also in the 
better methods, no matter how slight, will be valuable. In Chap-
ter 4 digital filtering procedures are presented reducing the ana-
lytic variance within the laboratory. The filtering procedures 
are based on a model describing the analytical processes. In this 
model the process fluctuations are described as instationarv sto-
chastic. The instationarities are assumed to take olace at fixed 
time intervals, namely between two runs. Results were obtained for 
analytical methods for the determination of five analytes and four 
different analytic systems were investigated: continuous flow sys-
tems (inorganic phosphate and creatinine), centrifugal fast ana-
lyser (aspartate aminotransferase and cholesterol), automatic am-
perometric titration (chloride) and an automatic discrete system 
(lactate dehydrogenase). Highly significant variance reductions 
are obtained by a simple low-pass filtering technique as well as 
by a more sophisticated Kalman-like filter described. The major 
advantage of the latter is the possibility to extend it to more 
complicated models describing the analytic processes including for 
example possible within run drift parameters. The introduction of 
digital filtering procedures in the clinical laboratory is advo-
cated. 
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Samenvat ting 
Kwaliteitsbewaking is een belangrijk onderdeel van de klinische 
chemie. Er worden in het algemeen twee soorten kwaliteitscontro-
le onderscheiden, namelijk intra- en interlaboratoriële. Met be-
hulp van intralaboratonële kwaliteitsbewaking controleren labo-
ratoria de fluctuaties van de analytische processen en fiatteren 
op gelelde hiervan metingen aan patiënten monsters. In interlabo-
ratoriële kwaliteitsbewakingsprogramma's worden resultaten,ver-
kregen m verschillende laboratoria, met elkaar vergeleken en 
wordt de kwaliteit van de interne bewaking van de deelnemers ge-
toetst. In hoofdstuk 1 worden aspecten en problemen verbonden 
aan beide soorten orogramma's besproken. De belangrijkste conclu-
sie is dat de analytische variabiliteit zowel binnen als tussen 
laboratoria verkleind dient te worden. 
In hoofdstuk 2 wordt een gekoppeld extern/intern kwaliteitsbewa-
kingsprogramma gepresenteerd dat in Nederland geïntroduceerd is 
door de Stichting Kwaliteitsbewaking Klinisch Chemische Zieken-
huislaboratoria. Dit programma biedt de mogelijkheid de interne 
kwaliteitsbewakingsprocedures op hun effectiviteit te toetsen. De 
'referentie' waarden, die in het programma berekend worden blij-
ken zeer goede benaderingen te zijn van waarden verkregen met zo-
genaamde definitieve en referentie methoden. Ook worden 'referen-
tie' tussen-dag standaarddeviaties berekend die niet beïnvloed 
worden door tussen-laboratona en systematische tijdseffecten. Er 
worden scores toegekend aan de laboratorium gemiddelden en stan-
daarddeviaties op grond van de 'referentie' waarden en standaard-
deviaties . 
Een mogelijke oplossing voor het probleem van de extreem grote in-
terlaboratoria variatie bij enzymbepalingen in serum staat be-
schreven in hoofdstuk 2.2. De bruikbaarheid van enzymstandaarden 
voor het verkleinen van deze variatie is aangetoond in een bij-
zondere enquête van het externe/interne programma. De bepaling van 
vijf veel aangevraagde enzymen werd onderzocht: alkalische fosfa-
tase, creatine kinase, lactaat dehydrogenase, alanine aminotrans-
ferase en γ-glutamyltransferase. Geconcludeerd wordt dat het ge­
bruik van enzymstandaarden kan leiden tot resultaten, die tenmin­
ste vergelijkbaar zijn met waarden die verkregen worden wanneer 
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met een gestandaardiseerde methode gewerkt wordt. Combinatie van 
deze twee technieken geeft de beste resultaten. Standaardisatie 
van het substraat is noodzakelijk voor γ-glutamyltransferase. 
In hoofdstukken 3 en 4 worden technieken gepresenteerd voor het 
vinden en wegnemen van oorzaken van onvoldoende inter- en intra-
laboratonële prestaties. Significante systematische tussen-labo-
ratoria verschillen kunnen veroorzaakt worden door inaccurate ana-
lyse methodieken. Evenzo kan een slechte analytische precisie van 
een laboratorium veroorzaakt worden door de gebruikte methodiek. 
Het herkennen van zulke bepalingstechnieken is dus van groot be-
lang. Even belangrijk is het geven van een kwaliteitsoordeel over 
andere analysetechnieken en vaststelling van de momenteel beste 
methodes die routinematig gebruikt kunnen worden. Een techniek, 
die een objectieve beoordeling van analyse methodes mogelijk 
maakt, staat beschreven in hoofdstuk 3. Met behulp van vier be-
schrijvende parameters verkregen uit enquêtes van het externe/in-
terne programma worden vectorpunten geconstrueerd die het gedrag 
van analyse methodes karakteriseren. Clusters van vectorpunten 
werden gevonden met behulp van patroonherkenningstechnieken. De 
analytische kwaliteit van de vectorpunten in de verschillende 
clusters werd bepaald. Voor zes van de zeven onderzochte serumcom-
ponenten kon één methode aangegeven worden die zich klassificeer-
de in de kwalitatief beste cluster, namelijk voor calcium, chlo-
ride, cholesterol, glucose, anorganisch fosfaat en ureum. Voor 
chloride, glucose, anorganisch fosfaat, uraat en ureum konden me-
thodes aangeduid worden die clusterden in kwalitatief slechte klas-
sen of helemaal niet clusterden. 
Een slecht funktionerende methode kan niet altijd vervangen wor-
den door een betere bijvoorbeeld vanwege de daaraan verbonden kos-
ten. Omgekeerd is het in gebruik nemen van de beste methode nog 
geen garantie voor een goed resultaat. Bovendien is zelfs de klein-
ste reductie van de analytische variantie, ook voor de betere me-
thodieken, waardevol, zoals in hoofdstuk 1 geconcludeerd wordt. 
Digitale filtering procedures, die de analytische variantie re-
duceren staan beschreven in hoofdstuk 4. In deze procedures wordt 
uitgegaan van een model dat de analytische processen beschrijft 
als mstationair stochastische processen. Er wordt verondersteld 
dat de mstationariteiten plaats vinden op vaste tijdstippen, 
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namelijk tussen de runs. Er werden resultaten verkregen voor ana-
lyse methodes voor vijf serum componenten waarbij vier verschil-
lende analytische systemen onderzocht zijn: continuous flow sys-
temen (anorganisch fosfaat en kreatinine), centrifugal fast ana-
lyzer (aspartaat aminotransferase en cholesterol), een automati-
sche amperometrische titratie (chloride) en een automatisch dis-
creet systeem (lactaat dehydrogenase). Zeer significante varian-
tie reducties werden verkregen zowel met een eenvoudig exponen-
tieel middelmgs filter, als ook met een ingewikkelder Kalman-ach-
tige filter. Het belangrijkste voordeel van het laatste filter is 
de mogelijkheid het uit te breiden voor meer gecompliceerde model-
len om de processen te beschrijven, bijvoorbeeld met al dan m e t 
aanwezige binnen-run drift parameters. Het gebruik van digitale 
filter procedures m het klinisch chemisch laboratorium wordt aan-
gemoedigd. 
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STELLINGEN 
1 
Bi] het vaststellen van het normale referentie-interval voor bloed 
glucose waarden, houden Morgenstern en Shearn ten onrechte geen 
rekening met het ббгкотеп van te lage bloed glucose waarden in 
de door hen onderzochte populatie. 
N.L. Morgenstern and M.A. Shearn. Ara. J. Clin 
Pathol. 76 (1981) 211-213 
2 
Commercieel verkrijgbare kits voor de enzymatische bepaling van 
cholesterol, welke bacterieel esterase bevatten, geven slechts 
accurate waarden, wanneer speciale lipolyse condities worden aan­
gewend om de cholesterol esters uit de "core" van de lipoproteïnen 
vrij te maken. 
P.N.M. Demacker, G.J.M. Boerma, R.J. van Strik, 
B. Leijnse, A.P. Jansen. Submitted for publication 
to Clin. Chem. 
3 
Voor de identificatie van auto-antilichamen gericht tegen kernanti-
genen bij humane niet-orgaanspecifieke auto-immuunziekten, is het 
gebruik van het zogenaamde ENA (extractable nuclear antigen)-ex-
tract minder geschikt. 
N. Kurata, E.M. Tan. Arthr. Rheum. J_9 (1976) 
574-580 
4 
Vanwege h e t g e l i j k t i j d i g voorkomen van absorpt iemaxima b i j 406 nm 
en 695 nm in h e t spectrum van een n i e t c o v a l e n t gebonden complex 
van twee cy tochroom-c- f ragmenten , l i j k t de door Schech t e r en 
Saludjiam v o o r g e s t e l d e l i g a n d e r i n g van h e t cytochroom-c i j z e r a t o o m 
door twee s t i k s t o f a t o m e n , behorende b i j een a b s o r p t i e van 406 nm 
in he t spectrum van f e r r i - c y t o c h r o o m - c , n i e t j u i s t . 
E. Schechter and P. Salud]lam. Biopolymers 5 
(1967) 788 ~ 
L. Westerhuis, G.I . Tesser , R . J .F . Nivard. 
I n t . J . Pept ide Prote in Res. 19 (1982) 290 
5 
Bi] de bepaling van serum cholesterol in epidemiologische onder­
zoeken, dienen deelnemende laboratoria gebruik te maken van serum­
standaarden met toegekende waarden. 
R.E. Wenk. Amer. J. Clin. Path. 5^5 (1971) 311-317 
б 
Het gebruik van consensus waarden als doelwaarden in kwaliteits-
bewakingsprogramma's is te prefereren boven het wachten op de 
komst van zogenaamde definitieve methodes voor het bepalen hier­
van. 
J.F. Pickup et al. Clm. Chera. 21_ (1975) 1416-1421 
R.K. Gilbert Amer. J. Clin. Path. 70 (1978) 450-
470 
7 
Het toepassen van digitale filtering technieken ter reductie van 
de analytische vanantie in laboratoria, die gebruik maken van 
analytisch chemische methoden, dient aanbevolen te worden. 
Dit proefschrift 
8 
Het is onjuist een controle serum zowel voor externe alsook voor 
interne kwaliteitsbewaking te gebruiken. 
9 
Een kenmerk van de ware stadsorgelman is, dat hi] de centenbak 
juist uit het ritme van zijn muziek schudt. 
10 
De kracht van de Nederlandse lente doet welhaast necrotische 
wintertenen ieder jaar weer prachtig rose opbloeien. 
Persoonli]ke ervaring 
R.T.P. Jansen 
Nijmegen, 12 november 1982 
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